Frederik Barkhof
#64,380
Most Influential Person Now
Researcher
Frederik Barkhof's AcademicInfluence.com Rankings
Frederik Barkhofcomputer-science Degrees
Computer Science
#2116
World Rank
#2198
Historical Rank
Programming
#29
World Rank
#31
Historical Rank
Computer Graphics
#36
World Rank
#38
Historical Rank
Download Badge
Computer Science
Why Is Frederik Barkhof Influential?
(Suggest an Edit or Addition)Frederik Barkhof's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Consistent resting-state networks across healthy subjects (2006) (4042)
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria (2017) (3544)
- Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) (3466)
- Defining the clinical course of multiple sclerosis (2014) (2372)
- Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. (2010) (2040)
- A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT (2001) (1575)
- Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. (1992) (1449)
- Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. (1997) (1280)
- Reduced resting-state brain activity in the "default network" in normal aging. (2008) (1099)
- Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study (2001) (1072)
- A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging (1993) (896)
- Cortical lesions in multiple sclerosis. (1999) (827)
- Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. (2006) (798)
- Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: An fMRI study (2005) (743)
- Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability (1999) (731)
- Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2 (1996) (724)
- The clinico‐radiological paradox in multiple sclerosis revisited (2002) (646)
- Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis (1998) (645)
- Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. (2002) (632)
- MRI CRITERIA FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS: MAGNIMS CONSENSUS GUIDELINES (2016) (631)
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial (2011) (625)
- Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations (2010) (596)
- Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes (2006) (576)
- PRISMS-4: Long-term efficacy of interferon-&bgr;-1a in relapsing MS (2001) (567)
- Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease (2004) (556)
- Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis (2005) (555)
- Loss of ‘Small-World’ Networks in Alzheimer's Disease: Graph Analysis of fMRI Resting-State Functional Connectivity (2010) (540)
- Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study (2007) (503)
- Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. (2005) (494)
- Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis (1999) (484)
- Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. (2015) (476)
- Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial (2008) (475)
- Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis (1996) (471)
- Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (2009) (464)
- Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis (1996) (464)
- Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. (2005) (442)
- A comprehensive study of gray matter loss in patients with Alzheimer’s disease using optimized voxel-based morphometry (2003) (432)
- Vitamin D as an early predictor of multiple sclerosis activity and progression. (2014) (428)
- Association between pathological and MRI findings in multiple sclerosis (2012) (418)
- Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers (2017) (414)
- Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. (1991) (396)
- Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. (1998) (392)
- Cortico‐hippocampal communication by way of parallel parahippocampal‐subicular pathways (2000) (391)
- Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. (2005) (385)
- Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort (2009) (384)
- Diagnostic criteria for primary progressive multiple sclerosis: A position paper (2000) (383)
- Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. (1996) (376)
- Imaging outcomes for neuroprotection and repair in multiple sclerosis trials (2009) (373)
- The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features. (2015) (370)
- Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial (2009) (368)
- Regional DTI differences in multiple sclerosis patients (2009) (367)
- Progression of White Matter Hyperintensities and Incidence of New Lacunes Over a 3-Year Period: The Leukoaraiosis and Disability Study (2008) (360)
- Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion (2002) (358)
- Alzheimer's disease: connecting findings from graph theoretical studies of brain networks (2013) (352)
- Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliability (1995) (349)
- Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging (1995) (349)
- Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. (2012) (347)
- Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process (2015) (346)
- MRI in multiple sclerosis: current status and future prospects (2008) (342)
- Grey matter pathology in multiple sclerosis (2008) (342)
- Hippocampal atrophy rates in Alzheimer disease (2009) (342)
- MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study (2007) (334)
- Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairment (2012) (333)
- Optimizing patient care and research: the Amsterdam Dementia Cohort. (2014) (325)
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease (2017) (322)
- Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. (2003) (320)
- Correlating MRI and clinical disease activity in multiple sclerosis (1995) (314)
- Arterial Spin Labeling Perfusion of the Brain: Emerging Clinical Applications. (2016) (307)
- Impact of White Matter Hyperintensities Scoring Method on Correlations With Clinical Data: The LADIS Study (2006) (302)
- Correlations between changes in disability and T2‐weighted brain MRI activity in multiple sclerosis (1995) (299)
- Spinal cord abnormalities in recently diagnosed MS patients (2004) (299)
- Visual assessment of posterior atrophy development of a MRI rating scale (2011) (296)
- Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes (2010) (295)
- Visual Rating of Age-Related White Matter Changes on Magnetic Resonance Imaging: Scale Comparison, Interrater Agreement, and Correlations With Quantitative Measurements (2003) (291)
- Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines. (2006) (290)
- The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis (1999) (287)
- White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. (1992) (286)
- White Matter Changes on CT and MRI: An Overview of Visual Rating Scales (1998) (283)
- Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. (1998) (282)
- Extensive Hippocampal Demyelination in Multiple Sclerosis (2007) (281)
- Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. (1993) (278)
- Standardized evaluation of algorithms for computer-aided diagnosis of dementia based on structural MRI: The CADDementia challenge (2015) (277)
- The clinical profile of right temporal lobe atrophy. (2004) (274)
- Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. (2001) (273)
- Resting-state functional MR imaging: a new window to the brain. (2014) (273)
- Precuneus atrophy in early-onset Alzheimer’s disease: a morphometric structural MRI study (2007) (271)
- Decreased interleukin‐10 and increased interleukin‐12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis (1999) (270)
- Brain atrophy and lesion load predict long term disability in multiple sclerosis (2013) (265)
- Small Vessel Disease and General Cognitive Function in Nondisabled Elderly: The LADIS Study (2005) (259)
- Deep gray matter volume loss drives disability worsening in multiple sclerosis (2017) (257)
- MRI criteria for MS in patients with clinically isolated syndromes (2010) (256)
- Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial (2004) (253)
- White matter tract integrity in aging and Alzheimer's disease (2009) (252)
- Frontostriatal system in planning complexity: a parametric functional magnetic resonance version of tower of london task (2003) (250)
- Accumulation of cortical lesions in MS: relation with cognitive impairment (2009) (247)
- CT and MRI Rating of White Matter Lesions (2002) (246)
- MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation” (2006) (245)
- Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines (2019) (241)
- Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. (2008) (238)
- Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: Results of a randomized, double-blind, placebo-controlled MR-monitored phase II trial (1997) (237)
- Treatment with laquinimod reduces development of active MRI lesions in relapsing MS (2005) (237)
- Magnetic resonance imaging pattern recognition in hypomyelinating disorders. (2010) (236)
- GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans (2014) (232)
- Functional MR imaging in Alzheimer's disease during memory encoding. (2000) (229)
- Resting state networks change in clinically isolated syndrome. (2010) (227)
- Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study (2011) (224)
- fMRI of visual encoding: Reproducibility of activation (1999) (224)
- Noradrenaline mediates amygdala activation in men and women during encoding of emotional material (2005) (220)
- Postmortem verification of MS cortical lesion detection with 3D DIR (2012) (219)
- Progression of regional grey matter atrophy in multiple sclerosis (2017) (217)
- Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. (2007) (216)
- Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. (2013) (214)
- Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant. (2016) (210)
- MR venography of multiple sclerosis. (2000) (210)
- Patterns of Cerebral Atrophy in Dementia with Lewy Bodies Using Voxel-Based Morphometry (2002) (207)
- The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis. (2000) (203)
- MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS) (1999) (202)
- Patients With Alzheimer Disease With Multiple Microbleeds: Relation With Cerebrospinal Fluid Biomarkers and Cognition (2009) (199)
- Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs)☆ (2013) (197)
- Neuronal damage in T1‐hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy (1999) (196)
- Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial (2012) (194)
- MRI T2 lesion burden in multiple sclerosis (2006) (193)
- Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging (2014) (193)
- Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images (2015) (193)
- CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment (2007) (193)
- Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer’s disease (2011) (191)
- Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI (2011) (189)
- Measuring progression of cerebral white matter lesions on MRI (2004) (188)
- The significance of medial temporal lobe atrophy (2007) (186)
- PML in a patient treated with dimethyl fumarate from a compounding pharmacy. (2013) (183)
- Longitudinal Cognitive Decline in Subcortical Ischemic Vascular Disease – The LADIS Study (2009) (182)
- The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity (2015) (182)
- Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. (2008) (182)
- A new leukoencephalopathy with brainstem and spinal cord involvement and high lactate (2003) (182)
- Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability (2011) (180)
- Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer’s disease (2005) (179)
- Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. (1995) (179)
- Combining shape and connectivity analysis: An MRI study of thalamic degeneration in Alzheimer's disease (2010) (178)
- Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial (2013) (178)
- Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. (2002) (176)
- Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease (2013) (176)
- Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease (2015) (175)
- Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging. (1997) (175)
- Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. (2006) (174)
- Imaging markers for Alzheimer disease (2013) (174)
- Endogenous cortisol level interacts with noradrenergic activation in the human amygdala (2007) (171)
- MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases (2016) (170)
- Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis (1998) (170)
- Within-subject reproducibility of visual activation patterns with functional magnetic resonance imaging using multislice echo planar imaging. (1998) (170)
- Blood–brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis (2005) (166)
- Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy (2006) (166)
- Correlations between monthly enhanced MRI Lesion rate and changes in T2 Lesion volume in multiple sclerosis (1998) (166)
- Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. (1992) (165)
- Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype. (2002) (165)
- Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias (2020) (163)
- Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. (2009) (162)
- Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography. (1999) (162)
- Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype. (2001) (161)
- Fatigue in multiple sclerosis: Interrelations between fatigue complaints, cerebral MRI abnormalities and neurological disability (1998) (160)
- Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla (2010) (160)
- Amnestic Mild Cognitive Impairment: Structural MR Imaging Findings Predictive of Conversion to Alzheimer Disease (2008) (160)
- Pattern of white matter abnormalities at MR imaging: use of polymerase chain reaction testing of Guthrie cards to link pattern with congenital cytomegalovirus infection. (2004) (159)
- Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease (2000) (159)
- Different patterns of gray matter atrophy in early- and late-onset Alzheimer’s disease (2013) (159)
- Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis (2015) (159)
- Altered diffusion tensor in multiple sclerosis normal‐appearing brain tissue: Cortical diffusion changes seem related to clinical deterioration (2006) (158)
- Standardized Assessment of Automatic Segmentation of White Matter Hyperintensities and Results of the WMH Segmentation Challenge (2019) (155)
- Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. (2007) (155)
- Cerebral Microbleeds: Imaging and Clinical Significance. (2018) (152)
- Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer’s disease (2002) (152)
- Operational Definitions for the NINDS-AIREN Criteria for Vascular Dementia: An Interobserver Study (2003) (151)
- Model‐free group analysis shows altered BOLD FMRI networks in dementia (2009) (151)
- Quantitative MRI changes in gadolinium‐DTPA enhancement after high‐dose intravenous methylprednisolone in multiple sclerosis (1991) (150)
- Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis (2012) (149)
- Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. (2000) (149)
- 24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial (2017) (148)
- POSTWITHDRAWAL REBOUND INCREASE IN T2 LESIONAL ACTIVITY IN NATALIZUMAB-TREATED MS PATIENTS (2008) (146)
- A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. (2009) (145)
- Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management (2005) (143)
- Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers. (2014) (143)
- Microglial activation in healthy aging (2012) (143)
- Microglial activation in Alzheimer's disease: an (R)-[11C]PK11195 positron emission tomography study (2013) (142)
- Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET (2012) (142)
- Lack of association between antimyelin antibodies and progression to multiple sclerosis. (2007) (141)
- Normal gyration and sulcation in preterm and term neonates: appearance on MR images. (1996) (141)
- Injury markers predict time to dementia in subjects with MCI and amyloid pathology (2012) (141)
- The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results. (2004) (141)
- Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients. (2008) (141)
- MR spectroscopic evidence for glial increase but not for neuro‐axonal damage in MS normal‐appearing white matter (2005) (140)
- Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis (2005) (140)
- Incident lacunes influence cognitive decline (2011) (139)
- Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease (2005) (139)
- White matter lesion progression (2004) (138)
- Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients. (2013) (138)
- Optimizing the association between disability and biological markers in MS (2001) (138)
- Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study (2015) (138)
- Spinal cord lesions in patients with clinically isolated syndrome (2013) (137)
- Diagnostic algorithm for relapsing acquired demyelinating syndromes in children (2017) (136)
- Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions (2002) (136)
- Neonatal porencephaly and adult stroke related to mutations in collagen IV A1 (2006) (135)
- Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon β1a (2003) (135)
- Resting‐state networks in awake five‐ to eight‐year old children (2012) (135)
- Test-retest analysis with functional MR of the activated area in the human visual cortex. (1997) (135)
- Detection of Alzheimer Pathology In Vivo Using Both 11C-PIB and 18F-FDDNP PET (2009) (134)
- Ibudilast in relapsing-remitting multiple sclerosis (2010) (134)
- The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study (2002) (134)
- No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study (2010) (134)
- Automated segmentation of multiple sclerosis lesion subtypes with multichannel MRI (2006) (134)
- Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT. (2009) (133)
- MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study (2006) (132)
- MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis (2006) (131)
- Progression of Mild Cognitive Impairment to Dementia: Contribution of Cerebrovascular Disease Compared With Medial Temporal Lobe Atrophy (2009) (131)
- Hippocampal atrophy in Alzheimer disease: Age matters (2006) (130)
- Neuroplasticity and functional recovery in multiple sclerosis (2012) (129)
- Brain atrophy accelerates cognitive decline in cerebral small vessel disease (2012) (129)
- Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study (2006) (128)
- Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study. (2016) (128)
- Visualizing brain activation during planning: the tower of London test adapted for functional MR imaging. (2000) (128)
- Clinical Relevance of Improved Microbleed Detection by Susceptibility-Weighted Magnetic Resonance Imaging (2011) (127)
- Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume (2007) (127)
- Functional connectivity and cognitive decline over 3 years in Parkinson disease (2014) (127)
- Primary and transitional progressive MS (1999) (126)
- Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. (2014) (126)
- Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033 (2014) (125)
- P2-313 Prevalence and severity of microbleeds in a memory clinic setting (2006) (125)
- Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis. (2001) (124)
- Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis (1994) (124)
- Unusual variants of Alexander's disease (2005) (123)
- White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. (1998) (123)
- Differential diagnosis of neurodegenerative diseases using structural MRI data (2016) (121)
- Visual association encoding activates the medial temporal lobe: A functional magnetic resonance imaging study (1997) (121)
- Subcortical atrophy and cognition (2012) (119)
- Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis (2015) (119)
- White matter lesions and hippocampal atrophy in Alzheimer’s disease (2004) (118)
- CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis (2004) (118)
- Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis (2014) (118)
- MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. (1997) (117)
- Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease (2021) (117)
- Hippocampal volume change measurement: Quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST (2014) (117)
- Functional brain network analysis using minimum spanning trees in Multiple Sclerosis: An MEG source-space study (2014) (117)
- Resting-State Brain Networks in Type 1 Diabetic Patients With and Without Microangiopathy and Their Relation to Cognitive Functions and Disease Variables (2012) (117)
- Structural and functional hippocampal changes in multiple sclerosis patients with intact memory function. (2010) (117)
- Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study (2009) (117)
- The role of MRI as a surrogate outcome measure in multiple sclerosis (2002) (117)
- Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Disease (2022) (116)
- Chronic cerebrospinal venous insufficiency and multiple sclerosis (2010) (115)
- Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study (2018) (115)
- CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease (2008) (114)
- Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis (2013) (114)
- Nonconventional MRI and microstructural cerebral changes in multiple sclerosis (2015) (113)
- A correlative triad of gadolinium‐DTPA MRI, EDSS, and CSF‐MBP in relapsing multiple sclerosis patients treated with high‐dose intravenous methylprednisolone (1992) (113)
- MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice (2020) (113)
- Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease (2009) (113)
- Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement. (2012) (112)
- Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance. (1999) (112)
- Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study. (2006) (112)
- Functional connectivity changes in multiple sclerosis patients: A graph analytical study of MEG resting state data (2013) (112)
- Visual Rating Scales for Age-Related White Matter Changes (Leukoaraiosis): Can the Heterogeneity Be Reduced? (2002) (111)
- Structural degree predicts functional network connectivity: A multimodal resting-state fMRI and MEG study (2014) (111)
- EFNS task force: the use of neuroimaging in the diagnosis of dementia (2012) (111)
- MRI Biomarkers of Vascular Damage and Atrophy Predicting Mortality in a Memory Clinic Population (2009) (111)
- Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes. (2008) (111)
- The functional basis of ocular dominance: functional MRI (fMRI) findings (1996) (110)
- 2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis (2021) (110)
- Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis (2012) (110)
- Cognitive impairment in MS (2013) (109)
- Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study (2005) (109)
- Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis (2011) (108)
- Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis (1997) (108)
- Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia (2008) (108)
- Predicting progression in primary progressive multiple sclerosis: A 10‐year multicenter study (2008) (107)
- One year follow up study of primary and transitional progressive multiple sclerosis (2000) (107)
- The current role of MRI in differentiating multiple sclerosis from its imaging mimics (2018) (107)
- Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales (2015) (106)
- Multi-contrast, isotropic, single-slab 3D MR imaging in multiple sclerosis (2008) (105)
- Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study (2004) (104)
- Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting (2018) (104)
- Accelerated aging, decreased white matter integrity, and associated neuropsychological dysfunction 25 years after pediatric lymphoid malignancies. (2013) (104)
- Inflammatory biomarkers in Alzheimer's disease plasma (2019) (104)
- Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: A longitudinal study (2010) (104)
- The limits of functional reorganization in multiple sclerosis (2010) (103)
- Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis (2014) (103)
- An algorithmic approach to structural imaging in dementia (2013) (103)
- Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration (2014) (103)
- Diffusion-Weighted Imaging and Cognition in the Leukoariosis and Disability in the Elderly Study (2010) (102)
- Arterial spin labeling may contribute to the prediction of cognitive deterioration in healthy elderly individuals. (2015) (102)
- Retinoblastoma: MR imaging parameters in detection of tumor extent. (2005) (101)
- T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment. (2001) (101)
- Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial (2011) (100)
- Whole-brain atrophy rate in Alzheimer disease (2008) (100)
- Single-Subject Grey Matter Graphs in Alzheimer's Disease (2013) (100)
- Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: Statistical power of parallel-groups and crossover designs (1994) (99)
- The Contribution of Medial Temporal Lobe Atrophy and Vascular Pathology to Cognitive Impairment in Vascular Dementia (2007) (99)
- Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study (2007) (99)
- Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis (1992) (99)
- Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: the LADIS Study (2006) (98)
- Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study (2017) (98)
- Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia (2013) (98)
- Fast Eigenvector Centrality Mapping of Voxel-Wise Connectivity in Functional Magnetic Resonance Imaging: Implementation, Validation, and Interpretation (2012) (98)
- Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis (2019) (97)
- Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis (2009) (97)
- TADPOLE Challenge: Prediction of Longitudinal Evolution in Alzheimer's Disease. (2018) (97)
- The 11-year long-term follow-up study from the randomized BENEFIT CIS trial (2016) (97)
- MRI monitoring of pathological changes in the spinal cord in patients with multiple sclerosis (2015) (97)
- Phase-Contrast Cine Mr Imaging of Normal Aqueductal CSF Flow (1994) (96)
- Multiple sclerosis (2003) (96)
- Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease (2015) (96)
- White Matter Lesion Progression in LADIS: Frequency, Clinical Effects, and Sample Size Calculations (2012) (94)
- MRI-Defined Subcortical Ischemic Vascular Disease: Baseline Clinical and Neuropsychological Findings (2009) (94)
- Alexander disease (2006) (94)
- Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI (2012) (93)
- Differential effects of cognitive reserve and brain reserve on cognition in Alzheimer disease (2018) (93)
- Spinal-cord MRI in multiple sclerosis (2003) (93)
- Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project (2018) (93)
- Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR (2000) (93)
- Loss of frontal fMRI activation in early frontotemporal dementia compared to early AD (2003) (93)
- Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment (2007) (92)
- Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions (2018) (92)
- Cerebral perfusion in the predementia stages of Alzheimer’s disease (2015) (92)
- MRI assessment of iron deposition in multiple sclerosis (2011) (91)
- Leukoaraiosis Predicts Hidden Global Functioning Impairment in Nondisabled Older People: The LADIS (Leukoaraiosis and Disability in the Elderly) Study (2006) (91)
- What drives MRI-measured cortical atrophy in multiple sclerosis? (2015) (91)
- Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer’s disease (2016) (90)
- In vivo MR imaging of hippocampal lesions in multiple sclerosis (2008) (90)
- Brain network alterations in Alzheimer's disease measured by Eigenvector centrality in fMRI are related to cognition and CSF biomarkers (2014) (90)
- High field MRI in the diagnosis of multiple sclerosis: high field–high yield? (2009) (90)
- Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology (2020) (90)
- Reliability and Sensitivity of Visual Scales versus Volumetry for Evaluating White Matter Hyperintensity Progression (2008) (89)
- Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla (2014) (88)
- The identification of cognitive subtypes in Alzheimer's disease dementia using latent class analysis (2015) (88)
- Accelerating regional atrophy rates in the progression from normal aging to Alzheimer’s disease (2009) (88)
- Identifying confounds to increase specificity during a “no task condition” Evidence for hippocampal connectivity using fMRI (2003) (88)
- Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study (2008) (87)
- Predicting Prodromal Alzheimer's Disease in Subjects with Mild Cognitive Impairment Using Machine Learning Classification of Multimodal Multicenter Diffusion‐Tensor and Magnetic Resonance Imaging Data (2015) (87)
- A paced visual serial addition test for fMRI (2003) (87)
- The pedunculopontine nucleus is related to visual hallucinations in Parkinson’s disease: preliminary results of a voxel-based morphometry study (2011) (87)
- Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials (1999) (87)
- Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment (2013) (86)
- Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis. (2006) (86)
- The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy (2013) (86)
- Incidence of cerebral microbleeds (2010) (86)
- A multicenter measurement of magnetization transfer ratio in normal white matter (1999) (85)
- On the Etiology of Incident Brain Lacunes: Longitudinal Observations From the LADIS Study (2008) (85)
- Imaging of White Matter Lesions (2002) (85)
- Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's disease (2017) (85)
- Regional White Matter Integrity Differentiates Between Vascular Dementia and Alzheimer Disease (2009) (85)
- Gender-related differences in functional connectivity in multiple sclerosis (2012) (85)
- Mild cognitive impairment with suspected nonamyloid pathology (SNAP) (2015) (85)
- Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease (2012) (84)
- Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT (2013) (84)
- Concurrent validity of the MS Functional Composite using MRI as a biological disease marker (2001) (84)
- Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis. (1999) (84)
- Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi‐centre fMRI study (2008) (83)
- Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis. (2006) (83)
- Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS (2013) (83)
- Human gray matter: feasibility of single-slab 3D double inversion-recovery high-spatial-resolution MR imaging. (2006) (83)
- Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis (1998) (83)
- Childhood white matter disorders: quantitative MR imaging and spectroscopy. (2006) (83)
- Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis. (2019) (83)
- Functional brain networks: Linking thalamic atrophy to clinical disability in multiple sclerosis, a multimodal fMRI and MEG Study (2014) (82)
- Interscanner variation in brain MRI lesion load measurements in MS: Implications for clinical trials (1997) (82)
- Functional segmentation of the hippocampus in the healthy human brain and in Alzheimer's disease (2013) (82)
- Interobserver variability in the radiological assessment of response to chemotherapy in glioma (2003) (82)
- The effect of interferon β-1b on quantities derived from MT MRI in secondary progressive MS (2003) (82)
- Quantitative 1H‐MRS of healthy human cortex, hippocampus, and thalamus: Metabolite concentrations, quantification precision, and reproducibility (2004) (82)
- Increased cortical atrophy in patients with Alzheimer’s disease and type 2 diabetes mellitus (2005) (81)
- Structural MRI correlates of cognitive impairment in patients with multiple sclerosis (2014) (81)
- Global Burden of Small Vessel Disease–Related Brain Changes on MRI Predicts Cognitive and Functional Decline (2019) (81)
- Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders (2019) (81)
- MS Functional Composite (2000) (80)
- Management of obstetric brachial plexus lesions: state of the art and future developments (2000) (80)
- EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis (2006) (80)
- Brain reward‐system activation in response to anticipation and consumption of palatable food is altered by glucagon‐like peptide‐1 receptor activation in humans (2015) (80)
- Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy (2001) (80)
- Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study (2016) (79)
- Cerebral perfusion and glucose metabolism in Alzheimer’s disease and frontotemporal dementia: two sides of the same coin? (2015) (79)
- Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results (2018) (79)
- The hippocampus in multiple sclerosis (2018) (79)
- Anterior Medial Temporal Lobe Activation during Attempted Retrieval of Encoded Visuospatial Scenes: An Event-Related fMRI Study (2001) (79)
- Lesion detection at seven Tesla in multiple sclerosis using magnetisation prepared 3D-FLAIR and 3D-DIR (2011) (78)
- Cognitive and Clinical Dysfunction, Altered MEG Resting-State Networks and Thalamic Atrophy in Multiple Sclerosis (2013) (78)
- Randomized trial of daily high-dose vitamin D3 in patients with RRMS receiving subcutaneous interferon β-1a (2019) (78)
- Alzheimer Disease and Behavioral Variant Frontotemporal Dementia: Automatic Classification Based on Cortical Atrophy for Single-Subject Diagnosis. (2016) (78)
- Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics (2015) (78)
- Disruption of structural and functional networks in long‐standing multiple sclerosis (2014) (78)
- Altered cerebrovascular reactivity velocity in mild cognitive impairment and Alzheimer's disease (2015) (78)
- Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging (2009) (77)
- Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease. (2012) (77)
- What explains gray matter atrophy in long-standing multiple sclerosis? (2014) (77)
- Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI Study (2014) (77)
- Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old (2010) (77)
- Prevalence of cortical superficial siderosis in a memory clinic population (2014) (76)
- Functional adaptive changes within the hippocampal memory system of patients with multiple sclerosis (2012) (76)
- The spatial distribution of age-related white matter changes as a function of vascular risk factors—Results from the LADIS study (2012) (76)
- Clinical correlations of brain lesion distribution in multiple sclerosis (2009) (76)
- Intercenter differences in diffusion tensor MRI acquisition (2010) (75)
- MRI pattern in asymptomatic natalizumab-associated PML (2014) (75)
- MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain (2007) (75)
- A three-year, multi-parametric MRI study in patients at presentation with CIS (2008) (75)
- Changes in brain electrical activity during extended continuous word recognition (2005) (75)
- Early central atrophy rate predicts 5 year clinical outcome in multiple sclerosis (2010) (75)
- Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum (2019) (74)
- Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b (2008) (74)
- Atrophy subtypes in prodromal Alzheimer’s disease are associated with cognitive decline (2018) (74)
- The current role of MRI in differentiating multiple sclerosis from its imaging mimics (2018) (74)
- Visual analysis of serial T2-weighted MRI in multiple sclerosis: intra- and interobserver reproducibility (1999) (74)
- Visual activation patterns in patients with optic neuritis (1998) (74)
- Does high-field MR imaging improve cortical lesion detection in multiple sclerosis? (2008) (73)
- Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease (2009) (73)
- Magnetic resonance imaging predictors of cognition in mild cognitive impairment. (2007) (73)
- Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial (2020) (73)
- Histopathologic correlates of radial stripes on MR images in lysosomal storage disorders. (2005) (73)
- Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study. (2006) (73)
- Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria (2005) (73)
- Cerebral Blood Flow by Using Pulsed Arterial Spin-Labeling in Elderly Subjects with White Matter Hyperintensities (2008) (73)
- Neurological Signs in Relation to Type of Cerebrovascular Disease in Vascular Dementia (2008) (73)
- Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter (2013) (72)
- Increased number of microinfarcts in Alzheimer disease at 7-T MR imaging. (2013) (72)
- Corpus callosum size correlates with asymmetric performance on a dichotic listening task in healthy aging but not in Alzheimer's disease (2006) (72)
- Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data (2021) (72)
- Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials (1997) (72)
- Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. (1999) (72)
- Linomide in the treatment of multiple sclerosis: MRI results from prematurely terminated phase-III trials (2000) (72)
- Increased default-mode network centrality in cognitively impaired multiple sclerosis patients (2017) (72)
- Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer’s Biomarkers in Daily Practice (ABIDE) Project (2017) (71)
- Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study (2019) (71)
- Clinical significance of corpus callosum atrophy in a mixed elderly population (2007) (71)
- Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: Relation to brain findings and clinical disability (2014) (71)
- MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials (2012) (71)
- Development of hypointense lesions on T1-weighted spin-echo magnetic resonance images in multiple sclerosis: relation to inflammatory activity. (1999) (71)
- Connectivity‐based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study (2015) (71)
- Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis (2017) (70)
- High dose cholecalciferol (vitamin D3) oil as add-on therapy in subjects with relapsing-remitting multiple sclerosis (RRMS) receiving subcutaneous interferon β-1a (scIFNβ-1a) (S44.005) (2017) (70)
- Enlarged Virchow-Robin spaces: do they matter? (2004) (70)
- Spinal-cord MRI in multiple sclerosis: conventional and nonconventional MR techniques. (2009) (70)
- Magnetic resonance imaging as a tool to examine the neuropathology of multiple sclerosis (2004) (70)
- MRI Visual Ratings of Brain Atrophy and White Matter Hyperintensities across the Spectrum of Cognitive Decline Are Differently Affected by Age and Diagnosis (2017) (70)
- Cognitive slowing in multiple sclerosis is strongly associated with brain volume reduction (2006) (69)
- Differential patterns of spinal cord and brain atrophy in NMO and MS (2015) (69)
- Pathological Aging of the Brain: An Overview (2004) (69)
- Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's disease (2013) (68)
- Unraveling treatment response in multiple sclerosis (2018) (68)
- Sex‐specific extent and severity of white matter damage in multiple sclerosis: Implications for cognitive decline (2014) (68)
- Intracranial aneurysms treated with coil placement: test characteristics of follow-up MR angiography--multicenter study. (2010) (67)
- Tumor-Volume Changes after Radiosurgery for Vestibular Schwannoma: Implications for Follow-Up MR Imaging Protocol (2008) (67)
- Diffusion changes predict cognitive and functional outcome: The LADIS study (2013) (67)
- MRI and CT in the diagnosis of vascular dementia (2004) (67)
- Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: A 3-year follow-up of the LADIS study cohort (2011) (67)
- Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes (2015) (67)
- White Matter Hyperintensities Relate to Clinical Progression in Subjective Cognitive Decline (2015) (67)
- Clinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets (2001) (67)
- Does high field MRI allow an earlier diagnosis of multiple sclerosis? (2008) (66)
- ‘Leukodystrophy‐like’ phenotype in children with myelin oligodendrocyte glycoprotein antibody‐associated disease (2018) (66)
- The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics (2018) (66)
- The effect of IFNβ-1b on the evolution of enhancing lesions in secondary progressive MS (2001) (66)
- Clinical–MRI correlations in a European trial of interferon beta-1b in secondary progressive MS (2001) (66)
- Neurophysiological correlates of increased verbal working memory in high-dissociative participants: a functional MRI study (2005) (66)
- Resection Probability Maps for Quality Assessment of Glioma Surgery without Brain Location Bias (2013) (66)
- Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional C omposite (2004) (65)
- Changes in functional network centrality underlie cognitive dysfunction and physical disability in multiple sclerosis (2014) (65)
- An fMRI study of planning-related brain activity in patients with moderately advanced multiple sclerosis (2004) (64)
- Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice. (2014) (64)
- Long-term clinical outcome of primary progressive MS: Predictive value of clinical and MRI data (2005) (64)
- Improved detection of active multiple sclerosis lesions: 3D subtraction imaging. (2010) (64)
- Diffusion-weighted MRI in severe neonatal hypoxic ischaemia: the white cerebrum. (2003) (64)
- Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis (2014) (64)
- Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis (2012) (63)
- Inter-rater agreement in glioma segmentations on longitudinal MRI (2019) (63)
- Resting state functional connectivity differences between behavioral variant frontotemporal dementia and Alzheimer's disease (2015) (63)
- Liraglutide Reduces CNS Activation in Response to Visual Food Cues Only After Short-term Treatment in Patients With Type 2 Diabetes (2015) (63)
- Abnormal connectivity of the sensorimotor network in patients with MS: A multicenter fMRI study (2009) (63)
- Guidelines for using quantitative magnetization transfer magnetic resonance imaging for monitoring treatment of multiple sclerosis (2003) (63)
- Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. (2016) (63)
- Early adaptive immune activation detected in monozygotic twins with prodromal multiple sclerosis. (2019) (63)
- Memory impairment in multiple sclerosis: Relevance of hippocampal activation and hippocampal connectivity (2015) (63)
- Assessment and correction of B1‐induced errors in magnetization transfer ratio measurements (2005) (63)
- Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD (2018) (63)
- The Dutch Parelsnoer Institute - Neurodegenerative diseases; methods, design and baseline results (2014) (62)
- Disrupted topological organization of structural and functional brain connectomes in clinically isolated syndrome and multiple sclerosis (2016) (62)
- Multicontrast MR Imaging at 7T in Multiple Sclerosis: Highest Lesion Detection in Cortical Gray Matter with 3D-FLAIR (2013) (62)
- Structural MRI substrates of cognitive impairment in neuromyelitis optica (2015) (61)
- Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design (2017) (61)
- Increased production of tumor necrosis factor α, and not of interferon γ, preceding disease activity in Patients with multiple sclerosis (1998) (61)
- Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long‐standing multiple sclerosis (2015) (60)
- ATN classification and clinical progression in subjective cognitive decline (2020) (60)
- Global and Regional Differences in Brain Anatomy of Young Children Born Small for Gestational Age (2011) (59)
- Shifting imaging targets in multiple sclerosis: From inflammation to neurodegeneration (2012) (59)
- Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework (2017) (59)
- Cognitive reserve and clinical progression in Alzheimer disease (2019) (59)
- Alterations in white matter volume and integrity in obesity and type 2 diabetes (2016) (59)
- Diffuse signal abnormalities in the spinal cord in multiple sclerosis: Direct postmortem in situ magnetic resonance imaging correlated with in vitro high‐resolution magnetic resonance imaging and histopathology (2002) (59)
- Segmentation of age-related white matter changes in a clinical multi-center study (2008) (59)
- Cognitive subtypes of probable Alzheimer's disease robustly identified in four cohorts (2017) (59)
- Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters (2007) (58)
- Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis: A Randomized Clinical Trial. (2015) (58)
- Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition (2008) (58)
- Cognitive Dysfunction in Early Multiple Sclerosis: Altered Centrality Derived from Resting-State Functional Connectivity Using Magneto-Encephalography (2012) (58)
- Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds. (2015) (57)
- Diffusion tensor imaging in type 1 diabetes: decreased white matter integrity relates to cognitive functions (2012) (57)
- Imaging outcome measures for progressive multiple sclerosis trials (2017) (57)
- White Matter Changes Contribute to Corpus Callosum Atrophy in the Elderly: The LADIS Study (2008) (57)
- CCL5 and CCR5 genotypes modify clinical, radiological and pathological features of multiple sclerosis (2007) (57)
- New Research Criteria for the Diagnosis of Alzheimer’s Disease Applied in a Memory Clinic Population (2010) (57)
- Distinct perfusion patterns in Alzheimer’s disease, frontotemporal dementia and dementia with Lewy bodies (2014) (57)
- Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease (2007) (57)
- Microbleeds relate to altered amyloid-beta metabolism in Alzheimer's disease (2012) (56)
- Diffusion-weighted and conventional MR imaging in neonatal hypoxic ischemia: two-year follow-up study. (2008) (56)
- In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET (2018) (56)
- Proliferative Retinopathy in Type 1 Diabetes Is Associated With Cerebral Microbleeds, Which Is Part of Generalized Microangiopathy (2014) (56)
- The Diagnostic Value of Magnetic Resonance Imaging and Technetium 99m‐HMPAO Single‐Photon-Emission Computed Tomography for the Diagnosis of Alzheimer Disease in a Community‐Dwelling Elderly Population (1997) (56)
- Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis (2013) (56)
- A 30‐Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes (2019) (56)
- Reproducibility of fMRI in the clinical setting: Implications for trial designs (2008) (55)
- Subtraction MR images in a multiple sclerosis multicenter clinical trial setting. (2009) (55)
- Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI. (2014) (55)
- Diffusely Abnormal White Matter in Progressive Multiple Sclerosis: In Vivo Quantitative MR Imaging Characterization and Comparison between Disease Types (2010) (55)
- Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease (2015) (55)
- ExploreASL: An image processing pipeline for multi-center ASL perfusion MRI studies (2019) (54)
- Small vessel versus large vessel vascular dementia (2008) (54)
- Early- and Late-Onset Depression in Late Life: A Prospective Study on Clinical and Structural Brain Characteristics and Response to Electroconvulsive Therapy. (2017) (54)
- Fetal origin of brain damage in 2 infants with a COL4A1 mutation: fetal and neonatal MRI. (2011) (54)
- T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis (2010) (54)
- Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis (2008) (53)
- rTMS affects working memory performance, brain activation and functional connectivity in patients with multiple sclerosis (2016) (53)
- Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer’s Disease biomarker discovery cohort (2019) (53)
- Single-Subject Gray Matter Graph Properties and Their Relationship with Cognitive Impairment in Early- and Late-Onset Alzheimer's Disease (2014) (53)
- Brain atrophy in multiple sclerosis: impact of lesions and of damage of whole brain tissue (2002) (53)
- Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images (2010) (53)
- Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease. (2016) (52)
- Isotropic 3D fast FLAIR imaging of the brain in multiple sclerosis patients: initial experience (2002) (52)
- Increased connectivity of hub networks and cognitive impairment in multiple sclerosis (2017) (52)
- Stereotactic radiosurgery for brain AVMs: role of interobserver variation in target definition on digital subtraction angiography. (2005) (52)
- White Matter Lesions Are Associated With Progression of Medial Temporal Lobe Atrophy in Alzheimer Disease (2006) (52)
- CTLA-4 and CD28 gene polymorphisms in susceptibility, clinical course and progression of multiple sclerosis (2003) (52)
- Connectomic profile and clinical phenotype in newly diagnosed glioma patients (2017) (52)
- Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesions. (1997) (52)
- Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions (2014) (51)
- Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions. (1997) (51)
- MRI features of benign multiple sclerosis (2009) (51)
- Comparison of the Alzheimer’s Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in Differentiating Elderly Individuals with Different Degrees of White Matter Changes (2007) (51)
- Widespread Disruption of Functional Brain Organization in Early-Onset Alzheimer’s Disease (2014) (51)
- Cine phase-contrast MR imaging in normal pressure hydrocephalus patients: relation to surgical outcome. (1998) (51)
- MRI mimics of multiple sclerosis. (2014) (51)
- Two-year follow-up study of primary and transitional progressive multiple sclerosis (2002) (51)
- Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results. (2007) (51)
- Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis (2013) (50)
- Cardiovascular and Interventional Radiological Society of Europe Commentary on the Treatment of Chronic Cerebrospinal Venous Insufficiency (2010) (50)
- A neuroimaging approach to capture cognitive reserve: Application to Alzheimer's disease (2017) (50)
- Molecular mechanism underlying the impact of vitamin D on disease activity of MS (2014) (50)
- Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually‐edited SIENA and SIENAX (2007) (50)
- MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance (2016) (50)
- The effect of interferon beta-1 b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis (2000) (50)
- Gray matter network disruptions and amyloid beta in cognitively normal adults (2016) (50)
- European Pentoxifylline Multi-Infarct Dementia Study. (1996) (50)
- Hypointense multiple sclerosis lesions on T1-weighted spin echo magnetic resonance images: their contribution in understanding multiple sclerosis evolution. (1998) (49)
- Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease? (2019) (49)
- Grid infrastructures for computational neuroscience: The neuGRID example (2009) (49)
- Image registration and subtraction to detect active T2 lesions in MS: an interobserver study (2002) (49)
- Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups (1998) (49)
- Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study. (2015) (49)
- White matter hyperintensities, medial temporal lobe atrophy, cortical atrophy, and response to electroconvulsive therapy in severely depressed elderly patients. (2011) (48)
- Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials (2005) (48)
- Parametric fMRI analysis of visual encoding in the human medial temporal lobe (1999) (48)
- Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics (2019) (48)
- T1 hypointensities and axonal loss. (2000) (48)
- Microbleeds do not affect rate of cognitive decline in Alzheimer's disease (2011) (48)
- Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis (2021) (48)
- Susceptibility-weighted Imaging: Technical Essentials and Clinical Neurologic Applications. (2021) (48)
- MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study (2018) (48)
- Short-term adaptation to a simple motor task: A physiological process preserved in multiple sclerosis (2009) (48)
- Assessing the reproducibility of the SienaX and Siena brain atrophy measures using the ADNI back-to-back MP-RAGE MRI scans (2011) (48)
- Cerebrospinal fluid ATP metabolites in multiple sclerosis (2010) (48)
- Magnetic resonance imaging of the brain in adults with severe falciparum malaria (2014) (48)
- Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline (2016) (47)
- Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes. (2016) (47)
- No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT (2015) (47)
- Elevated Postoperative Endogenous GLP-1 Levels Mediate Effects of Roux-en-Y Gastric Bypass on Neural Responsivity to Food Cues (2017) (47)
- Head-to-Head Comparison of Two Popular Cortical Thickness Extraction Algorithms: A Cross-Sectional and Longitudinal Study (2015) (47)
- Determinants of iron accumulation in deep grey matter of multiple sclerosis patients (2014) (47)
- CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high‐dose intravenous methylprednisolone (1992) (47)
- Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks☆ (2014) (47)
- Magnetization Transfer Ratio of the Spinal Cord in Multiple Sclerosis: Relationship to Atrophy and Neurologic Disability (2000) (47)
- Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease (2017) (47)
- Emotional eating is associated with increased brain responses to food‐cues and reduced sensitivity to GLP‐1 receptor activation (2015) (46)
- A Longitudinal Study on Resting State Functional Connectivity in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease. (2016) (46)
- Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients (2005) (46)
- Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy (2003) (46)
- Use of ultrasmall superparamagnetic particles of iron oxide (USPIO)‐enhanced MRI to demonstrate diffuse inflammation in the normal‐appearing white matter (NAWM) of multiple sclerosis (MS) patients: An exploratory study (2009) (46)
- Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis (2016) (46)
- Hippocampal sulcus width and cavities: comparison between patients with Alzheimer disease and nondemented elderly subjects. (2006) (46)
- Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features. (1998) (46)
- A clinical-radiological framework of the right temporal variant of frontotemporal dementia (2020) (46)
- Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method (2016) (45)
- More atrophy of deep gray matter structures in frontotemporal dementia compared to Alzheimer's disease. (2015) (45)
- White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study (2009) (45)
- The changing face of multiple sclerosis clinical trial populations (2011) (45)
- MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS (2015) (45)
- Multislice T1 relaxation time measurements in the brain using IR‐EPI: Reproducibility, normal values, and histogram analysis in patients with multiple sclerosis (2003) (45)
- Primary progressive multiple sclerosis diagnostic criteria: a reappraisal (2009) (45)
- Cerebral Blood Flow and Cognitive Functioning in a Community-Based, Multi-Ethnic Cohort: The SABRE Study (2018) (45)
- Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI (2018) (45)
- Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma. (2003) (44)
- Thalamic Lesions in Vascular Dementia: Low Sensitivity of Fluid-Attenuated Inversion Recovery (FLAIR) Imaging (2004) (44)
- Endogenous GLP1 and GLP1 analogue alter CNS responses to palatable food consumption. (2016) (44)
- Improved reliability of hippocampal atrophy rate measurement in mild cognitive impairment using fluid registration (2007) (44)
- Applying the ATN scheme in a memory clinic population (2019) (44)
- Microbleeds, Mortality, and Stroke in Alzheimer Disease: The MISTRAL Study. (2015) (44)
- Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized study (2003) (43)
- Early postoperative MRI overestimates residual tumour after resection of gliomas with no or minimal enhancement (2011) (43)
- Comparison of a conventional cardiac-triggered dual spin-echo and a fast STIR sequence in detection of spinal cord lesions in multiple sclerosis (2000) (43)
- Motor evoked potential: A reliable and objective measure to document the functional consequences of multiple sclerosis? Relation to disability and MRI (2007) (43)
- Perivascular spaces in MS patients at 7 Tesla MRI: A marker of neurodegeneration? (2015) (43)
- Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis (2010) (43)
- Bacillus cereus meningoencephalitis in preterm infants: neuroimaging characteristics. (2005) (43)
- Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study (2019) (43)
- Longitudinal assessment of multiple sclerosis with the brain-age paradigm. (2020) (43)
- Disentangling Human Error from the Ground Truth in Segmentation of Medical Images (2020) (43)
- Translating pathology in multiple sclerosis: the combination of postmortem imaging, histopathology and clinical findings (2009) (43)
- Spatial patterns of white matter hyperintensities associated with Alzheimer’s disease risk factors in a cognitively healthy middle-aged cohort (2019) (42)
- Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers (2013) (42)
- Differences in structural covariance brain networks between behavioral variant frontotemporal dementia and Alzheimer's disease (2016) (42)
- Reduced dynamics of functional connectivity and cognitive impairment in multiple sclerosis (2020) (42)
- Interferon beta-1 a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis : a randomised , double-blind , placebo-controlled trial (2004) (42)
- Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study. (2008) (42)
- The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium (2008) (42)
- Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation? (2013) (42)
- Seasonal variation in immune measurements and MRI markers of disease activity in MS (2002) (42)
- Regional brain atrophy development is related to specific aspects of clinical dysfunction in multiple sclerosis (2007) (42)
- Gray matter networks and clinical progression in subjects with predementia Alzheimer's disease (2018) (42)
- Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis (2015) (41)
- Assessing Amyloid Pathology in Cognitively Normal Subjects Using 18F-Flutemetamol PET: Comparing Visual Reads and Quantitative Methods (2018) (41)
- Memantine and brain atrophy in Alzheimer's disease: a 1-year randomized controlled trial. (2012) (41)
- Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matter. (2006) (41)
- N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry (2007) (41)
- Unraveling the neuroimaging predictors for motor dysfunction in long-standing multiple sclerosis (2015) (41)
- Interindividual differences of medial temporal lobe activation during encoding in an elderly population studied by fMRI (2004) (41)
- Longitudinal gray matter changes in multiple sclerosis—Differential scanner and overall disease‐related effects (2012) (41)
- Magnetic Resonance Imaging of Epilepsy in Multiple Sclerosis: A Case Control Study. Implications for Treatment Trials with 4-Aminopyridine (1996) (41)
- CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS (2014) (40)
- Raloxifene affects brain activation patterns in postmenopausal women during visual encoding. (2001) (40)
- Single Subject Classification of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Anatomical, Diffusion Tensor, and Resting-State Functional Magnetic Resonance Imaging. (2018) (40)
- Different patterns of cortical gray matter loss over time in behavioral variant frontotemporal dementia and Alzheimer's disease (2016) (40)
- Amyloid and its association with default network integrity in Alzheimer's disease (2014) (40)
- Chemokine receptor expression on T cells is related to new lesion development in multiple sclerosis (2002) (40)
- Joint assessment of white matter integrity, cortical and subcortical atrophy to distinguish AD from behavioral variant FTD: A two-center study (2015) (40)
- Improvement of white matter changes on neuroimaging modalities after stem cell transplant in metachromatic leukodystrophy. (2013) (39)
- Lower cerebral blood flow in subjects with Alzheimer's dementia, mild cognitive impairment, and subjective cognitive decline using two-dimensional phase-contrast magnetic resonance imaging (2017) (39)
- The distribution of new enhancing lesion counts in multiple sclerosis: further explorations (2009) (39)
- The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing–Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in multiple sclerosis (2014) (39)
- Visual rating of hippocampal atrophy: correlation with volumetry. (1994) (39)
- Dementia imaging in clinical practice: a European-wide survey of 193 centres and conclusions by the ESNR working group (2019) (39)
- Multitracer model for staging cortical amyloid deposition using PET imaging (2020) (39)
- Morphological features of MS lesions on FLAIR* at 7 T and their relation to patient characteristics (2014) (39)
- Long-term motor and behavioral outcome after perinatal hypoxic-ischemic encephalopathy. (2015) (39)
- Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis (1994) (39)
- No major association of A poE genotype with disease characteristics and MRI findings in multiple sclerosis (2004) (38)
- Interferon β-1b–neutralizing antibodies 5 years after clinically isolated syndrome (2011) (38)
- Cognitive reserve moderates long-term cognitive and functional outcome in cerebral small vessel disease (2016) (38)
- Quantitation of brain tissue changes associated with white matter hyperintensities by diffusion‐weighted and magnetization transfer imaging: The LADIS (leukoaraiosis and disability in the elderly) study (2009) (38)
- Evidence for atrophy of the corpus callosum in Alzheimer's disease. (1994) (38)
- Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients. (2017) (38)
- Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study (2016) (38)
- Sporadic Creutzfeldt‐Jakob disease in a young Dutch valine homozygote: Atypical molecular phenotype (2001) (38)
- Fetal lung volume: three‐dimensional ultrasonography compared with magnetic resonance imaging (2006) (38)
- Sagittal MR of multiple sclerosis in the spinal cord: fast versus conventional spin-echo imaging. (1998) (37)
- Patterns of white matter hyperintensities associated with cognition in middle-aged cognitively healthy individuals (2019) (37)
- Modelling new enhancing MRI lesion counts in multiple sclerosis (2001) (37)
- Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS (2003) (37)
- Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space study☆ (2013) (37)
- The EMIF-AD PreclinAD study: study design and baseline cohort overview (2018) (37)
- The Alzheimer's Disease Prediction Of Longitudinal Evolution (TADPOLE) Challenge: Results after 1 Year Follow-up (2020) (37)
- HLA-DRB1*1501 and spinal cord magnetic resonance imaging lesions in multiple sclerosis. (2009) (37)
- Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study. (2009) (37)
- The FAS−670 polymorphism influences susceptibility to multiple sclerosis (2002) (36)
- Test‐retest reliability of the default mode network in a multi‐centric fMRI study of healthy elderly: Effects of data‐driven physiological noise correction techniques (2016) (36)
- The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study (2019) (36)
- Long‐interval T2‐weighted subtraction magnetic resonance imaging: A powerful new outcome measure in multiple sclerosis trials (2009) (36)
- Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis (2010) (36)
- Secondary prevention of Alzheimer’s dementia: neuroimaging contributions (2018) (36)
- Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis (2008) (36)
- Cortical atrophy accelerates as cognitive decline worsens in multiple sclerosis (2019) (36)
- Five-class differential diagnostics of neurodegenerative diseases using random undersampling boosting (2017) (36)
- 7T T2 ∗-weighted magnetic resonance imaging reveals cortical phase differences between early- and late-onset Alzheimer's disease (2015) (36)
- Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-Analysis (2017) (35)
- Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly (2015) (35)
- Medial temporal lobe atrophy in an open population of very old persons (1995) (35)
- Predicting clinical progression in multiple sclerosis after 6 and 12 years (2019) (35)
- Validation of the automated method VIENA: An accurate, precise, and robust measure of ventricular enlargement (2014) (35)
- Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay (2019) (35)
- Segmentation of Subtraction Images for the Measurement of Lesion Change in Multiple Sclerosis (2008) (35)
- Cortical imaging in multiple sclerosis: recent findings and 'grand challenges'. (2013) (35)
- Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (2018) (35)
- Association between MRI parameters and the MS severity scale: a 12 year follow-up study (2009) (35)
- Determinants of cerebral atrophy rate at the time of diagnosis of multiple sclerosis. (2007) (35)
- Linking late cognitive outcome with glioma surgery location using resection cavity maps (2018) (34)
- High-resolution T1-relaxation time mapping displays subtle, clinically relevant, gray matter damage in long-standing multiple sclerosis (2016) (34)
- Building a new paradigm for the early recognition of behavioral variant frontotemporal dementia: Late Onset Frontal Lobe Syndrome study. (2014) (34)
- Detecting frontotemporal dementia syndromes using MRI biomarkers (2019) (34)
- Progression of cerebral white matter lesions in Alzheimer’s disease: a new window for therapy? (2005) (34)
- Multimodal Quantitative MR Imaging of the Thalamus in Multiple Sclerosis and Neuromyelitis Optica. (2015) (34)
- Gray matter network measures are associated with cognitive decline in mild cognitive impairment (2018) (34)
- Mind the gap: from neurons to networks to outcomes in multiple sclerosis (2021) (34)
- Pseudo-healthy Image Synthesis for White Matter Lesion Segmentation (2016) (34)
- Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS (2017) (34)
- Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease (2008) (34)
- Regional atrophy is associated with impairment in distinct cognitive domains in Alzheimer's disease (2014) (34)
- Multicenter Validation of Mean Upper Cervical Cord Area Measurements from Head 3D T1-Weighted MR Imaging in Patients with Multiple Sclerosis (2016) (34)
- Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS (2010) (34)
- Performance of five automated white matter hyperintensity segmentation methods in a multicenter dataset (2019) (33)
- Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis (2018) (33)
- Growth‐associated protein 43 in lesions and cerebrospinal fluid in multiple sclerosis (2006) (33)
- Lifespan normative data on rates of brain volume changes (2019) (33)
- Quantitative regional validation of the visual rating scale for posterior cortical atrophy (2014) (33)
- Correlating Quantitative MR Imaging with Histopathology in X-Linked Adrenoleukodystrophy (2011) (33)
- Performance of five automated white matter hyperintensity segmentation methods in a multicenter dataset (2019) (33)
- Whole brain analysis of T2* weighted baseline FMRI signal in dementia (2007) (33)
- Cerebrospinal fluid levels of Alzheimer’s disease biomarkers in middle-aged patients with type 1 diabetes (2014) (33)
- Clinical phenotype, atrophy, and small vessel disease in APOEε2 carriers with Alzheimer disease (2018) (33)
- Quantification of cerebral blood flow in healthy volunteers and type 1 diabetic patients: Comparison of MRI arterial spin labeling and [15O]H2O positron emission tomography (PET) (2014) (33)
- APOE ε4 status is associated with white matter hyperintensities volume accumulation rate independent of AD diagnosis (2017) (33)
- Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease‐modifying therapies (2020) (33)
- Raloxifene Treatment Enhances Brain Activation during Recognition of Familiar Items: a Pharmacological fMRI Study in Healthy Elderly Males (2006) (33)
- An MRI Rating Scale for Amyloid-Related Imaging Abnormalities with Edema or Effusion (2013) (33)
- Raloxifene exposure enhances brain activation during memory performance in healthy elderly males; its possible relevance to behavior (2005) (33)
- Inflammation high-field magnetic resonance imaging. (2012) (33)
- Altered eigenvector centrality is related to local resting‐state network functional connectivity in patients with longstanding type 1 diabetes mellitus (2017) (32)
- Vascular Cognitive Impairment in a Memory Clinic Population: Rationale and Design of the “Utrecht-Amsterdam Clinical Features and Prognosis in Vascular Cognitive Impairment” (TRACE-VCI) Study (2017) (32)
- Brain volume and white matter hyperintensities as determinants of cerebral blood flow in Alzheimer's disease (2014) (32)
- Patterns of Brain Magnetic Resonance Abnormalities on T2-Weighted Spin Echo Images in Clinical Subgroups of Multiple Sclerosis: A Large Cross-Sectional Study (1998) (32)
- The structure of the geriatric depressed brain and response to electroconvulsive therapy (2014) (32)
- SVM recursive feature elimination analyses of structural brain MRI predicts near-term relapses in patients with clinically isolated syndromes suggestive of multiple sclerosis (2019) (32)
- Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ε4 genotype (2020) (32)
- Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET (2017) (32)
- Ventral Striatum, but Not Cortical Volume Loss, Is Related to Cognitive Dysfunction in Type 1 Diabetic Patients With and Without Microangiopathy (2014) (32)
- A more randomly organized grey matter network is associated with deteriorating language and global cognition in individuals with subjective cognitive decline (2018) (32)
- Multiple sclerosis: MRI—the perfect surrogate marker for multiple sclerosis? (2009) (32)
- Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort (2021) (31)
- Blood Pressure, White Matter Lesions and Medial Temporal Lobe Atrophy: Closing the Gap between Vascular Pathology and Alzheimer’s Disease? (2005) (31)
- The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis (1992) (31)
- Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy (2017) (31)
- Impact of APOE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults (2016) (31)
- Inadvertent i.v. administration of gadopentetate dimeglumine during early pregnancy. (1992) (31)
- Diagnostic Accuracy of the Frontotemporal Dementia Consensus Criteria in the Late-Onset Frontal Lobe Syndrome (2016) (31)
- Ethics of placebo-controlled clinical trials in multiple sclerosis (2008) (31)
- Unenhanced and enhanced magnetic resonance imaging in the diagnosis of multiple sclerosis. (1998) (31)
- Progression in disability and regional grey matter atrophy in relapsing–remitting multiple sclerosis (2014) (31)
- Personalized extended interval dosing of natalizumab in MS (2020) (30)
- The Holy Grail in diagnostic neuroradiology: 3T or 3D? (2010) (30)
- Subcutaneous interferon β-1a in the treatment of clinically isolated syndromes: 3-year and 5-year results of the phase III dosing frequency-blind multicentre REFLEXION study (2016) (30)
- Histone deacetylase gene variants predict brain volume changes in multiple sclerosis (2013) (30)
- Infratentorial Abnormalities in Vascular Dementia (2006) (30)
- The Predictive Value of 3D Time-of-Flight MR Angiography in Assessment of Brain Arteriovenous Malformation Obliteration after Radiosurgery (2012) (30)
- A multicentre study of motor functional connectivity changes in patients with multiple sclerosis (2011) (30)
- Gray matter networks and cognitive impairment in multiple sclerosis (2018) (30)
- Alzheimer’s disease—one clinical syndrome, two radiological expressions: a study on blood pressure (2004) (30)
- Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous results (1999) (30)
- Serial isotropic three-dimensional fast FLAIR imaging: using image registration and subtraction to reveal active multiple sclerosis lesions. (2002) (30)
- Spinal cord magnetic resonance imaging in suspected multiple sclerosis (2000) (30)
- Longitudinal spinal cord atrophy in multiple sclerosis using the generalized boundary shift integral (2019) (29)
- Smaller medial temporal lobe volumes in individuals with subjective cognitive decline and biomarker evidence of Alzheimer's disease—Data from three memory clinic studies (2018) (29)
- Unraveling pathology in juvenile Alexander disease: serial quantitative MR imaging and spectroscopy of white matter (2009) (29)
- Bullseye's representation of cerebral white matter hyperintensities (2017) (29)
- Disrupted white matter structural networks in healthy older adult APOE ε4 carriers – An international multicenter DTI study (2017) (29)
- αB-Crystallin genotype has impact on the multiple sclerosis phenotype (2003) (29)
- A phase II trial of anti-CD4 antibodies in the treatment of multiple sclerosis (1996) (29)
- The influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease (2015) (29)
- Asymptomatic Carotid Artery Stenosis: Past, Present and Future (2006) (29)
- Postmortem validation of MRI cortical volume measurements in MS (2016) (29)
- Preliminary evidence of hippocampal damage in chronic users of ecstasy (2011) (29)
- Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis (2019) (29)
- Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review (2018) (28)
- Characteristics of Early MRI in Children and Adolescents with Vanishing White Matter (2012) (28)
- Gray Matter Network Disruptions and Regional Amyloid Beta in Cognitively Normal Adults (2018) (28)
- Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset (2019) (28)
- APOE and cortical superficial siderosis in CAA (2019) (28)
- Personalized risk for clinical progression in cognitively normal subjects—the ABIDE project (2019) (28)
- Gut Microbiota Composition Is Related to AD Pathology (2022) (28)
- Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study (2021) (28)
- MR imaging in retinoblastoma (2007) (28)
- Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place? (2014) (28)
- White matter hyperintensities and cognitive impairment during electroconvulsive therapy in severely depressed elderly patients. (2014) (28)
- Motor outcome at the age of one after perinatal hypoxic-ischemic encephalopathy. (2007) (27)
- AMYPAD Diagnostic and Patient Management Study: Rationale and design (2018) (27)
- Differentiation of edema and glioma infiltration: proposal of a DTI-based probability map (2014) (27)
- Leucoencephalopathy with brainstem and spinal cord involvement and high lactate: quantitative magnetic resonance imaging. (2011) (27)
- Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis (2018) (27)
- Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes (2014) (27)
- Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression (2020) (27)
- Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS (2019) (27)
- Dementia Mimicking Alzheimer's Disease Owing to a Tau Mutation: CSF and PET Findings (2010) (26)
- Cerebral amyloid burden is associated with white matter hyperintensity location in specific posterior white matter regions (2019) (26)
- Predictors of progression from mild cognitive impairment to dementia in the placebo-arm of a clinical trial population. (2013) (26)
- Corpus Callosum Tissue Loss and Development of Motor and Global Cognitive Impairment: The LADIS Study (2012) (26)
- MR outcome parameters in multiple sclerosis: comparison of surface-based thresholding segmentation and magnetization transfer ratio histographic analysis in relation to disability (a preliminary note). (1998) (26)
- Future clinical challenges in multiple sclerosis (2011) (26)
- Cerebral white matter abnormalities in 6p25 deletion syndrome. (2006) (26)
- Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum (2019) (26)
- Quantitative MR imaging and spectroscopy in congenital cytomegalovirus infection and periventricular leukomalacia suggests a comparable neuropathological substrate of the cerebral white matter lesions. (2009) (26)
- Diagnosis of Progressive Multiple Sclerosis From the Imaging Perspective: A Review. (2020) (26)
- Progressive brain rich-club network disruption from clinically isolated syndrome towards multiple sclerosis (2018) (26)
- Antibody‐mediated suppression of Vβ5.2/5.3+ T cells in multiple sclerosis: Results from an MRI‐monitored phase II clinical trial (2002) (26)
- Cerebrospinal Fluid IgM Index Correlates with Cranial MRI Lesion Load in Patients with Multiple Sclerosis (2007) (25)
- Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer’s Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity (2016) (25)
- The European DTI Study on Dementia — A multicenter DTI and MRI study on Alzheimer's disease and Mild Cognitive Impairment (2017) (25)
- Detection of Root Avulsion in the Dominant C7 Obstetric Brachial Plexus Lesion: Experience with Three-dimensional Constructive Interference in Steady-state Magnetic Resonance Imaging and Electrophysiology (2005) (25)
- Disturbed oscillatory brain dynamics in subcortical ischemic vascular dementia (2012) (25)
- Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients (2016) (25)
- Follow‐up study of MS patients treated with high‐dose intravenous methylprednisolone (1994) (25)
- In vivo tau pathology is associated with synaptic loss and altered synaptic function (2021) (25)
- Measuring Resilience and Resistance in Aging and Alzheimer Disease Using Residual Methods (2021) (25)
- Clinical Characteristics of Patients With Frontotemporal Dementia With and Without Lobar Atrophy on MRI (2010) (24)
- Improved performance of the 2017 McDonald criteria for diagnosis of multiple sclerosis in children in a real-life cohort (2020) (24)
- TNFα production by CD4+ T cells predicts long-term increase in lesion load on MRI in MS (2001) (24)
- Data-Driven Differential Diagnosis of Dementia Using Multiclass Disease State Index Classifier (2018) (24)
- Novel MRI and PET markers of neuroinflammation in multiple sclerosis. (2016) (24)
- Diffusion magnetic resonance imaging in multiple sclerosis. (2011) (24)
- Hippocampal profiling: Localized magnetic resonance imaging volumetry and T2 relaxometry for hippocampal sclerosis (2019) (24)
- Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease (2019) (24)
- Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease (2019) (24)
- Incidence of enhancement of the trigeminal nerve on MRI in patients with multiple sclerosis (2002) (24)
- Episodic memory and the medial temporal lobe: not all it seems. Evidence from the temporal variants of frontotemporal dementia (2012) (24)
- Reproducibility of hippocampal atrophy rates measured with manual, FreeSurfer, AdaBoost, FSL/FIRST and the MAPS-HBSI methods in Alzheimer's disease (2016) (24)
- Neuroimaging in Dementia (2011) (24)
- Cardiovascular Risk Factors and White Matter Hyperintensities: Difference in Susceptibility in South Asians Compared With Europeans (2018) (24)
- Delineation of brain AVMs on MR-Angiography for the purpose of stereotactic radiosurgery. (2007) (24)
- Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase II therapeutic trials (1997) (24)
- Real-world keystroke dynamics are a potentially valid biomarker for clinical disability in multiple sclerosis (2020) (24)
- Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS (2011) (24)
- Immune signatures of prodromal multiple sclerosis in monozygotic twins (2020) (24)
- Determination of individual stimulus–response curves in the visual cortex (2002) (23)
- LOW VITAMIN B6 LEVELS ARE ASSOCIATED WITH WHITE MATTER LESIONS IN ALZHEIMER'S DISEASE (2005) (23)
- Associations between magnetic resonance imaging measures and neuropsychological impairment in early and late onset alzheimer's disease. (2013) (23)
- Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS (2017) (23)
- Gray matter T1‐w/T2‐w ratios are higher in Alzheimer's disease (2019) (23)
- Thinner cortex in patients with subjective cognitive decline is associated with steeper decline of memory (2018) (23)
- Comparison of two MR sequences for the detection of multiple sclerosis lesions in the spinal cord. (1996) (23)
- Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment (2017) (23)
- The development of clinical activity in relapsing–remitting MS is associated with a decrease of FasL mRNA and an increase of Fas mRNA in peripheral blood (2003) (23)
- Spatiotemporal distribution of white matter lesions in relapsing–remitting and secondary progressive multiple sclerosis (2012) (23)
- Multiple sclerosis therapy. A practical guide. (1995) (23)
- Comparing Glioblastoma Surgery Decisions Between Teams Using Brain Maps of Tumor Locations, Biopsies, and Resections (2019) (23)
- Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis (2016) (23)
- Disrupted subject‐specific gray matter network properties and cognitive dysfunction in type 1 diabetes patients with and without proliferative retinopathy (2016) (23)
- Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis (2019) (23)
- Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes (2013) (23)
- Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study (2018) (23)
- Is the whole brain periventricular? (2006) (23)
- Switching from branded to generic glatiramer acetate: 15-month GATE trial extension results (2017) (23)
- Amygdalar nuclei and hippocampal subfields on MRI: Test-retest reliability of automated volumetry across different MRI sites and vendors (2020) (22)
- Decreased vitamin B12 and folate levels in cerebrospinal fluid and serum of multiple sclerosis patients after high-dose intravenous methylprednisolone (1993) (22)
- Can MS lesion stages be distinguished with MRI? A postmortem MRI and histopathology study (2015) (22)
- Accurate Delineation of Glioma Infiltration by Advanced PET/MR Neuro-Imaging (FRONTIER Study): A Diagnostic Study Protocol. (2016) (22)
- TADPOLE Challenge: Accurate Alzheimer's Disease Prediction Through Crowdsourced Forecasting of Future Data (2019) (22)
- Shifting Paradigms in Dementia (2007) (22)
- Facing privacy in neuroimaging: removing facial features degrades performance of image analysis methods (2019) (22)
- Changes in MEG resting-state networks are related to cognitive decline in type 1 diabetes mellitus patients (2014) (22)
- Interobserver agreement for diagnostic MRI criteria in suspected multiple sclerosis (1999) (22)
- MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry (2018) (21)
- Head Motion Parameters in fMRI Differ Between Patients with Mild Cognitive Impairment and Alzheimer Disease Versus Elderly Control Subjects (2014) (21)
- The quantitative neuroradiology initiative framework: application to dementia. (2019) (21)
- Polymorphisms in the genes encoding interferon-gamma and interferon-gamma receptors in multiple sclerosis. (2004) (21)
- Hypometabolism of the posterior cingulate cortex is not restricted to Alzheimer's disease (2018) (21)
- Association between tumor location and neurocognitive functioning using tumor localization maps (2019) (21)
- Multi-study validation of data-driven disease progression models to characterize evolution of biomarkers in Alzheimer's disease☆ (2019) (21)
- 2010 revisions to mcDonald criteria for diagnosis of multiple sclerosis: Impact of 3‐tesla magnetic resonance imaging (2011) (21)
- The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial (2014) (21)
- Glutamate gene polymorphisms predict brain volumes in multiple sclerosis (2013) (21)
- Longitudinal absolute metabolite quantification of white and gray matter regions in healthy controls using proton MR spectroscopic imaging (2014) (21)
- Disturbed phase relations in white matter hyperintensity based vascular dementia: An EEG directed connectivity study (2015) (21)
- Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cells (2001) (21)
- Multicenter R2* mapping in the healthy brain (2014) (21)
- CSF biomarkers in frontotemporal lobar degeneration: relations with clinical characteristics, apolipoprotein E genotype, and neuroimaging (2006) (21)
- Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency (2010) (21)
- Three-Tesla MRI does not improve the diagnosis of multiple sclerosis (2018) (21)
- Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics? (2009) (20)
- In vivo imaging of chronic active lesions in multiple sclerosis (2020) (20)
- Novel hypomyelinating leukoencephalopathy affecting early myelinating structures. (2012) (20)
- Radiomics in multiple sclerosis and neuromyelitis optica spectrum disorder (2019) (20)
- Imaging of remyelination (1997) (20)
- Evaluating combinations of diagnostic tests to discriminate different dementia types (2018) (20)
- Early-Stage White Matter Lesions Detected by Multispectral MRI Segmentation Predict Progressive Cognitive Decline (2015) (20)
- PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases (2019) (20)
- Performance of five research-domain automated WM lesion segmentation methods in a multi-center MS study (2017) (20)
- Agreement between different input image types in brain atrophy measurement in multiple sclerosis using SIENAX and SIENA (2008) (20)
- Gender-related association between the TGFB1+869 polymorphism and multiple sclerosis. (2004) (20)
- Pathologic correlates of the magnetization transfer ratio in multiple sclerosis (2020) (20)
- The precision of T1 hypointense lesion volume quantification in multiple sclerosis treatment trials: a multicenter study (2000) (20)
- Disrupted Module Efficiency of Structural and Functional Brain Connectomes in Clinically Isolated Syndrome and Multiple Sclerosis (2018) (20)
- Partially saturated fluid attenuated inversion recovery (FLAIR) sequences in multiple sclerosis: comparison with fully relaxed FLAIR and conventional spin-echo. (1995) (20)
- The Association of Glucose Metabolism and Eigenvector Centrality in Alzheimer's Disease (2016) (20)
- Expression of adhesion molecules on peripheral lymphocytes predicts future lesion development in MS (2005) (20)
- White matter hyperintensities mediate gray matter volume and processing speed relationship in cognitively unimpaired participants (2019) (20)
- A paradoxical relationship (20)
- Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome (2014) (20)
- Normal Aging Brain Collection Amsterdam (NABCA): A comprehensive collection of postmortem high-field imaging, neuropathological and morphometric datasets of non-neurological controls (2019) (19)
- The interleukin-1 gene family in multiple sclerosis susceptibility and disease course (2003) (19)
- Infratentorial and spinal cord lesions: Cumulative predictors of long-term disability? (2019) (19)
- Assessing treatment effects on axonal loss—evidence from MRI monitored clinical trials (2004) (19)
- Design of the ExCersion-VCI study: The effect of aerobic exercise on cerebral perfusion in patients with vascular cognitive impairment (2017) (19)
- A novel partial volume correction method for accurate quantification of [18F] flortaucipir in the hippocampus (2018) (19)
- Cortical and subcortical gray matter structural alterations in normoglycemic obese and type 2 diabetes patients: relationship with adiposity, glucose, and insulin (2018) (19)
- Wearable technologies to measure clinical outcomes in multiple sclerosis: A scoping review (2020) (19)
- Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6 (2021) (19)
- One year activity on subtraction MRI predicts subsequent 4 year activity and progression in multiple sclerosis (2011) (19)
- Assessment of spinal cord damage in MS using MRI (2000) (19)
- A randomized, placebo-controlled, phase 2 trial of laquinimod in primary progressive multiple sclerosis (2020) (19)
- Disease trajectories in behavioural variant frontotemporal dementia, primary psychiatric and other neurodegenerative disorders presenting with behavioural change. (2018) (19)
- MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome (2009) (19)
- Validation of mean upper cervical cord area (MUCCA) measurement techniques in multiple sclerosis (MS): High reproducibility and robustness to lesions, but large software and scanner effects (2019) (19)
- Subgenual Cingulate Cortex Functional Connectivity in Relation to Depressive Symptoms and Cognitive Functioning in Type 1 Diabetes Mellitus Patients (2016) (18)
- Multiple sclerosis: interobserver agreement in reporting active lesions on serial brain MRI using conventional spin echo, fast spin echo, fast fluid-attenuated inversion recovery and post-contrast T1-weighted images (1999) (18)
- Automatically computed rating scales from MRI for patients with cognitive disorders (2019) (18)
- T‐cell subsets in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients treated with high‐dose intravenous methylprednisolne (1993) (18)
- Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis (2015) (18)
- Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study (2018) (18)
- Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study (2020) (18)
- Impairment in complex activities of daily living is related to neurodegeneration in Alzheimer's disease–specific regions (2019) (18)
- Automated quantitative MRI volumetry reports support diagnostic interpretation in dementia: a multi-rater, clinical accuracy study (2021) (18)
- Coil-treated aneurysms: decision making regarding additional treatment based on findings of MR angiography and intraarterial DSA. (2012) (18)
- Callosal tissue loss parallels subtle decline in psychomotor speed. A longitudinal quantitative MRI study. The LADIS Study (2012) (18)
- Brain atrophy measurements should be used to guide therapy monitoring in MS – NO (2016) (18)
- Cortical cerebral blood flow in ageing: effects of haematocrit, sex, ethnicity and diabetes (2019) (18)
- Inter-rater variability in reporting enhancing lesions present on standard and triple dose gadolinium scans of patients with multiple sclerosis (1997) (17)
- Association of CSF, Plasma, and Imaging Markers of Neurodegeneration With Clinical Progression in People With Subjective Cognitive Decline (2022) (17)
- Magnetization transfer imaging of the spinal cord and the optic nerve in patients with multiple sclerosis. (1999) (17)
- Functional brain network centrality is related to APOE genotype in cognitively normal elderly (2018) (17)
- Retinal and Cerebral Microvasculopathy: Relationships and Their Genetic Contributions. (2018) (17)
- The use of magnetic resonance imaging in multiple sclerosis treatment trials: power calculations for annual lesion load measurement (2000) (17)
- Whole brain functional connectivity in clinically isolated syndrome without conventional brain MRI lesions (2016) (17)
- Diagnostic tools for the study of vascular cognitive dysfunction in hypertension and antihypertensive drug research. (2006) (17)
- Disease-related determinants are associated with mortality in dementia due to Alzheimer’s disease (2018) (17)
- Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS (2017) (17)
- Effects of Insulin Detemir and NPH Insulin on Body Weight and Appetite-Regulating Brain Regions in Human Type 1 Diabetes: A Randomized Controlled Trial (2014) (17)
- Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia (2019) (17)
- Brain network alterations in Alzheimer's disease measured by eigenvector centrality in fMRI are related to cognition and CSF biomarkers (2013) (17)
- Accelerated brain ageing and disability in multiple sclerosis (2019) (17)
- Comparing lesion segmentation methods in multiple sclerosis: Input from one manually delineated subject is sufficient for accurate lesion segmentation (2019) (17)
- Accurate MR Image Registration to Anatomical Reference Space for Diffuse Glioma (2020) (17)
- Pre- and post-mortem MR imaging of unsuspected multiple sclerosis in a patient with Alzheimer's disease (1993) (17)
- Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis—a systematic review (2021) (16)
- Regional analysis of volumes and reproducibilities of automatic and manual hippocampal segmentations (2017) (16)
- Prenatal Diagnosis of Aneurysms of the Vein of Galen (Vena Magna Cerebri) With Conventional Sonography, Three‐dimensional Sonography, and Magnetic Resonance Imaging (2003) (16)
- Brain reward responses to food stimuli among female monozygotic twins discordant for BMI (2017) (16)
- Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS). (2014) (16)
- Performance of PML diagnostic criteria in natalizumab-associated PML: data from the Dutch-Belgian cohort (2018) (16)
- How to use spinal cord magnetic resonance imaging in the McDonald diagnostic criteria for multiple sclerosis (2005) (16)
- Restricted diffusion in vanishing white matter. (2012) (16)
- Magnetic resonance image registration in multiple sclerosis: Comparison with repositioning error and observer‐based variability (2002) (16)
- White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β. (2016) (16)
- Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study (2021) (16)
- Histopathology-validated recommendations for cortical lesion imaging in multiple sclerosis (2020) (16)
- Brain microstructural and metabolic alterations detected in vivo at onset of the first demyelinating event (2021) (16)
- Indicators for cognitive performance and subjective cognitive complaints in multiple sclerosis: a role for advanced MRI? (2014) (16)
- Disorders Primarily Affecting White Matter (2002) (16)
- Manual and automated tissue segmentation confirm the impact of thalamus atrophy on cognition in multiple sclerosis: A multicenter study (2020) (16)
- Volumetric MRI data correlate to disease severity in metachromatic leukodystrophy (2015) (16)
- Language comprehension in nonspeaking children with severe cerebral palsy: Neuroanatomical substrate? (2015) (16)
- Cerebral rituximab uptake in multiple sclerosis: A 89Zr-immunoPET pilot study (2017) (16)
- Novel infantile-onset leukoencephalopathy with high lactate level and slow improvement. (2012) (15)
- Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort: The ABIDE project (2019) (15)
- Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab (2020) (15)
- “Top of the basilar” syndrome: A comparison of clinical and MR findings (2004) (15)
- 4H Leukodystrophy: A Brain Magnetic Resonance Imaging Scoring System. (2017) (15)
- Automated fiber tract reconstruction for surgery planning: Extensive validation in language-related white matter tracts (2019) (15)
- Interobserver agreement on the radiological criteria of the International Panel on the diagnosis of multiple sclerosis (2006) (15)
- Clinical relevance of acute cerebral microinfarcts in vascular cognitive impairment (2019) (15)
- Investigating the clinico-anatomical dissociation in the behavioral variant of Alzheimer disease (2019) (15)
- The natural history of primary progressive aphasia: beyond aphasia (2021) (15)
- Generalised boundary shift integral for longitudinal assessment of spinal cord atrophy (2019) (15)
- Cortical involvement determines impairment 30 years after a clinically isolated syndrome (2021) (15)
- Hypointense Lesions on T 1-Weighted Spin-Echo Magnetic Resonance Imaging Relation to Clinical Characteristics in Subgroups of Patients With Multiple Sclerosis (2001) (15)
- Characterization of symptoms and determinants of disease burden in dementia with Lewy bodies: DEvELOP design and baseline results (2021) (15)
- White matter hyperintensities and vascular risk factors in monozygotic twins (2018) (15)
- Can post-mortem MRI be used as a proxy for in vivo? A case study (2019) (15)
- Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study (2014) (14)
- Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis (2021) (14)
- White-Matter Changes on MRI as Surrogate Marker (2003) (14)
- Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders (2017) (14)
- Week 144 Results of a Phase II, Randomized, Multicenter Trial Assessing the Safety and Efficacy of Ocrelizumab in Patients with Relapsing–Remitting Multiple Sclerosis (RRMS) (S31.004) (2013) (14)
- Prediction of H3K27M-mutant brainstem glioma by amide proton transfer–weighted imaging and its derived radiomics (2021) (14)
- Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the study. (1995) (14)
- Degenerative adversarial neuroimage nets for brain scan simulations: Application in ageing and dementia (2019) (14)
- Robust Deep Learning–based Segmentation of Glioblastoma on Routine Clinical MRI Scans Using Sparsified Training (2020) (14)
- Molecular Imaging Approaches in Dementia. (2021) (14)
- Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies (2021) (14)
- Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study (2010) (14)
- Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis (2018) (14)
- Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis (2021) (14)
- Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers. (2015) (14)
- Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer’s Disease Multimodal Biomarker Discovery Cohort (2020) (14)
- Computer-assisted prediction of clinical progression in the earliest stages of AD (2018) (14)
- Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis (2017) (14)
- Cortical phase changes measured using 7‐T MRI in subjects with subjective cognitive impairment, and their association with cognitive function (2016) (14)
- High-dimensional detection of imaging response to treatment in multiple sclerosis (2019) (14)
- Brain miliary enhancement (2020) (13)
- Harmonization of neuroimaging biomarkers for neurodegenerative diseases: A survey in the imaging community of perceived barriers and suggested actions (2018) (13)
- Fingolimod Treatment Increases the Proportion of Patients Who Are Free from Disease Activity in Multiple Sclerosis Compared to IFN-b1a: Results from a Phase 3, Active-Controlled Study (TRANSFORMS) (PD5.006) (2012) (13)
- Motor testing at 1 year improves the prediction of motor and mental outcome at 2 years after perinatal hypoxic–ischaemic encephalopathy (2010) (13)
- Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study. (2020) (13)
- Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression (2012) (13)
- Single-subject gray matter networks predict future cortical atrophy in preclinical Alzheimer's disease (2020) (13)
- Differences between subgroups of MS: MRI findings and correlation with histopathology (2003) (13)
- The SIENA/FSL whole brain atrophy algorithm is no more reproducible at 3T than 1.5T for Alzheimer׳s disease (2014) (13)
- Oral or intravenous methylprednisolone for acute relapses of MS? (1997) (13)
- Correction: Single-Subject Grey Matter Graphs in Alzheimer's Disease (2013) (13)
- Quantitative MRI in hypomyelinating disorders (2016) (13)
- Latent atrophy factors related to phenotypical variants of posterior cortical atrophy (2020) (13)
- Disappearance of multiple sclerosis lesions with severely prolonged T1 on images obtained by a FLAIR pulse sequence. (1996) (13)
- Magnetization transfer contrast (MTC) and long repetition time spin-echo MR imaging in multiple sclerosis. (1998) (13)
- Meningeal Gd-DTPA enhancement in multiple sclerosis. (1992) (13)
- Erratum : Magnetic resonance imaging pattern recognition in hypomyelinating disorders (Brain (2010) 133 (2971-2982) DOI:10.1093/brain/awq257) (2013) (13)
- No structural cerebral differences between children with a history of bacterial meningitis and healthy siblings (2008) (13)
- Thallium-201 SPECT: the optimal prediction of response in glioma therapy (2006) (13)
- Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS (2021) (13)
- Suspected early dementia (2011) (13)
- Are Apathy and Depressive Symptoms Related to Vascular White Matter Hyperintensities in Severe Late Life Depression? (2020) (13)
- The sequence of structural, functional and cognitive changes in multiple sclerosis (2020) (13)
- Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types (2016) (13)
- Improved interobserver agreement for visual detection of active T2 lesions on serial MR scans in multiple sclerosis using image registration (2001) (13)
- Relationships between white matter hyperintensities, cerebral amyloid angiopathy and dementia in a population-based sample of the oldest old. (2013) (13)
- Automatic multiple sclerosis brain lesion localization and volumetry (2014) (12)
- Chronic hepatic encephlopathy studied by NMR spectroscopy and MRI in man (1991) (12)
- Magnetic resonance (MR) imaging as a marker for multiple sclerosis. (1999) (12)
- Disability in multiple sclerosis is related to thalamic connectivity and cortical network atrophy (2021) (12)
- Monocyte activation and disease activity in multiple sclerosis. A longitudinal analysis of serum MRP8/14 levels (2004) (12)
- Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent (2021) (12)
- Preoperative Resectability Estimates of Nonenhancing Glioma by Neurosurgeons and a Resection Probability Map. (2018) (12)
- Multimodal characterization of gray matter alterations in neuromyelitis optica (2018) (12)
- The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus. (2019) (12)
- A search for new MRI criteria for dissemination in space in subjects with a clinically isolated syndrome (2009) (12)
- Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre study (2011) (12)
- ASSOCIATION BETWEEN VITAMIN B6 AND WHITE MATTER HYPERINTENSITIES IN PATIENTS WITH ALZHEIMER'S DISEASE NOT MEDIATED BY HOMOCYSTEINE METABOLISM (2007) (12)
- Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes (2021) (12)
- Gadopentetate dimeglumine enhancement of multiple sclerosis lesions on long TR spin-echo images at 0.6 T. (1992) (12)
- 4H Leukodystrophy: A Brain Magnetic Resonance Imaging Scoring System (2017) (12)
- Performance of the Swanton multiple sclerosis criteria for dissemination in space (2010) (12)
- The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer’s disease (2014) (11)
- Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple Sclerosis (2022) (11)
- Reduced accuracy of MRI deep grey matter segmentation in multiple sclerosis: an evaluation of four automated methods against manual reference segmentations in a multi-center cohort (2020) (11)
- Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives (2021) (11)
- Quantifying eloquent locations for glioblastoma surgery using resection probability maps. (2020) (11)
- Value of fluid-attenuated inversion recovery sequences in early MRI of the brain in neonates with a perinatal hypoxic-ischemic encephalopathy (2000) (11)
- Hirayama disease; an atypical clinical manifestation of a cervical myelopathy with typical MRI features (2017) (11)
- Distinct influence of different vascular risk factors on white matter brain lesions in multiple sclerosis (2020) (11)
- A multi-shell multi-tissue diffusion study of brain connectivity in early multiple sclerosis (2020) (11)
- Contribution of white matter hyperintensities, medial temporal lobe atrophy and cortical atrophy on outcome, seven to twelve years after ECT in severely depressed geriatric patients. (2015) (11)
- Assessment of the biliary tract by ultrasonography and cholangiography during laparoscopic cholecystectomy: a prospective study. (1999) (11)
- Genetic Correlations of Brain Lesion Distribution in Multiple Sclerosis: An Exploratory Study (2011) (11)
- Demyelinating Diseases of the CNS (Brain and Spine) (2020) (11)
- Nonlinear Changes in Brain Activity During Continuous Word Repetition: An Event-Related Multiparametric Functional MR Imaging Study (2007) (11)
- Impact of Imaging and Cerebrospinal Fluid Biomarkers on Behavioral Variant Frontotemporal Dementia Diagnosis within a Late-Onset Frontal Lobe Syndrome Cohort (2015) (11)
- Risk of dementia in APOE ε4 carriers is mitigated by a polygenic risk score (2021) (10)
- No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardiolipin antibody testing based on magnetic resonance imaging and long term follow-up (2007) (10)
- Can leptomeningeal enhancement be linked to multiple sclerosis? (2015) (10)
- DHA intake relates to better cerebrovascular and neurodegeneration neuroimaging phenotypes in middle-aged adults at increased genetic risk of Alzheimer disease (2021) (10)
- Spinal cord atrophy in a primary progressive multiple sclerosis trial: Improved sample size using GBSI (2020) (10)
- ARPEGGIO: A randomized, placebo-controlled study to evaluate oral laquinimod in patients with primary progressive multiple sclerosis (PPMS) (P7.210) (2015) (10)
- Effects of MR scanner type, scanning sequence and segmentation algorithm on MR-based partial volume corrections of [11C](R)-PK11195 studies (2006) (10)
- Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis (2021) (10)
- Spatial concordance of DNA methylation classification in diffuse glioma (2021) (10)
- Medial temporal lobe atrophy and posterior atrophy scales normative values (2019) (10)
- Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab. (2019) (10)
- White matter microstructure disruption in early stage amyloid pathology (2021) (10)
- Fingolimod-Effect on Brain Atrophy and Clinical/MRI Correlations in Three Phase 3 Studies – TRANSFORMS, FREEDOMS and FREEDOMS II (S51.006) (2013) (10)
- Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosis (2020) (10)
- Using Unsupervised Learning to Identify Clinical Subtypes of Alzheimer's Disease in Electronic Health Records (2020) (10)
- Right temporal variant frontotemporal dementia is pathologically heterogeneous: a case-series and a systematic review (2021) (10)
- Multiple sclerosis progression: time for a new mechanism-driven framework (2022) (9)
- Methylphenidate and galantamine in patients with vascular cognitive impairment–the proof-of-principle study STREAM-VCI (2020) (9)
- TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels (2021) (9)
- Smartphone‐derived keystroke dynamics are sensitive to relevant changes in multiple sclerosis (2021) (9)
- Brain structural and functional alterations in MOG antibody disease (2020) (9)
- Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome (2021) (9)
- CSF cutoffs for MCI due to AD depend on APOEε4 carrier status (2019) (9)
- Quantification of spinal cord atrophy in MS: which software, which vertebral level, spinal cord or brain MRI? A multi-centric, longitudinal comparison of three different volumetric approaches. (2018) (9)
- An International Standardized Magnetic Resonance Imaging Protocol for Diagnosis and Follow-up of Patients with Multiple Sclerosis: Advocacy, Dissemination, and Implementation Strategies. (2020) (9)
- Derangement of adipose tissue: a case report of multicentric retroperitoneal liposarcomas, retroperitoneal lipomatosis and multiple subcutaneous lipomas. (1991) (9)
- Structural neuroimaging outcomes in clinical dementia trials, with special reference to disease modifying designs. (2006) (9)
- Quantification of amyloid PET for future clinical use: a state-of-the-art review (2022) (9)
- Quantification of Cervical Cord Cross-Sectional Area: Which Acquisition, Vertebra Level, and Analysis Software? A Multicenter Repeatability Study on a Traveling Healthy Volunteer (2021) (9)
- Nutritional status and structural brain changes in Alzheimer's disease: The NUDAD project (2020) (9)
- MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process (vol 11, pg 471, 2015) (2015) (9)
- Causes, effects and connectivity changes in MS-related cognitive decline (2016) (9)
- Cerebral blood flow and cognitive functioning in patients with disorders along the heart–brain axis (2020) (9)
- Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment: the effect of age at onset (2019) (9)
- Learning to Segment When Experts Disagree (2020) (9)
- Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study (2020) (9)
- OPL099 Betaferon® in newly emerging multiple sclerosis for initial treatment (BENEFIT): First results (2005) (9)
- Comparison of film-screen combination and digital fluorography in gastrointestinal barium examinations in a clinical setting. (1996) (9)
- A Semi-supervised Large Margin Algorithm for White Matter Hyperintensity Segmentation (2016) (9)
- Oral Fingolimod (FTY720) Treatment Improves the Performance of Daily Activities Compared with Intramuscular Interferon beta-1a: Patient-Reported Indices for Multiple Sclerosis (PRIMUS)-Activities Results from a Phase III Study (TRANSFORMS) (2010) (9)
- The relation between APOE genotype and cerebral microbleeds in cognitively unimpaired middle- and old-aged individuals (2020) (8)
- Multiple Sclerosis Therapy (1995) (8)
- Spatial-Temporal Patterns of β-Amyloid Accumulation: A Subtype and Stage Inference Model Analysis. (2022) (8)
- [18F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers (2021) (8)
- Classification of patients with a clinically isolated syndrome based on signs and symptoms is supported by magnetic resonance imaging results (2007) (8)
- Familial adult‐onset muscular dystrophy with leukoencephalopathy (1992) (8)
- Radiotherapy response of cerebral metastases quantified by serial MR imaging (2005) (8)
- Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer’s disease subgroups (2021) (8)
- The Right Temporal Variant of Frontotemporal Dementia Is Not Genetically Sporadic: A Case Series (2021) (8)
- Double-blind, placebo-controlled, MR monitored exploratory trial of chimeric anti-CD4 antibodies in MS. (1995) (8)
- Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple Sclerosis (2021) (8)
- Impact of Gradient Number and Voxel Size on Diffusion Tensor Imaging Tractography for Resective Brain Surgery. (2017) (8)
- Magnetic Resonance Imaging Hyperintensities in Alzheimer's Disease-Reply (1991) (8)
- Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT (2020) (8)
- MRI of the spinal cord in multiple sclerosis (1997) (8)
- Replication study of plasma proteins relating to Alzheimer's pathology (2021) (8)
- Differences in topological progression profile among neurodegenerative diseases from imaging data (2019) (8)
- Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials (2019) (8)
- Clinical evaluation of automated quantitative MRI reports for assessment of hippocampal sclerosis (2020) (8)
- Tau-related grey matter network breakdown across the Alzheimer’s disease continuum (2021) (8)
- Accelerated executive functions decline and gray matter structural changes in middle‐aged type 1 diabetes mellitus patients with proliferative retinopathy (2018) (8)
- Plasma Proteomic Biomarkers Relating to Alzheimer’s Disease: A Meta-Analysis Based on Our Own Studies (2021) (8)
- At the heart of primary progressive multiple sclerosis: three cases with diffuse MRI abnormalities only (2008) (7)
- P2-158 Effect of galantamine treatment on brain atrophy as assessed by MRI in patients with mild cognitive impairment (2004) (7)
- Meeting abstracts from the 5th International Clinical Trials Methodology Conference (ICTMC 2019) (2019) (7)
- Relationship between β-amyloid and structural network topology in decedents without dementia (2020) (7)
- HLA-DRB 1 * 1501 and Spinal Cord Magnetic Resonance Imaging Lesions in Multiple Sclerosis (2009) (7)
- Microbleeds are associated with depressive symptoms in Alzheimer's disease (2017) (7)
- Spinal cord MRI should always be performed in clinically isolated syndrome patients: Yes (2014) (7)
- MRI Natural History of the Leukodystrophy Vanishing White Matter. (2021) (7)
- Exploring resting state connectivity in patients with psychotic depression (2019) (7)
- Multiple Sclerosis and Variants (2019) (7)
- Strategies to reduce sample sizes in Alzheimer’s disease primary and secondary prevention trials using longitudinal amyloid PET imaging (2021) (7)
- Can Virtual Reality games improve scores on clinical balance scales in children with cerebral palsy: preliminary results of a randomized controlled clinical trial (2017) (7)
- Corpus Callosum Partitioning Schemes and Their Effect on Callosal Morphometry (2006) (7)
- cacy of vitamin D 3 as add-on therapy in patients with relapsing – remitting multiple sclerosis receiving subcutaneous interferon beta-1 a : A Phase II , multicenter , double-blind , randomized , placebo-controlled trial (2011) (7)
- MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies (2022) (7)
- Language Comprehension in Young People with Severe Cerebral Palsy in Relation to Language Tracts: A Diffusion Tensor Imaging Study (2013) (7)
- Impact of white matter hyperintensity location on depressive symptoms in memory-clinic patients: a lesion–symptom mapping study (2019) (7)
- Polymorphisms in the genes encoding interferon-γ and interferon-γ receptors in multiple sclerosis (2004) (7)
- Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study (2022) (7)
- Interaction of Vascular Damage and Alzheimer Dementia: Focal Damage and Disconnection. (2017) (7)
- Non-linear registration improves statistical power to detect hippocampal atrophy in aging and dementia (2019) (7)
- Validation of an MRI Rating Scale for Amyloid‐Related Imaging Abnormalities (2017) (7)
- Impact of early interferon beta-1b treatment on disease evolution over five years in patients with a first event suggestive of multiple sclerosis (2008) (7)
- Evaluation of prospective motion correction of high-resolution 3D-T2-FLAIR acquisitions in epilepsy patients☆ (2018) (7)
- Brain network alterations in Alzheimer's disease measured by eigenvector centrality in fMRI are related to cognition and cerebrospinal fluid biomarkers (2013) (7)
- Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease (2018) (6)
- Non-invasively measured brain activity and radiological progression in diffuse glioma (2021) (6)
- Accumulation of hypointense lesions (“black holes”) on T1 weighted images of multiple sclerosis patients correlates with disease progression in secondary progressive MS patients (1995) (6)
- How Do Different Forms of Vascular Brain Injury Relate to Cognition in a Memory Clinic Population: The TRACE-VCI Study. (2019) (6)
- Linear brain atrophy measures in multiple sclerosis and clinically isolated syndromes: a 30-year follow-up (2021) (6)
- Imaging phenotypes in multiple sclerosis. (2015) (6)
- Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy (2020) (6)
- Role of MR imaging in the diagnosis of MS (1996) (6)
- The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee (2004) (6)
- Serial quantitative MR assessment of optic neuritis in a case of neuromyelitis optica, using Gadolinium-“enhanced” STIR imaging (2004) (6)
- Glioblastoma Surgery Imaging–Reporting and Data System: Validation and Performance of the Automated Segmentation Task (2021) (6)
- Increased Sodium Intake Is Not Associated with MS Activity or Progression in BENEFIT (S37.002) (2016) (6)
- Minimal supportive treatment in natalizumab-related PML in a MS patient (2014) (6)
- Prediction of poor clinical outcome in vascular cognitive impairment: TRACE‐VCI study (2020) (6)
- Single-subject structural cortical networks in clinically isolated syndrome (2020) (6)
- Amyloid-driven disruption of default mode network connectivity in cognitively healthy individuals (2021) (6)
- Quantitative computer-assisted analysis vs. visual estimation of MR imaging response of brain metastases to radiotherapy. (1997) (6)
- Spinal cord atrophy rates (2018) (6)
- Multiple sclerosis: CCSVI deconstructed and discarded (2013) (6)
- Clinical Neuroradiology: The ESNR Textbook (2019) (6)
- Erratum: Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy (Journal of the Neurological Sciences 184 (2001) (155-162) PII: S0022510X01004312) (2001) (6)
- Localisation of the central sulcus region in glioma patients with three-dimensional fluid-attenuated inversion recovery and volume rendering: comparison with functional and conventional magnetic resonance (2011) (6)
- B Cells in the CNS at Postmortem Are Associated With Worse Outcome and Cell Types in Multiple Sclerosis (2021) (6)
- Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation (2022) (6)
- Molecular markers of Alzheimer's Disease pathology and their relationship with default mode network integrity (2011) (6)
- Randomized, Double-Blind, Placebo-Controlled Studies to Evaluate Treatment with Aducanumab (BIIB037) in Patients with Early Alzheimer’s Disease: Phase 3 Study Design (S1.003) (2016) (6)
- The presence of cerebral white matter lesions and lower skin microvascular perfusion predicts lower cognitive performance in type 1 diabetes patients with retinopathy but not in healthy controls—A longitudinal study (2019) (6)
- Erratum: Fetal origin of brain damage in 2 infants with a COL4A1 mutation: Fetal and neonatal MRI (Neuropediatrics (2011) 42:1 (1-3) DOI: 10.1055/s-0031-1275343) (2011) (6)
- Guidelines for Brain Imaging in Vascular Dementia Clinical Trials (2003) (6)
- Identifying and evaluating clinical subtypes of Alzheimer’s disease in care electronic health records using unsupervised machine learning (2021) (6)
- Grey matter network trajectories across the Alzheimer’s disease continuum and relation to cognition (2020) (6)
- Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients (2021) (6)
- Association of Education and Intracranial Volume With Cognitive Trajectories and Mortality Rates Across the Alzheimer Disease Continuum (2022) (6)
- Highly accurate volumetry of the spinal cord (2015) (6)
- NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study (2020) (6)
- Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum (2019) (6)
- Life course, genetic, and neuropathological associations with brain age in the 1946 British Birth Cohort: a population-based study. (2022) (6)
- Cerebral effects of glucagon‐like peptide‐1 receptor blockade before and after Roux‐en‐Y gastric bypass surgery in obese women: A proof‐of‐concept resting‐state functional MRI study (2020) (6)
- Differential impact of subclinical carotid artery disease on cerebral structure and functioning in type 1 diabetes patients with versus those without proliferative retinopathy (2014) (6)
- Use of Imaging in Multiple Sclerosis (2010) (6)
- Long-Term Efficacy and Safety of Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): Week 96 Results of a Phase II, Randomized, Multicenter Trial (S30.006) (2012) (5)
- Body mass index as a predictor of MS activity and progression among participants in BENEFIT (2022) (5)
- A novel CCM2 variant in a family with non‐progressive cognitive complaints and cerebral microbleeds (2016) (5)
- Uncertainty analysis of MR-PET image registration for precision neuro-PET imaging (2021) (5)
- ARPEGGIO: a placebo-controlled trial of oral laquinimod in primary progressive multiple sclerosis (S8.003) (2018) (5)
- Circulating metabolites are associated with brain atrophy and white matter hyperintensities (2020) (5)
- AI-based decision support improves reproducibility of tumor response assessment in neuro-oncology: an international multi-reader study. (2022) (5)
- Gray matter network differences between behavioral variant frontotemporal dementia and Alzheimer's disease (2017) (5)
- Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individuals (2021) (5)
- Human Gray Matter: Feasibility of Single-Slab3DDoubleInversion- RecoveryHigh-Spatial-Resolution (2006) (5)
- Clinical Applications of Functional Brain MRI (2016) (5)
- ExploreASL: image processing toolbox for multi-center arterial spin labeling population analyses (2017) (5)
- Mapping Deep Gray Matter Iron in Multiple Sclerosis by Using Quantitative Magnetic Susceptibility. (2018) (5)
- Novel imaging phantom for accurate and robust measurement of brain atrophy rates using clinical MRI (2019) (5)
- Subtyping relapsing–remitting multiple sclerosis using structural MRI (2021) (5)
- Spatial-Temporal Patterns of β-Amyloid Accumulation (2022) (5)
- Laminar cortical damage in multiple sclerosis. (2015) (5)
- TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer’s disease biomarker levels (2020) (5)
- Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis (2022) (5)
- Neurological Signs in Relation to White Matter Hyperintensity Volumes in Memory Clinic Patients (2010) (5)
- Glioblastoma Surgery Imaging—Reporting and Data System: Standardized Reporting of Tumor Volume, Location, and Resectability Based on Automated Segmentations (2021) (5)
- Association of APOE polymorphisms with disease severity in MS is limited to women (2004) (5)
- A randomized, double-blind, placebo-controlled dose-finding trial of intravenous immunoglobulin (IVIG; Octagam® 10%, Octapharma AG) in patients with mild to moderate Alzheimer's disease (GAM10-04) (2011) (5)
- The protective gene dose effect of the APOE ε2 allele on gray matter volume in cognitively unimpaired individuals (2021) (5)
- AMYLOID-BETA ACCUMULATION AFFECTS IN VIVO STAGING OF TAU DEPOSITION IN COGNITIVELY IMPAIRED INDIVIDUALS (2019) (5)
- Idiopathic acute transverse myelitis : Application of the recent diagnostic criteria. Author's reply (2006) (5)
- WHAT DETERMINES COGNITIVE FUNCTIONING IN THE OLDEST-OLD? THE EMIF-AD 90+ STUDY (2019) (5)
- Opportunities for Understanding MS Mechanisms and Progression With MRI Using Large-Scale Data Sharing and Artificial Intelligence (2021) (5)
- Associations of Brain Pathology Cognitive and Physical Markers With Age in Cognitively Normal Individuals Aged 60–102 Years (2019) (5)
- Amyloid‐β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest‐old (2021) (5)
- Alemtuzumab-Treated Patients with RRMS Demonstrate Durable Slowing of Brain Volume Loss Over 5 Years Despite Most Being Treatment-Free for 4 Years: CARE-MS I and II Extension Study (S51.001) (2016) (5)
- Relationship Between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis (2022) (5)
- The optic nerve should be included as one of the typical CNS regions for establishing dissemination in space when diagnosing MS – Commentary (2018) (5)
- Sex differences in memory clinic patients with possible vascular cognitive impairment (2020) (5)
- Whole-brain T1-relaxation time measurements in multiple sclerosis (2002) (4)
- Automated Classification of Intramedullary Spinal Cord Tumors and Inflammatory Demyelinating Lesions Using Deep Learning. (2022) (4)
- 2014 Joint ACTRIMS-ECTRIMS Meeting (MSBoston 2014): Oral Presentations (2014) (4)
- Severe irreversible optic neuritis following Mantoux tuberculin skin test in a child with multiple sclerosis--a case report. (1997) (4)
- Biomarker testing in MCI patients—deciding who to test (2021) (4)
- Basal forebrain and hippocampus as predictors of conversion to Alzheimer’s disease in patients with mild cognitive impairment: A multicenter DTI and volumetry study (2015) (4)
- FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosis (2020) (4)
- INVESTIGATING ARTERIAL SPIN LABELING AS A LARGE VESSEL CORRELATE OF SVD, AD, AND PD (2018) (4)
- Direct comparison of [11C] choline and [18F] FET PET to detect glioma infiltration: a diagnostic accuracy study in eight patients (2019) (4)
- Genetically identical twins show comparable tau PET load and spatial distribution (2022) (4)
- Description of a European memory clinic cohort undergoing amyloid‐PET: The AMYPAD Diagnostic and Patient Management Study (2022) (4)
- Neuromyelitis Optica Spectrum Disorders (NMOSD) (2019) (4)
- Methylprednisolone treatment in multiple sclerosis: effect of treatment, pharmacokinetics, future (1996) (4)
- Diagnostic relevance of high field MRI in clinical neuroradiology: the advantages and challenges of driving a sports car (2012) (4)
- Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's disease (2016) (4)
- Clustering of autoimmune disease in families at high risk for multiple sclerosis (2007) (4)
- The role of spinal cord imaging in the diagnosis of multiple sclerosis (2006) (4)
- A systematic review on the use of quantitative imaging to detect cancer therapy adverse effects in normal-appearing brain tissue (2021) (4)
- Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6 (2021) (4)
- Targeted Screening for Alzheimer's Disease Clinical Trials Using Data-Driven Disease Progression Models (2021) (4)
- PREDICTION OF PRODROMAL AD IN MCI SUBJECTS USING MULTICENTER DTI AND MRI DATA AND MULTIPLE KERNELS SVM: AN EDSD STUDY (2014) (4)
- Serum 25-hydroxyvitamin D concentrations among patients in BENEFIT predicts conversion to multiple sclerosis, MRI lesions, and brain volume loss (2012) (4)
- Impact of partial volume corrections on quantitative brain PET studies (2012) (4)
- Interindividual differences in stimulus response curve in the striate cortex as a function of flicker frequency: an fMRI study (2001) (4)
- A powerful tool in diagnosis and prognosis Spinal cord lesions in patients with clinically isolated syndrome : March 8 (4)
- Ocrelizumab May Reduce Tissue Damage in Chronic Active Lesions as Measured by Change in T1 Hypo-Intensity of Slowly Evolving Lesions in Patients With Primary Progressive Multiple Sclerosis (P3.376) (2018) (4)
- Impact of 3 Tesla MRI on diagnosis in clinically isolated syndrome: a MAGNIMS multicentre study (2016) (4)
- Grey zone amyloid burden affects memory function: the SCIENCe project (2020) (4)
- Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset (2022) (4)
- Effect of fingolimod versus interferon-beta1a on no evidence of disease activity or worsening (NEDA-4) in the TRANSFORMS study (P4.001) (2015) (4)
- Structural and functional hippocampal alterations in Multiple sclerosis and neuromyelitis optica spectrum disorder (2021) (4)
- Cranio-caudal patterns of cervical cord atrophy progression in MS according to disease phenotype and clinical worsening: a multicenter study. (2018) (4)
- Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis (2022) (4)
- Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease (2019) (4)
- Tau-first subtype of Alzheimer's disease consistently identified across in vivo and post mortem studies (2020) (4)
- Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study (2022) (4)
- Redefining multiple sclerosis phenotypes using MRI (2019) (3)
- A Randomized Trial of High-Dose Vitamin D2 in Relapsing-remitting Multiple Sclerosis (2012) (3)
- “Benign” and “normal appearing”: it’s in the eye of the beholder (2009) (3)
- Consistent Reduction In The Annualized Rate Of Brain Volume Loss Across Phase 3 Core And Extension Trials Of Fingolimod In Relapsing Multiple Sclerosis (P3.180) (2014) (3)
- The Open-Access European Prevention of Alzheimer’s Dementia (EPAD) MRI dataset and processing workflow (2022) (3)
- Optimizing diffusion measurements for large-scale, multicenter multiple sclerosis trials: a pan-European study (2008) (3)
- Grey matter network markers identify individuals with prodromal Alzheimer’s disease who will show rapid clinical decline (2022) (3)
- Evaluating severity of white matter lesions from computed tomography images with convolutional neural network (2020) (3)
- DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) (2012) (3)
- Small vessel disease lesion type and brain atrophy: The role of co‐occurring amyloid (2020) (3)
- Differential trajectories of hypometabolism across cognitively-defined Alzheimer’s disease subgroups (2021) (3)
- Vitamin D as a predictor of multiple sclerosis activity and progression. (2013) (3)
- Transient Cognitive Impairment and White Matter Hyperintensities in Severely Depressed Older Patients Treated With Electroconvulsive Therapy. (2021) (3)
- The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study (2017) (3)
- Why Is Amyloid-β PET Requested After Performing CSF Biomarkers? (2019) (3)
- No influence of KIF1B on neurodegenerative markers in multiple sclerosis (2011) (3)
- Comorbid amyloid-β pathology affects clinical and imaging features in VCD (2019) (3)
- Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer’s Disease Pathology (2020) (3)
- COMPUTED RATING SCALES FOR COGNITIVE DISORDERS FROM MRI (2017) (3)
- Amyloid-β, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer’s disease (2021) (3)
- Where is VALDO? VAscular Lesions Detection and segmentatiOn challenge at MICCAI 2021 (2022) (3)
- Imaging Alzheimer in 2011 (2011) (3)
- Association of the ATN Research Framework With Clinical Profile, Cognitive Decline, and Mortality in Patients With Dementia With Lewy Bodies (2022) (3)
- The European Prevention of Alzheimer’s Dementia (EPAD) MRI Dataset and Processing Workflow (2021) (3)
- Imaging beta amyloid deposition in vivo: Quantitative comparison of [18F]FDDNP and [11C]PIB (2007) (3)
- Symptomatic Treatment of Vascular Cognitive Impairment (STREAM-VCI): Protocol for a Cross-Over Trial (2018) (3)
- The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis (2022) (3)
- RESTING STATE CEREBRAL PERFUSION AND METABOLISM IN SUBJECTIVE MEMORY COMPLAINTS: ALZHEIMER'S DISEASE AND FRONTOTEMPORAL DEMENTIA–TWO SIDES OF THE SAME COIN? (2014) (3)
- Modeling MR Imaging Enhancing-Lesion Volumes in Multiple Sclerosis: Application in Clinical Trials (2011) (3)
- Predicting Alzheimer's disease progression: Results from the TADPOLE Challenge (2020) (3)
- Making better use of our brain MRI research data (2012) (3)
- CORTICAL PHASE CHANGES AT 7T MRI IN SUBJECTIVE COGNITIVE IMPAIRMENT AND THEIR ASSOCIATION WITH COGNITIVE FUNCTION (2014) (3)
- REGIONAL DISTRIBUTION OF WHITE MATTER HYPERINTENSITY CORRELATES WITH COGNITION IN THE ALFA COHORT (2018) (3)
- Preoperative Brain Tumor Imaging: Models and Software for Segmentation and Standardized Reporting (2022) (3)
- Risk of false negative JC virus PCR in CSF of natalizumab-associated PML patients reflects low PML lesion volume. (2016) (3)
- MRI Analyses in RRMS Patients with Highly Active Disease: Results from FREEDOMS and TRANSFORMS Phase 3 Studies (P01.134) (2012) (3)
- Corrigendum to “Combining shape and connectivity analysis: An MRI study of thalamic degeneration in Alzheimer's disease” [NeuroImage 49 (2010) 1–8] (2010) (3)
- Predicting prodromal Alzheimer's disease in people with mild cognitive impairment using multicenter diffusion-tensor imaging data and machine learning algorithms (2013) (3)
- Analysis of Psychological Symptoms Following Disclosure of Amyloid–Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline (2023) (3)
- ADVANCED DIFFUSION WEIGHTING IMAGING (DWI) TRACTOGRAPHY OF THE LIMBIC SYSTEM: NOVEL BIOMARKERS OF NEURODEGENERATIVE CHANGES DURING PROGRESSION/CONVERSION FROM COGNITIVE NORMALITY TO AD DEMENTIA (2014) (3)
- RRMS Patients Switching from SC IFNB-1a to Alemtuzumab in the CARE-MS I and II Extension Study Have a Reduced Rate of Brain Volume Loss (P6.183) (2016) (3)
- Different patterns of cortical gray matter loss in behavioral variant FTD and AD (2015) (3)
- Effects of Dapagliflozin and Combination Therapy With Exenatide on Food-Cue Induced Brain Activation in Patients With Type 2 Diabetes (2022) (3)
- Erratum to: Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis (2014) (3)
- clinical and MRI outcomes in multiple sclerosis (2015) (3)
- Diagnostic algorithm for relapsing demyelinating syndromes of the CNS in children (2017) (3)
- Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging (2022) (3)
- Voxelwise statistical methods to localize practice variation in brain tumor surgery (2019) (3)
- Damage in the Thalamocortical Tracts is Associated With Subsequent Thalamus Atrophy in Early Multiple Sclerosis (2020) (3)
- Patterns of white matter hyperintensities associated with cognition in middle-aged cognitively healthy individuals (2019) (3)
- Choosing Drug Therapy for Multiple Sclerosis (1998) (3)
- Earliest radiological progression in glioblastoma by multidisciplinary consensus review (2018) (3)
- Secondary prevention of Alzheimer ' s dementia (2018) (3)
- Long-term Impact of Early MS Treatment with Interferon Beta-1b (IFNB-1b): Clinical, MRI, Employment, and Patient-Reported Outcomes (PROs) at the 11-Year Follow-up of BENEFIT (BENEFIT 11) (P7.012) (2015) (3)
- Interleukin-2 therapy does not exacerbate multiple sclerosis (1997) (3)
- Prion disease diagnosis using subject-specific imaging biomarkers within a multi-kernel Gaussian process (2019) (3)
- Quantifying spinal cord demyelination with magnetic transfer imaging (2005) (3)
- Evaluating robustness of the Centiloid scale against variations in amyloid PET image resolution (2021) (3)
- Subjective cognitive decline and self‐reported sleep problems: The SCIENCe project (2022) (2)
- Amyloid-β, p-tau, and reactive microglia load are correlates of MRI cortical atrophy in Alzheimer’s disease (2021) (2)
- Author Correction: Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data (2021) (2)
- Normalized brain volume predicts cognitive performance in MS: an analysis of a large cohort from fingolimod phase III studies (P7.284) (2015) (2)
- Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple Sclerosis (2022) (2)
- MRI monitoring of cerebral atrophy during a placebo-controlled trial of interferon-beta-1b in secondary progressive multiple sclerosis (2000) (2)
- PREDICTION OF PRODROMAL AD IN MCI SUBJECTS USING MULTICENTER DTI AND MRI DATA AND MULTIPLE KERNELS SVM: AN EDSD STUDY (2014) (2)
- ADVANCED DIFFUSION WEIGHTING IMAGING (DWI) TRACTOGRAPHY OF THE LIMBIC SYSTEM: NOVEL BIOMARKERS OF NEURODEGENERATIVE CHANGES DURING PROGRESSION/CONVERSION FROM COGNITIVE NORMALITY TO AD DEMENTIA (2014) (2)
- P1-371: New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population (2008) (2)
- Fetal Familial Cerebral Cavernous Malformation With a Novel Heterozygous KRIT1 Variation (2021) (2)
- Application of the revised version of the 2010 McDonald diagnostic criteria: retrospective comparison using the BEN-EFIT clinical study dataset (2012) (2)
- Imaging biomarkers for the diagnosis of Prion disease (2018) (2)
- Alterations in white matter volume and integrity in obesity and type 2 diabetes (2016) (2)
- Ibuprofen does not suppress active multiple sclerosis lesions on gadolinium‐enhanced MR images (1997) (2)
- Prognostic relevance of antimyelin antibodies for progression to multiple sclerosis after a first demyelinating event: results from the BENEFIT study (2006) (2)
- Parametric imaging of dual-time window [18F]flutemetamol and [18F]florbetaben studies (2021) (2)
- A Beginner's Guide to Arterial Spin Labeling (ASL) Image Processing (2022) (2)
- Daclizumab in multiple sclerosis: a high-yield extension study (2014) (2)
- The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease (2020) (2)
- Pharmacovigilance during treatment of multiple sclerosis: early recognition of CNS complications (2020) (2)
- Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study (2022) (2)
- Segmental muscular atrophy of the distal upper extremity (Hirayama disease) : An atypical case with anterior dural detachment (2009) (2)
- Early Initiation of Interferon Beta-1b after a First Clinical Event Suggestive of Multiple Sclerosis: Clinical Outcomes and Use of Disease-Modifying Therapy from the BENEFIT Extension Study (PD5.002) (2012) (2)
- Structural MRI predictors of cognitive decline in MS (2017) (2)
- The bvFTD phenocopy syndrome: a case study supported by repeated MRI, [18F]FDG-PET and pathological assessment (2021) (2)
- Interferon-beta-1b reduces development of T1 black holes on MRI in secondary progressive multiple sclerosis (2000) (2)
- 3 D Double Inversion Recovery for High Resolution Gray Matter Brain Imaging (2001) (2)
- Comparison of Medial Temporal Lobe Activation in Young and Elderly Subjects and Patients with Alzheimer's Disease. (1998) (2)
- Visual Function and Brief Cognitive Assessment for Multiple Sclerosis in Optic Neuritis Clinically Isolated Syndrome Patients (2021) (2)
- A deep learning algorithm for white matter hyperintensity lesion detection and segmentation (2021) (2)
- The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis (2022) (2)
- Comparison of measurements of medial temporal lobe atrophy in the prediction of Alzheimer's Disease in subjects with MCI (2011) (2)
- Predicting short-term disability progression in early MS : added value of MRI parameters (2011) (2)
- MR imaging criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance (2018) (2)
- Feature extraction and strategy of analyzing structural neuroimaging in dementia. (2008) (2)
- Simulation and Synthesis in Medical Imaging (2016) (2)
- High reproducibility and robustness to lesions, but large software and scanner effects for mean upper cervical cord area (MUCCA) measurement in MS (2018) (2)
- Multiple Sclerosis and Chronic Cerebrospinal Venous Insufficiency: The Neuroimaging Perspective (2011) (2)
- Determining the Minimal Important Change of Everyday Functioning in Dementia (2022) (2)
- Classification of Dementia (2002) (2)
- ACROSS-SESSION REPRODUCIBILITY OF AUTOMATIC WHITE MATTER HYPERINTENSITIES SEGMENTATION: A EUROPEAN MULTI-SITE 3T STUDY (2017) (2)
- White Matter Lesion Progression in LADIS (2012) (2)
- MICROBLEEDS ARE ASSOCIATED WITH DEPRESSIVE SYMPTOMS IN ALZHEIMER’S DISEASE (2017) (2)
- Long-term effect of early treatment with interferon-beta-1b after a first clinical event suggestive of multiple sclerosis: 8-year observational extension of the phase 3 BENEFIT trial (2011) (2)
- Grey matter networks and clinical progression in subjects with predementia Alzheimer ’ s disease (2017) (2)
- ePresentation Sessions (2018) (2)
- Aggression and multiple sclerosis (1991) (2)
- arterial s pin l abeling May contribute to the Prediction of cognitive Deterioration in (2015) (2)
- Differential impact of apolipoprotein E genotype on distributions of amyloid load and glucose metabolism in Alzheimer's disease (2012) (2)
- Defining multiple sclerosis subtypes using machine learning (2019) (2)
- Converging evidence for a “gray‐zone” of amyloid burden and its relevance (2020) (2)
- The role of MRI as a surrogate outcome measure in multiple sclerosis (2002) (2)
- DISEASE-STAGE SPECIFIC RELATIONSHIP BETWEEN COGNITIVE RESERVE AND CLINICAL PROGRESSION IN ALZHEIMER’S DISEASE (2018) (2)
- Lesion detection at 7 Tesla in Multiple Sclerosis using 3 D magnetization prepared 3 D-FLAIR and 3 D-DIR (2012) (2)
- Cerebral amyloid burden is associated with white matter hyperintensity location in speci fi c posterior white matter regions Neurobiology of Aging (2019) (2)
- Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer’s disease (2022) (2)
- Switching to Alemtuzumab From Subcutaneous Interferon Beta-1a After CARE-MS II Further Improved MRI Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis (P7.248) (2015) (2)
- Development of multivariable prediction models for institutionalization and mortality in the full spectrum of Alzheimer’s disease (2022) (2)
- Post-mortem correlates of Virchow-Robin spaces detected on in vivo MRI (2022) (2)
- First ever longitudinal [11C]PIB and [18F]FDDNP PET studies in patients with Alzheimer's disease or mild cognitive impairment and healthy controls (2010) (2)
- Cognitive Functioning and Hippocampal Connectivity in Patients With Longstanding Type 1 Diabetes and Apolipoprotein E ε4 (2021) (2)
- Cerebral amyloid angiopathy in Alzheimer’s disease is associated with increased blood-brain barrier permeability: A quantitative [11C]PiB-PET study (2013) (2)
- EVENT-BASED MODELING OF THE TEMPORAL ORDERING OF REGIONAL β-AMYLOID DEPOSITION IN THE BRAIN (2018) (2)
- Regional associations of white matter hyperintensities and early cortical amyloid pathology (2022) (2)
- Atrophy , hypometabolism and clinical trajectories in amyloid negative probable AD patients (2018) (2)
- Cerebral blood flow, amyloid burden, and cognition in cognitively normal individuals (2022) (2)
- Database for serial magnetic resonance imaging in multiple sclerosis (2004) (2)
- Differential Dementia Diagnosis on Incomplete Data with Latent Trees (2016) (2)
- Application of mechanistic methods to clinical trials in multiple sclerosis: the simvastatin case (2018) (2)
- Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective (2022) (2)
- Quantitative PET and Histology of Brain Biopsy Reveal Lack of Selective Pittsburgh Compound-B Binding to Intracerebral Amyloidoma. (2018) (2)
- IMPACT OF WHITE MATTER HYPERINTENSITY LOCATION ON DEPRESSIVE SYMPTOMS IN MEMORY CLINIC PATIENTS: A LESION-SYMPTOM MAPPING STUDY (2018) (2)
- Methylprednisolone for Acute Relapses of Multiple Sclerosis (1998) (1)
- Patterns of cerebral atrophy detected by voxel-based morphometry (VBM) in Alzheimer's disease (2002) (1)
- Multikernel Gaussian Processes for patient stratification from imaging biomarkers with heterogeneous patterns (2017) (1)
- Resting-state Functional mR imaging : A New Window to the Brain 1 (2014) (1)
- Differential diagnosis in brain abnormalities with a miliary enhancing pattern (2011) (1)
- P029: A Dutch 24-week randomised controlled study exploring the Effect of a Nutritional Intervention on brain Glucose Metabolism in early Alzheimer's disease (NL-ENIGMA) rationale and design (2014) (1)
- Brain atrophy quantification in multiple sclerosis (2014) (1)
- Baseline Predictors of Disease Activity in Patients with CIS Treated with Interferon beta-1b in the BENEFIT 11 Trial (P2.121) (2016) (1)
- ATN classification in dementia with Lewy bodies: Association with clinical profile, cognitive decline and survival (2021) (1)
- 1 4 H leukodystrophy : a brain MRI scoring system (2017) (1)
- COGNITIVELY DEFINED SUBTYPES OF ALZHEIMER’S DISEASE ARE ASSOCIATED WITH DISTINCT PATTERNS OF ATROPHY (2018) (1)
- The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact (2023) (1)
- Structural and functional hippocampal changes in multiple sclerosis patients with intact memory (2011) (1)
- Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice (2022) (1)
- Structural MRI corrrelates of cognitive impairment in patients with multiple sclerosis: a multicentre study (2013) (1)
- Large-scale objective comparison of 29 novel algorithms for computer-aided diagnosis of dementia based on structural MRI (2015) (1)
- Grey matter network disruptions are related to amyloid-beta in cognitively healthy elderly (2015) (1)
- The prognostic significance of early blood neurofilament light chain concentration and magnetic resonance imaging variables in relapse‐onset multiple sclerosis (2022) (1)
- VOLUMETRIC ACCURACY OF A FULLY AUTOMATIC TOOL FOR WHITE MATTER HYPERINTENSITIES (WMHS) SEGMENTATION (2018) (1)
- A more unstable resting-state functional network in cognitively declining multiple sclerosis (2022) (1)
- Predicting conversion to clinically definite multiple sclerosis using machine learning on the basis of cerebral grey matter segmentations (2015) (1)
- Longitudinal changes in specific [11C]PIB and [18F]FDDNP binding: Paired PET studies in patients with Alzheimer's disease, mild cognitive impairment and healthy controls (2011) (1)
- Distinctive structural and functional MRI footprint for cognitive dysfunction in pediatric MS? (2014) (1)
- Subject Index Vol. 13, Suppl. 2, 2002 (2002) (1)
- NIMG-38. QUALITY OF SURGICAL DECISION MAKING FOR PATIENTS WITH A GLIOBLASTOMA IS SIMILAR BETWEEN NEURO-ONCOLOGICAL CARE TEAMS FROM THE UNITED STATES OF AMERICA AND THE NETHERLANDS (2017) (1)
- Influence of incidental off-resonance RF excitation in conventional multislice T1-weichted SE MR imaging: Implications for assessment of “Black holes” (1995) (1)
- Data-driven detection of latent atrophy factors related to phenotypical variants of posterior cortical atrophy (2019) (1)
- RNFL as a Surrogate Outcome Marker in Patients with Multiple Sclerosis: Design of the OCTiMS study, Baseline Characteristics and OCT Test Reproducibility (P7.224) (2015) (1)
- Erratum to “Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy” [J. Neurol. Sci. 184 (2001) 155–162] (2001) (1)
- Effects of interferon beta-1 b on cognitive performance in patients with a first event suggestive of multiple (2012) (1)
- IC-P3-229: Assessment of global cortical atrophy and medial temporal lobe atrophy in suspected and definite dementia: Comparison of magnetic resonance imaging and 64 multi-detector row computed tomography (2008) (1)
- Seeing more with less: virtual gadolinium-enhanced glioma imaging. (2021) (1)
- DISCOVERY, REPLICATION AND EXTENSION STUDY OF PLASMA PROTEOMIC BIOMARKERS RELATING TO BRAIN AMYLOID BURDEN AND ALZHEIMER’S DISEASE PROGRESSION (2018) (1)
- PERSONALIZED RISK ESTIMATES FOR MCI PATIENTS: TAKING BIOMARKERS INTO THE CLINIC (2016) (1)
- HARMONIZATION OF NEUROIMAGING BIORMARKERS FOR NEURODEGENERATIVE DISEASES: A SURVEY FOR BEST PRACTICE GUIDELINES (2017) (1)
- O1-03-06 Consistency of Resting State Networks across healthy subjects measured with FMRI (2006) (1)
- Asymptomatic spinal cord lesions do not predict long term disability in patients with CIS or early MS (2016) (1)
- Reply from the authors [2] (2007) (1)
- MR imaging in monitoring the treatment of MS: Making good use of resources (1996) (1)
- What do data‐driven Alzheimer’s disease subtypes tell us about white matter pathology and clinical progression? (2021) (1)
- Magnetic Resonance and Dementia (2002) (1)
- Learning from multiple annotators for medical image segmentation (2023) (1)
- Amygdalar nuclei and hippocampal subfields on MRI: Test‐retest reliability of automated segmentation in old and young healthy volunteers (2020) (1)
- VOXEL-BASED AMYLOID PET STAGING FOR THE WHOLE ALZHEIMER’S DISEASE CONTINUUM (2019) (1)
- Vascular and amyloid pathologies in memory clinic patients: Synergetic or independent? (2015) (1)
- In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET (2018) (1)
- Genetic modification of 25(OH)D levels in MS (2014) (1)
- Proposed guidelines for MS cortical lesion scoring using double inversion recovery (DIR) MRI. (2010) (1)
- Functional brain networks in AD: Randomization of a “small-world” (2009) (1)
- Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6 (2021) (1)
- IC-P-102 Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression: The LADIS study (2006) (1)
- O 051 – Does video game-based balance-training improve gait stability in children with cerebral palsy? (2018) (1)
- Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan: Response. (2017) (1)
- Leukodystrophies and Inherited Metabolic Conditions (2019) (1)
- Increased parietal amyloid burden and metabolic dysfunction in Alzheimer's disease (2012) (1)
- Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6 (2021) (1)
- White matter integrity disruption in early amyloid accumulators (2020) (1)
- Structural neuroimaging: CT and MRI (2009) (1)
- ADDED VALUE OF MRI BIOMARKERS TO NEUROPSYCHOLOGICAL TEST PERFORMANCE FOR PREDICTION OF AD IN SUBJECTS WITH MCI (2014) (1)
- EUROPEAN MEDICAL INFORMATION FRAMEWORK FOR ALZHEIMER’S DISEASE (EMIF-AD): THE BIOMARKER DISCOVERY STUDY (2017) (1)
- Contribution of CSF to the Diagnosis of McDonald MS: Retrospective Analysis in the BENEFIT Study (P03.235) (2013) (1)
- AMYLOID VISUALIZATION IN THE RETINA OF ALZHEIMER’S DISEASE PATIENTS WITH CURCUMIN (2017) (1)
- Lower cerebral blood flow is associated with cognitive decline in patients with Alzheimer’s disease (2015) (1)
- P2-222 A comparison of whole-brain activation during face encoding between healthy aging, mild cognitive impairment and Alzheimer's disease (2004) (1)
- STUDY PROTOCOL: THE EFFECT OF PHYSICAL EXERCISE ON CEREBRAL BLOOD FLOW AND COGNITION IN PATIENTS WITH MILD VASCULAR COGNITIVE IMPAIRMENT (2014) (1)
- Author Correction: High-dimensional detection of imaging response to treatment in multiple sclerosis (2019) (1)
- MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study (2018) (1)
- Automatic classification of AD and bvFTD based on cortical atrophy for single-subject diagnosis (2015) (1)
- Rare variants in IFFO1, DTNB and NLRC3 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation (2021) (1)
- THUR 174 The magnify-ms study: mavenclad® tablets in active rms (2018) (1)
- Hypometabolism of the posterior cingulate cortex is not restricted to Alzheimer's disease (2015) (1)
- DECLINE IN GREY MATTER CONNECTIVITY OVER TIME IS RELATED TO CLINICAL PROGRESSION IN MCI DUE TO AD (2018) (1)
- MRI data-driven clustering reveals different subtypes of Dementia with Lewy bodies (2023) (1)
- Poster Session‐Sunday (2016) (1)
- Small vessel disease lesion type and brain atrophy: The role of coâ•’occurring amyloid (2020) (1)
- The association of cerebral small vessel disease and frailty in patients with vascular cognitive impairment (2013) (1)
- T-cell vaccination in MS with CSF-derived activated CD4(+) T-cells: Results of a placebo-controlled trial (2006) (1)
- Structural brain imaging (2006) (1)
- Timing of glioblastoma surgery and patient outcomes: a multicenter cohort study (2021) (1)
- Development and evaluation of a manual segmentation protocol for deep grey matter in multiple sclerosis: Towards accelerated semi-automated references (2021) (1)
- AMYPAD: A EUROPEAN PUBLIC-PRIVATE PARTNERSHIP TO INVESTIGATE THE VALUE OF β-AMYLOID BRAIN SCANS AS A DIAGNOSTIC AND THERAPEUTIC MARKER FOR ALZHEIMER’S DISEASE (2017) (1)
- Multiomics profiling of human plasma and CSF reveals ATN derived networks and highlights causal links in Alzheimer's disease (2022) (1)
- MRI enhancing lesion frequency from patients with MS enrolled in the placebo arms of clinical trials or in natural history studies. (1999) (1)
- Advanced MR Techniques for Preoperative Glioma Characterization: Part 2. (2023) (1)
- VOXEL-BASED AMYLOID PET STAGING FOR THE WHOLE ALZHEIMER’S DISEASE CONTINUUM (2019) (1)
- Neuroprotective Treatment in Primary Progressive Multiple Sclerosis: a Phase I/II Study with Riluzole (2004) (1)
- 24. Brain Reward-System Activation in Response to Anticipation and Consumption of Palatable Food Is Altered by GLP-1 Receptor Activation in Humans (384-OR) (2015) (1)
- Imaging of gray matter lesions in multiple sclerosis (2011) (1)
- Diagnostic algorithm for relapsing acquired demyelinating syndromes of the central nervous system in children (P1.345) (2017) (1)
- Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis (2022) (1)
- Integrating MR techniques to study Alzheimer's disease (2009) (1)
- IC-P-053 Relevance of temporo-parietal atrophy in MCI conversion to Alzheimer’s disease: A voxel-based morphometry study (2006) (1)
- Inter-observer variation in segmenting glioma on MRI before and after resection (2017) (1)
- Title: Proliferative retinopathy in type 1 diabetes is associated with cerebral microbleeds, which is part of generalized microangiopathy Running title: Retinopathy, microbleeds and skin capillaries (2013) (1)
- Disorders Mainly Affecting White Matter (2011) (1)
- DEEP GRAY MATTER ATROPHY DOES NOT PREDICT SHORT-TERM CONVERSION FROM MILD COGNITIVE IMPAIRMENT TO ALZHEIMER'S DISEASE (2014) (1)
- Dynamic PET imaging reduces sample sizes to detect longitudinal amyloid accumulation (2020) (1)
- Rapid Onset of Ocrelizumab Suppression of Brain MRI Activity in Relapsing-Remitting Multiple Sclerosis (S12.008) (2017) (1)
- Mild cognitive impairment with Lewy bodies: Clinical characteristics and risk factors for progression (2020) (1)
- Atrophy ofmedial temporal lobes on MRI in "probable" Alzheimer's disease andnormal ageing: diagnostic value andneuropsychological (1992) (1)
- Advanced MR Techniques for Preoperative Glioma Characterization: Part 1. (2023) (1)
- Cerebral amyloid angiopathy in Alzheimer’s disease is associated with increased blood-brain barrier permeability: A quantitative [11C]PiB-PET study (2013) (1)
- Disease activity during the first year predicts clinical long-term outcomes: impact of fingolimod in the TRANSFORMS phase III trial and its extension (P7.205) (2015) (1)
- Prediction of neurodevelopmental outcome in the preterm infant: MR imaging versus US. (1990) (1)
- Early Detection of Incipient Alzheimer Pathology (2021) (1)
- Neurodegenerative Disorders: Classification and Imaging Strategy (2019) (1)
- DNA methylation classification in diffuse glioma shows little spatial heterogeneity after adjusting for tumor purity (2020) (1)
- RATIONALE AND DESIGN OF THE NL-ENIGMA STUDY: A DUTCH 24-WEEK RANDOMISED CONTROLLED STUDY TO EXPLORE THE EFFECT OF NUTRITIONAL INTERVENTION ON BRAIN GLUCOSE METABOLISM IN EARLY ALZHEIMER DISEASE (2014) (1)
- Monitoring atrophy in individual patients (2015) (1)
- Advanced quantitative evaluation of PET systems using the ACR phantom and NiftyPET software (2022) (1)
- IC-P-032 Consistency of resting state networks across healthy subjects measured with fMRI (2006) (1)
- White Matter Hyperintensity Spatial Patterns Provide Clues About Underlying Disease (2022) (1)
- Clinical and MRI measures to identify non-acute MOG-antibody disease in adults. (2022) (1)
- Cerebral hypoperfusion is a late pathological event in the course of Alzheimer's disease (2021) (1)
- Clinico-radiological dissociation of disease activity in MS patients: frequency and clinical relevance (2020) (1)
- MORE ATROPHY OF DEEP GRAY MATTER STRUCTURES IN BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA COMPARED TO ALZHEIMER'S DISEASE (2014) (1)
- Subject Index Vol. 13, Suppl. 2, 2002 (2002) (1)
- On the cutting edge of glioblastoma surgery: where neurosurgeons agree and disagree on surgical decisions. (2021) (1)
- Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis (2022) (1)
- Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine Tablets (2022) (1)
- Hypometabolism of the posterior cingulate cortex is not restricted to Alzheimer's disease (2015) (1)
- A distributed platform for making large scale manual reference datasets for MS lesion segmentation (2018) (1)
- An integrated imaging informatics software platform to improve the analysis of clinical trials and research data in MS (2016) (1)
- Presumed small vessel disease, imaging and cognition markers in the Alzheimer’s Disease Neuroimaging Initiative (2021) (1)
- Incidence of enhancement of the trigeminal nerve on MRI in patients with multiple sclerosis (2002) (1)
- THINNER CORTICAL THICKNESS IN PATIENTS WITH SUBJECTIVE COGNITIVE DECLINE IS RELATED TO POOR MEMORY PERFORMANCE AND FASTER DECLINE OF EXECUTIVE FUNCTION (2016) (1)
- EVENT-BASED MODELING OF THE TEMPORAL ORDERING OF REGIONAL β-AMYLOID DEPOSITION IN THE BRAIN (2018) (1)
- Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non‐Alzheimer's disease pathophysiology (2022) (1)
- [Diagnostic imaging in dementia: use of imaging modalities in Dutch memory clinics]. (2016) (1)
- TIME TO PROGRESSION AND VOLUME AT PROGRESSION DEPEND ON DEFINITION OF PROGRESSION IN GLIOBLASTOMA (2017) (1)
- 4147 Consistency Checks for Partial Volume Correction of ASL perfusion maps (2013) (1)
- A randomized trial predicting response to cognitive rehabilitation in multiple sclerosis: Is there a window of opportunity? (2022) (1)
- Predicting AT(N) pathologies in Alzheimer’s disease from blood-based proteomic data using neural networks (2022) (1)
- Relationship Between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis A Systematic Review (1)
- Vitamin D and the development and evolution of permanent black holes among patients with clinically isolated syndrome (2015) (1)
- Differential Brain Atrophy Patterns and Neurogenetic Profiles in Cognitively-Defined Alzheimer’s Disease Subgroups (2020) (1)
- Corrigendum to “Functional segmentation of the hippocampus in the healthy human brain and in Alzheimer's disease” [Neuroimage 66 (2013) 28–35] (2013) (1)
- Vascular Cognitive Impairment and cognitive decline; a longitudinal study comparing different types of vascular brain injury - The TRACE-VCI study (2022) (1)
- Disturbed oscillatory brain dynamics in subcortical ischemic vascular dementia (2012) (1)
- SPECT, CT and MRI in a Turkish family with huntington's disease (1993) (1)
- GENOMICS AND EPIGENOMICS ANALYSES IN THE EMIF-AD MULTIMODAL BIOMARKER DISCOVERY STUDY (2018) (1)
- Impact of removing facial features from MR images of MS patients on automatic lesion and atrophy metrics (2017) (1)
- The spatio-temporal relationship between white matter lesion volume changes and brain atrophy in clinically isolated syndrome and early multiple sclerosis (2022) (1)
- Betaferon (R)/betaseron (R) in newly emerging multiple sclerosis for initial treatment (benefit): Effects of early vs. delayed treatment with interferon beta-1B (2007) (1)
- Clinical Neuroradiology (2019) (1)
- Eigenvector centrality dynamics are related to Alzheimer’s disease pathological changes in non-demented individuals (2023) (1)
- P2-331 Differential effects of white matter lesions on medial temporal lobe atrophy in early versus late onset Alzheimer’s disease (2006) (1)
- Longitudinal change in ATN biomarkers in cognitively normal individuals (2022) (1)
- AmyPype: an automated system to quantify AMYPAD’s [ 18 F]flutemetamol and [ 18 F]florbetaben images including regional SUVR and Centiloid analysis (2019) (1)
- Investigating Functional Network Abnormalities and Associations With Disability in Multiple Sclerosis (2022) (1)
- Betaferon(R) in newly emerging multiple sclerosis for initial treatment (BENEFIT): Clinical outcomes (2006) (1)
- [Contribution of morphological imaging in the diagnosis of dementia. I--Alzheimer disease]. (1994) (1)
- P2-309 MRI biomarkers as predictors of mortality in dementia (2006) (1)
- Pathologically proven Alzheimer's disease without medial temporal lobe atrophy: The importance of posterior cerebral atrophy (2011) (1)
- Predicting disability progression and cognitive worsening in multiple sclerosis using grey matter network measures (2021) (1)
- Lower cerebral blood flow is related to more severe cognitive impairment in patients with dementia due to Alzheimer's disease (2015) (1)
- FMRI of the visual cortex: A pilot study in patients with optic neuritis using monocular stimulation (1997) (1)
- EXPLORING THE EFFECT OF SOUVENAID ON CEREBRAL GLUCOSE METABOLISM IN EARLY ALZHEIMER’S DISEASE (2019) (1)
- Assessing Treatment Effects on Axonal Loss - Evidence from MRI Monitored Clinical Trials (2005) (1)
- Upper cervical cord atrophy is independent of cervical cord lesion volume in early multiple sclerosis: A two-year longitudinal study. (2022) (1)
- Dementia prevention in memory clinics: recommendations from the European task force for brain health services (2023) (1)
- Current state and guidance on arterial spin labeling perfusion MRI in clinical neuroimaging (2023) (1)
- Distinct disease mechanisms may underlie cognitive decline related to hearing loss in different age groups (2023) (1)
- ATROPHY SUBTYPES IN ALZHEIMER’S DISEASE IDENTIFIED THROUGH NON-NEGATIVE MATRIX FACTORIZATION (2018) (1)
- Quantitative amyloid PET in the AMYPAD diagnostic and patient management study (2021) (1)
- Impact of cerebral blood flow and amyloid load on SUVR bias (2022) (1)
- Classification of resting-state cerebral perfusion maps from patients with Alzheimer's disease and patients with frontotemporal dementia (2015) (1)
- THE MEASUREMENT OF HIPPOCAMPAL ATROPHY RATES WITH MRI FOR A 3-YEAR STUDY APPEARS TO BE AT LEAST 3 TIMES MORE SENSITIVE THAN A 1-YEAR STUDY BASED ON BACK-TO-BACK REPRODUCIBILITY (2016) (1)
- “It’s not what you look at that matters, it’s what you see.” (2015) (0)
- Spatial patterns of white matter hyperintensities associated with Alzheimer’s disease risk factors in a cognitively healthy middle-aged cohort (2019) (0)
- Predicting institutionalization and mortality across the spectrum of Alzheimer’s disease (2021) (0)
- RELATING CSF MARKERS NEUROGRANIN, NEUROFILAMENT-LIGHT AND YKL-40 TO Aβ, APOE ε4 AND COGNITION: RESULTS FROM THE EMIF-AD MULTIMODAL BIOMARKER DISCOVERY STUDY (2018) (0)
- CSF proteins involved in neuroplasticity are associated with altered whole brain connectivity in prodromal AD (2022) (0)
- Cerebrospinal fluid adenosine triphospate metabolites in multiple sclerosis (2009) (0)
- A Multinational, Multicenter, Randomized, Double-Blind, Parallel-Group, Active-Control Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Laquinimod 0.6mg or 1.2mg QD versus IFNβ-1a in Patients with Relapsing Remitting Multiple Sclerosis (P3.153) (2014) (0)
- LONGITUDINAL-STUDY ON CORRELATIONS BETWEEN DISABILITIES AND CEREBRAL MR CHANGES IN MULTIPLE-SCLEROSIS (1994) (0)
- Brain reward responses to food stimuli among female monozygotic twins discordant for BMI (2017) (0)
- Microglial activation in healthy aging (2010) (0)
- Operationalization of the ATN classification scheme in preclinical AD: Findings from EPAD V500.0 data release (2020) (0)
- Long-interval T 2 w subtraction MRI : A powerful new outcome measure in MS trials Running Head : T 2 w subtraction MR imaging in phase II MS trials (2009) (0)
- Subjective cognitive decline and self‐reported sleep at a memory clinic: The SCIENCe project (2021) (0)
- MRI PREDICTORS OF AMYLOID PATHOLOGY: RESULTS FROM THE EMIF-AD BIOMARKER DISCOVERY STUDY (2018) (0)
- Increased microglial activation in MCI and AD: An (R)-[11C]PK11195 PET study (2010) (0)
- CHARACTERIZING INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE: THE SUBJECTIVE COGNITIVE IMPAIRMENT COHORT (SCIENCE) (2017) (0)
- Characterization of the behavioral and dysexecutive variants of Alzheimer's disease (2015) (0)
- Leukoaraiosis and disability: The LADIS (leukoaraiosis and disability) study experience (2009) (0)
- Videogame-based balance training while standing does not affect reactive gait stability after slip perturbations in children with cerebral palsy (2020) (0)
- Otto van Eikema Hommes – 7 February 1932 – 16 August 2022 (2022) (0)
- The Queen Square Adult Leukodystrophy Group: 10 years-experience of a multidisciplinary diagnostic service (P10-4.006) (2023) (0)
- CSF beta-amyloid 1-42, but not CSF tau, phosphorylated tau or hippocampal atrophy on MRI relate to Alzheimer's disease pathology load in the brain (2013) (0)
- Grey zone amyloid burden heralds future memory decline: The SCIENCe Project (2020) (0)
- Choroid plexus volume is associated with levels of CSF proteins predominantly expressed by the choroid plexus in non‐demented individuals with AD pathophysiology. (2022) (0)
- COGNITIVELY DEFINED SUBTYPES OF ALZHEIMER’S DISEASE ARE ASSOCIATED WITH DISTINCT PATTERNS OF ATROPHY (2018) (0)
- 219 Probability Maps of Glioblastoma Indicate Variation in Surgical Decisions Between 10 Surgical Teams (2018) (0)
- Widespread disruption of functional brain organization in people with early-onset Alzheimer's disease (2013) (0)
- Neuroinflammation in progressive multiple sclerosis: in vivo assessment using [18F]DPA714 (2018) (0)
- Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease. (2023) (0)
- ATROPHY PATTERNS PREDICTING COGNITIVE DECLINE IN NON-DEMENTED SUBJECTS ARE INDEPENDENT OF AMYLOID PATHOLOGY (2016) (0)
- CEREBROVASCULAR DISEASE IN LATE ONSET FRONTAL LOBE SYNDROME (2014) (0)
- WHITE MATTER MICROSTRUCTURE AND AMYLOID AGGREGATION IN COGNITIVELY HEALTHY, ELDERLY IDENTICAL TWINS (2018) (0)
- Quantitative MRI in leukodystrophies (2023) (0)
- Functional Connectivity Group Differences in Young-Onset Alzheimer's Disease as Investigated by Volume- And Surface-Based fMRI Analysis Strategies (2022) (0)
- Prediction of H3K27M-mutant Brainstem Glioma by Amide Proton Transfer Weighted Imaging and Its Derived Radiomics (0)
- Predicting personalised risk of disability worsening in multiple sclerosis with machine learning (2022) (0)
- CHAPTER 3 Clinical significance of patient selection in Alzheimer ’ s disease using baseline MRI (2011) (0)
- Cranial nerve denervation, what signs to recognise and common pitfalls. (2014) (0)
- THE IMPACT OF AMYLOID PET ON DIAGNOSIS AND PATIENT MANAGEMENT IN AN UNSELECTED MEMORY CLINIC COHORT: THE ABIDE PROJECT (2017) (0)
- Disease progression in dementia with Lewy bodies: A longitudinal study on clinical symptoms, quality of life and functional impairment (2022) (0)
- Cerebrovascular and Alzheimer's disease: A synergistic pathogenesis (2013) (0)
- Reproducibility of hippocampal atrophy rate at 1.5T and 3T for freesurfer and MAPS-HBSI using the ADNI1 data set (2015) (0)
- Chapter 2 . 1 Different patterns of gray matter atrophy in early and late-onset AD (2015) (0)
- Neuroanatomy for the Neuroradiologist (2019) (0)
- LOWER STRUCTURAL DEGREE AND HIGHER LOCAL EFFICIENCY RELATED TO DIFFUSE AMYLOID-BETA LOAD IN CORTEX OF NON-NEUROLOGICAL AGED DONORS (2018) (0)
- A multi‐study analysis of the spatial‐temporal progression of amyloid deposition and its utility for longitudinal studies (2020) (0)
- Differential influence of age at onset on the effect of white matter hyperintensities and global atrophy on cognition in Alzheimer's disease (2010) (0)
- International magnims-CMSC-NAIMS consensus recommendations on the use of standardized MRI in MS (2021) (0)
- Loss of corpus callosum tissue is associated with subjective memory complaints: The LADIS study (2010) (0)
- Research diagnostic criteria for Alzheimer’s disease: findings from the LipiDiDiet randomized controlled trial (2021) (0)
- Do microbleeds predict stroke in Alzheimer's disease (MISTRAL)? Study design and first results (2013) (0)
- The BENEFIT study: characteristics of patients with potentially benign multiple sclerosis (2007) (0)
- Radiologically isolated syndrome (2015) (0)
- Detecting Alzheimer pathology in vivo: Comparing regional binding of [11C]PIB and [18F]FDDNP (2008) (0)
- Long Term Impact of Early Initiation of Interferon beta-1b after a First Clinical Event Suggestive of Multiple Sclerosis: Additional Relapse Rate, EDSS, and MSSS Analyses after 8 Years (P07.117) (2013) (0)
- 6. Atrophy of the medial temporal lobes as early marker in Alzheimer's disease: a MRI study (1992) (0)
- Cerebral blood flow, measured with ASL perfusion MRI at 3T, and structural brain changes in Alzheimer's disease (2012) (0)
- Chapter 9 MICROBLEEDS ARE ASSOCIATED WITH DEPRESSIVE SYMPTOMS IN ALZHEIMER ’ S DISEASE (0)
- SPECIFIC COGNITIVE IMPAIRMENTS (2018) (0)
- DIFFERENTIATING THE BEHAVIOURAL VARIANT OF ALZHEIMER’S DISEASE FROM BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA AND TYPICAL ALZHEIMER’S DISEASE: THE VALUE OF NEUROIMAGING (2019) (0)
- Deep Learning for Noninvasive Assessment of H3 K27M Mutation Status in Diffuse Midline Gliomas Using MR Imaging. (2023) (0)
- The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial (2014) (0)
- ACTIVE AND PASSIVE RESERVE DIFFERENTIALLY MITIGATE COGNITIVE SYMPTOMS IN DEMENTED AND NON-DEMENTED STAGES OF ALZHEIMER’S DISEASE (2016) (0)
- Lower cerebral blood flow is associated with cognitive decline in patients with Alzheimer’s disease (2015) (0)
- Reply (2006) (0)
- Biological Brain Age Prediction Using Machine Learning on Structural Neuroimaging Data: Multi‐Cohort Validation Against Biomarkers of Alzheimer’s Disease and Neurodegeneration (2022) (0)
- Can the performance of the FSL/Siena whole brain atrophy measure be improved at 3T and 1.5T on ADNI back-to-back MPRAGES by using a non-default settings? (2012) (0)
- Further examination of diagnostic performance in the context of a fellows' journal club article : Reply (2012) (0)
- STEPWISE PATIENT SELECTION FOR AMYLOID MEASUREMENTS (2019) (0)
- Associations of brain connectivity with disease progression and cognitive dysfunction in autosomal‐dominant Alzheimer disease depend on imaging modality (2020) (0)
- MORE ATROPHY OF DEEP GRAY MATTER STRUCTURES IN BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA COMPARED TO ALZHEIMER'S DISEASE (2014) (0)
- ACTIVE AND PASSIVE RESERVE DIFFERENTIALLY MITIGATE COGNITIVE SYMPTOMS IN DEMENTED AND NON-DEMENTED STAGES OF ALZHEIMER’S DISEASE (2016) (0)
- REDUCED WHITE MATTER INTEGRITY OF THE ROSTRAL LIMBIC SYSTEM PATHWAYS IN HEALTHY ELDERLY APOE E4 ALLELE CARRIERS (2016) (0)
- Testing causality in the association between amyloid‐β and tau in genetically identical twins (2022) (0)
- Blood Biomarker Dynamics in Highly Active Relapsing Multiple Sclerosis Patients Treated With Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study (S16.006) (2023) (0)
- CORRELATION OF GREY MATTER NETWORK MEASURES IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS (2017) (0)
- Gray matter atrophy but not vascular brain injury is related to cognitive impairment in patients with heart failure (2020) (0)
- Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease (2018) (0)
- THE MEASUREMENT OF HIPPOCAMPAL ATROPHY RATES WITH MRI FOR A 3-YEAR STUDY APPEARS TO BE AT LEAST 3 TIMES MORE SENSITIVE THAN A 1-YEAR STUDY BASED ON BACK-TO-BACK REPRODUCIBILITY (2016) (0)
- EARLY ALTERATIONS IN RESTING-STATE FUNCTIONAL CONNECTIVITY IS ASSOCIATED WITH AMYLOID PATHOLOGY IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWINS (2017) (0)
- IC-P3-211: Increased randomness of functional brain networks in AD: ‘Small-world' network analysis of non-linear functional connectivity (2008) (0)
- Structural Neuroimaging Outcomes (2006) (0)
- CLASSIFICATION OF PATHOLOGY USING BRAIN SUBSTRUCTURE VOLUMES IN POSTMORTEM CONFIRMED DEMENTIAS (2014) (0)
- ESTABLISHING THE EFFECT OF CODING VARIANTS ON ALZHEIMER’S DISEASE RELATED ENDOPHENOTYPES (2017) (0)
- P.5.b.001 Longitudinal [11C]PIB and [18F]FDDNP PET studies on memory in patients and controls (2010) (0)
- Functional network imbalance underlies severity of cognitive impairment in multiple sclerosis (2015) (0)
- DISCOVERY, REPLICATION AND EXTENSION STUDY OF PLASMA PROTEOMIC BIOMARKERS RELATING TO BRAIN AMYLOID BURDEN (CSF Aβ OR AMYLOID-PET) IN THE EMIF-AD BIOMARKER DISCOVERY COHORT (2017) (0)
- Design and demographics of the original interferon beta-1a in Multiple Sclerosis (ORIGIMS) Study (2005) (0)
- Longitudinal assessment of cervical cord atrophy across MS clinical phenotypes: a multicenter study (2016) (0)
- LONGITUDINAL CHANGES IN GREY MATTER CONNECTIVITY ARE RELATED TO COGNITIVE DECLINE IN PRODROMAL ALZHEIMER’S DISEASE (2018) (0)
- Direct and indirect process in the quantification of cerebral atrophy in MS Results of a longitudinal study over 5.5 years (2009) (0)
- P2-298 Neuropsychiatric and behavioral symptoms do not reflect brain changes as observed on MRI in AD (2006) (0)
- Mechanisms of disability in relapse onset multiple sclerosis of long disease duration (2012) (0)
- Dementia with Lewy bodies subtypes identified by cluster analysis on structural MRI (2021) (0)
- First results of the AMYPAD Prognostic and Natural History Study: amyloid‐PET centiloids predicts cognitive functioning in a pre‐dementia population (2022) (0)
- Primary Grey Matter Loss (2011) (0)
- Cranial Nerves (2019) (0)
- Memory functions of the perirhinal and parahippocampal cortices of the human medial temporal lobe (2003) (0)
- IC-P-100 A LONGITUDINAL STUDY OF THE EFFECTS OF EDUCATION AND INTRACRANIALVOLUME ON COGNITIVE CHANGES AND MORTALITY RATES IN ALZHEIMER’S DISEASE (2019) (0)
- METHODOLOGICAL AND LOGISTIC STRATEGIES FOR A LARGE MULTI-CENTER β-AMYLOID PET EUROPEAN PROJECT: AMYLOID IMAGING TO PREVENT ALZHEIMER’S DISEASE (AMYPAD) (2017) (0)
- study resonance venography and flow-quantification drainage with multiple sclerosis : a magnetic No association of abnormal cranial venous (0)
- IMPAIRMENT IN COMPLEX ACTIVITIES OF DAILY LIVING IS RELATED TO NEURODEGENERATION IN ALZHEIMER’S DISEASE SPECIFIC REGIONS (2018) (0)
- Amyloid pathology, but not vascular pathology, is associated with risk of incident dementia in non‐demented memory clinic participants (2020) (0)
- T2w subtraction MR imaging in phase II MS trials: a powerful new outcome measure (2009) (0)
- Boundary shift integral to compute brain and cervical spinal cord longitudinal volume changes using the same 3DT1w volumetric scans in multiple sclerosis (2017) (0)
- Imaging for MCI/Alzheimer's trials: How to do it? (2011) (0)
- Automated quantification of small vessel disease brain changes on MRI predicts cognitive and functional decline (2019) (0)
- The Presence of Cerebral White Matter Lesions and Lower Skin Microvascular Perfusion Predict Decline in General Cognitive Ability in Type 1 Diabetes Patients but Not in Healthy Controls (2018) (0)
- GREY MATTER CONNECTIVITY IS ASSOCIATED WITH TIME TO CLINICAL PROGRESSION IN MILD COGNITIVE IMPAIRMENT, INDEPENDENT OF AMYLOID STATUS (2016) (0)
- Functional segregation of memory for objects and locations (2000) (0)
- Visual rating of hypointensities in the brain using susceptibility-weighted Imaging; a pilot study (2011) (0)
- PREDICTING PROGRESSION IN PRE-DEMENTIA STAGES OF ALZHEIMER’S DISEASE WITH A NEUROIMAGING MEASURE OF COGNITIVE RESERVE (2017) (0)
- Building a manual reference dataset for deep grey matter segmentation: volumetric versus anatomical bias (2016) (0)
- Rationale and design of the “NEurodegeneration: Traumatic brain injury as Origin of the Neuropathology (NEwTON)” study: a prospective cohort study of individuals at risk for chronic traumatic encephalopathy (2022) (0)
- Dementia: Clinical Background (2011) (0)
- LOBAR MICROBLEEDS PREDICT STROKE IN PATIENTS WITH ALZHEIMER'S DISEASE: THE MISTRAL STUDY (2014) (0)
- Graph analysis of resting state fMR images: gender effect in healthy controls not present in MS patients (2009) (0)
- Evaluating the sensitivity of Centiloid quantification to pipeline design and image resoloution (2022) (0)
- USING SUBTRACTION MRI TO IMPROVE THE DETECTION OF AMYLOID-RELATED IMAGING ABNORMALITIES WITH EDEMA OR EFFUSION (ARIA-E) IN PATIENTS AFFECTED BY ALZHEIMER’S DISEASE RECEIVING IMMUNOTHERAPY: AN INTER-OBSERVER STUDY (2017) (0)
- LATENT ATROPHY FACTORS IN POSTERIOR CORTICAL ATROPHY RELATE TO SPECIFIC COGNITIVE IMPAIRMENTS (2018) (0)
- Corpus Callosum Atrophy in Alzheimer's Disease and Subcortical Vascular Dementia : The LADIS Study (2010) (0)
- FDG-PET REVEALS DISTINCT HYPOMETABOLIC TRAJECTORIES IN COGNITIVELY-DEFINED SUBGROUPS OF ALZHEIMER’S DISEASE (2019) (0)
- The effect of linomide on gadolinium-enhancing lesions in multiple sclerosis (1998) (0)
- O1-02-01: Progression of mild cognitive impairment to dementia: The contribution of atrophy and vascular disease (2008) (0)
- Familial British dementia: a clinical and multi-modal imaging case study (2022) (0)
- EUSI-ESO News (2008) (0)
- LOSS OF GREY MATTER CONNECTIVITY IN THE PRECUNEUS IS ASSOCIATED WITH FASTER ATROPHY RATES IN PRECLINICAL ALZHEIMER’S DISEASE (2018) (0)
- MRI comparison of dual echo SE and MT-presaturated GE in the detection of spinal MS lesions (1995) (0)
- T cell vaccination in multiple sclerosis with CSF-derived activated cd4+T cells: results of a placebo-controlled trial (2006) (0)
- MRI Phenotypes As Predictors Of Clinical Outcomes In Patients With CIS in the BENEFIT Population (P1.226) (2014) (0)
- Cerebral perfusion: arterial spin-labeling MRI (2014) (0)
- Could the serotonin theory give rise to a treatment for levodopa-induced dyskinesia in Parkinson's disease? (2015) (0)
- Regional thalamic damage and cognitive impairment in patients with multiple sclerosis: a multicenter study (2014) (0)
- NI-34BRAIN LOCATIONS INVOLVED IN COGNITIVE ALTERATIONS AFTER RESECTIVE BRAIN SURGERY IDENTIFIED BY RESECTION PROBABILITY MAPS (2014) (0)
- Book Review: Magnetic Resonance Spectroscopy in Multiple Sclerosis (2001) (2001) (0)
- CEREBROVASCULAR DISEASE IS ASSOCIATED WITH SLOWER COGNITIVE DECLINE IN ALZHEIMER PATIENTS ON CHOLINESTERASE INHIBITORS (2014) (0)
- Ibudilast (2020) (0)
- Chapter 6 . 2 High-resolution T 1-relaxation time mapping displays subtle , clinically relevant , gray matter damage in long-standing multiple sclerosis (2016) (0)
- P-6-729 Cinephase-contrast MR imaging in normal pressure hydrocephalus patients. Relation with outcome (1997) (0)
- Semi-automatic hippocampal segmentation based on optimized hippocampal shape functions (2011) (0)
- Chapter 3 . 1 Can MS lesion stages be distinguished with MRI ? A post mortem MRI and histopathology study (2016) (0)
- P01.062 Probability maps of glioblastoma indicate variation in surgical decisions between twelve surgical teams (2018) (0)
- Evaluating the sensitivity of Centiloid quantification to pipeline design and image resolution (2022) (0)
- The role of ASL-measured cerebral blood flow in the differential diagnosis of Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies (2013) (0)
- CEREBRAL BLOOD FLOW MEASURED WITH PHASE-CONTRAST MRI IN AD, MCI AND CONTROLS (2016) (0)
- Reproducibility of 3 T APT‐CEST in Healthy Volunteers and Patients With Brain Glioma (2022) (0)
- MRI Predictors for disability at 5 years after the diagnosis of MS (2011) (0)
- Fractal differences in MRI time series between Alzheimer's disease patients and controls (2011) (0)
- Multiparametric MRI assessment of brain and cord damage in primary progressive multiple sclerosis: a large-scale, multicentre study (2006) (0)
- P16.12BRAIN LOCATIONS INVOLVED IN BASELINE COGNITIVE FUNCTIONING OF PATIENTS WITH GLIOMA BEFORE THERAPY (2014) (0)
- PS1 - 4. Widespread decreased white matter tract integrity in T1DM patients with microangiopathy and its relation to cognitive functions (2011) (0)
- Glioma perfusion quantification with ASL and DSC: head-to-head comparison with 15O-H2O PET (2022) (0)
- CHAPTER 5 Differential effects of insulin therapies on body weight and appetite regulating brain regions in human type 1 diabetes (2013) (0)
- MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry (2018) (0)
- Large-scale normative volumes of brain structures as assessed by SIENAX (2018) (0)
- Amyloid- b , p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer’s disease (2021) (0)
- Gray matter hypoperfusion is a late pathological event in the course of Alzheimer’s disease (2022) (0)
- MATTERS ARISING (1992) (0)
- IC-P2-140: Progression of MCI to dementia: The contribution of atrophy and vascular disease (2008) (0)
- P3-098: Whole-brain atrophy rate and CSF biomarker levels in mild cognitive impairment and Alzheimer's disease: A longitudinal study (2008) (0)
- P1-246: White matter hyperintensities in Alzheimer patients and non-demented elderly: Postmortem quantitative MRI and neuropathological characteristics (2008) (0)
- Early onset of Action and Sustained Efficacy of MRI Outcomes during Cladribine Tablets Treatment in Highly Active Relapsing Multiple Sclerosis: Results of the 2-Year MAGNIFY-MS Study (2023) (0)
- REDUCED CALLOSAL WHITE MATTER INTEGRITY SURPASSES CEREBROSPINAL FLUID AND ATROPHY MARKERS AS PREDICTOR OF DECLINE IN SUBJECTS WITH MILD COGNITIVE IMPAIRMENT: A COMBINED VOLUMETRY AND DTI STUDY (2014) (0)
- How to define ‘N’ in the ATN classification in subjective cognitive decline: The SCIENCe project (2021) (0)
- Genome-wide association study of Alzheimer's disease brain imaging biomarkers and neuropsychological phenotypes in the EMIF-AD Multimodal Biomarker Discovery dataset (2021) (0)
- Brain age gap in neuromyelitis optica spectrum disorders and multiple sclerosis (2022) (0)
- Normative rates of healthy age-related brain volume changes as assessed by SIENA on a large MRI dataset (2017) (0)
- P2-295 White matter hyperintensity load is a possible predictor of corpus callosum atrophy in the elderly: The LADIS study (2006) (0)
- MRI-measured cerebral microbleeds and their relation to cognitive functioning and cerebral activity in patients with longstanding type 1 diabetes mellitus (2010) (0)
- MAGNETIC RESONANCE IMAGING HYPERINTENSITIES IN ALZHEIMER'S DISEASE. AUTHOR'S REPLIES (1991) (0)
- THE AMYPAD-DX CONTROLLED TRIAL ON THE DIAGNOSTIC VALUE OF AMYLOID PET (2017) (0)
- IC-P-019 Automatic segmentation of age-related white-matter changes in a multi-center study (2006) (0)
- Arterial spin labeled cerebral perfusion in cognitively normal monozygotic twins (2017) (0)
- Specific cerebellar atrophy patterns in cross-sectional and longitudinal physical disability and cognitive impairment in multiple sclerosis (2019) (0)
- Current status and quantitative results of the AMYPAD prognostic and natural history study (2020) (0)
- 3 . 2 Resting-state connectivity in mild cognitive impairment and Alzheimer ’ s disease (2012) (0)
- TOWARDS DATA-DRIVEN MEDICINE IN DIFFERENTIAL DIAGNOSTICS OF NEURODEGENERATIVE DISEASES (2016) (0)
- Pseudo-continuous arterial spin-labelling at 3T in Alzheimer disease - initial experience in a memory clinic (2011) (0)
- Quantitative regional validation of the rating scale for posterior cortical atrophy (2013) (0)
- The Tower of London test adapted for fMRI. (1998) (0)
- GREY MATTER CONNECTIVITY IS ASSOCIATED WITH CLINICAL PROGRESSION IN NON-DEMENTED, AMYLOID POSITIVE PATIENTS (2016) (0)
- CROSS-SECTIONAL MODELING OF REGIONAL PERFUSION AND GRAY MATTER VOLUME IN ALZHEIMER'S DISEASE (2016) (0)
- Polygenic risk score for Alzheimer’s disease is related to amyloid positivity in subjective cognitive decline: The SCIENCe project (2020) (0)
- Grey matter network disruptions are related to amyloid beta in cognitively healthy elderly (2015) (0)
- IC-P-004 AMYLOID BURDEN AND CORTICAL ATROPHY IN NON-DEMENTED DOWN SYNDROME USING COMPARING VISUAL SEMI-QUANTITATIVE (2018) (0)
- Quantifying AD‐related brain amyloid with linearised progression models: model‐based vs. data‐based. (2022) (0)
- Effect of fingolimod versus interferon-beta1a on neda-4 (no evidence of disease activity or worsening) in the transforms study (2015) (0)
- Spatial‐temporal subtypes of amyloid deposition show distinct baseline and longitudinal cognitive profiles (2022) (0)
- Miscellaneous Forms of Dementia (2002) (0)
- Regional tau pathology is associated with loss of synapses and reduced synaptic activity: A combined [18F]flortaucipir, [11C]UCB‐J and magnetoencephalography study (2020) (0)
- WHEN MEASURING HIPPOCAMPAL ATROPHY, DO THE SEGMENTATION NOISE DISTRIBUTIONS OF METHODS, AS DETERMINED BY THE BACK-TO-BACK REPRODUCIBILITY, HAVE GAUSSIAN DISTRIBUTIONS? (2017) (0)
- P3-096 Effects of galantamine challenge on episodic and working memory systems in patients with mild cognitive impairment: an FMRI study (2004) (0)
- Disease-related determinants are associated with mortality in dementia due to Alzheimer’s disease (2018) (0)
- ATL1102 treatment reduces conversion of active multiple sclerosis lesions into persistent black holes (2017) (0)
- The role of ASL-measured cerebral blood flow in the differential diagnosis of Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies (2013) (0)
- Patient-Reported Quality of Life in the BENEFIT Trial (P4.180) (2014) (0)
- CLINICAL AND RADIOLOGICAL FINDINGS IN PATIENTS WITH PATHOLOGICALLY CONFIRMED CAA (2017) (0)
- Examining centiloid quantification against visual assessment using [18F]flutemetamol PET (2020) (0)
- AUTOMATED SELECTION OF MULTIMODAL MRI BIOMARKERS FOR DIAGNOSIS OF DEMENTIA (2017) (0)
- GREY MATTER CONNECTIVITY TRAJECTORIES ACROSS THE ALZHEIMER’S DISEASE CONTINUUM AND ASSOCIATIONS WITH COGNITIVE DECLINE (2019) (0)
- A standard benchmark for assessing the reproducibility of brain atrophy measures in Alzheimer's disease using the ADNI1 data set (2013) (0)
- Development of multivariable prediction models for institutionalization and mortality in the full spectrum of Alzheimer’s disease (2022) (0)
- Structural MRI Corrrelates of Cognitive Impairment in Patients with Multiple Sclerosis: A Multi Center Study (S33.002) (2014) (0)
- Reduced Dynamism of Functional Connectivity Is Associated with Cognitive Impairment in Multiple Sclerosis Patients: A Dynamic Functional Connectivity Study in a Multi-Center Setting (P3.379) (2018) (0)
- ENVISION: A phase 3b/4 randomized, double‐blind, placebo‐controlled, parallel‐group study to verify the clinical benefit of aducanumab in participants with early Alzheimer’s disease (2022) (0)
- Changes in magnetization trasfer ratio of new enhanching lesions: A new way to assess tissue damage in vivo (1999) (0)
- Reliability of cross-sectional and longitudinal brain volume measurements in MS patients using FreeSurfer: a multi-vendor MRI study at 3 Tesla (2018) (0)
- The Lancet Neurology Amyloid and FDG-PET in the diagnostic work-up of Alzheimer’s disease and other dementias (2020) (0)
- Secondary prevention of Alzheimer’s dementia: neuroimaging contributions (2018) (0)
- Structural and molecular changes along the continuum of Alzheimer's disease (2011) (0)
- Assessing Brain Involvement in Fabry Disease with Deep Learning and the Brain-Age Paradigm (2023) (0)
- R2*based iron mapping in multiple sclerosis: a multicentre study (2012) (0)
- Differential brainstem atrophy in multiple sclerosis and neuromyelitis optica spectrum disorders among Hong Kong Chinese (2017) (0)
- [18F]AV1451 PET IN RELATION TO ATROPHY ACROSS THE ALZHEIMER’S DISEASE SPECTRUM (2018) (0)
- MATRIX METALLOPROTEINASES IN RELATION TO ALZHEIMER'S DISEASE AND CAA (2014) (0)
- Functional Correlates of Impaired Working Memory in MS Patients: A Multicentre Study (P6.123) (2014) (0)
- WHITE MATTER HYPERINTENSITIES AND VASCULAR RISK FACTORS IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS (2017) (0)
- Activation in the Hippocampal Region Increases as Function of Encoding Load (1998) (0)
- Brain volume changes in type 1 diabetes mellitus patients with microangiopathy are related to poorer cognitive functioning (2010) (0)
- Baseline features of the AMYPAD Diagnostic and Patient Management Study (DPMS) participants (2020) (0)
- UNBIASED METHOD TO DETERMINE CUT-POINTS FOR CSF TOTAL TAU LEVELS REVEALS PRESENCE OF BIOLOGICAL SUBTYPES IN A LARGE ALZHEIMER’S DISEASE POPULATION (2018) (0)
- Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson’s disease dementia (2023) (0)
- Creating a consensus evaluation and expert opinion reporting platform for brain MRI in Multiple Sclerosis with higher increased risk of Progressive Multifocal Leukoencephalopathy. (2016) (0)
- Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits. (2022) (0)
- Effects of Age-Related White Matter Changes on Loss of Corpus Callosum Tissue: The Ladis Study (2010) (0)
- GREY MATTER CONNECTIVITY IS RELATED TO A STEEPER LOSS OF MEMORY AND LANGUAGE FUNCTIONING OVER TIME IN PATIENTS WITH SUBJECTIVE COGNITIVE DECLINE (2017) (0)
- PATH-48. THE DNA METHYLATION LANDSCAPE OF CORE AND PERIPHERAL DIFFUSE GLIOMA REGIONS SHOWS LITTLE SPATIAL SUBTYPE HETEROGENEITY AFTER CONSIDERING TUMOR PURITY (2019) (0)
- GRADUATE I AND II: Findings of Two Phase III Randomized Placebo-controlled Studies Assessing the Efficacy and Safety of Subcutaneous Gantenerumab in Early Alzheimer’s Disease (AD) (S26.010) (2023) (0)
- DISEASE-STAGE–SPECIFIC RELATIONSHIP BETWEEN COGNITIVE RESERVE AND CLINICAL PROGRESSION IN ALZHEIMER’S DISEASE (2018) (0)
- Long-term predictors of disability worsening in patients with multiple sclerosis in the phase 3 TRANSFORMS study (2017) (0)
- DIFFERENTIATING THE BEHAVIOURAL VARIANT OF ALZHEIMER’S DISEASE FROM BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA AND TYPICAL ALZHEIMER’S DISEASE: THE VALUE OF NEUROIMAGING (2019) (0)
- The E ff ect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis (0)
- Visual assessment in postmortem-proven dementias: Clinical expertise versus machine learning (2015) (0)
- Long-term safety of interferon beta-1b (IFNB-1b) treatment in early multiple sclerosis ( MS): The 11-year follow-up of BENEFIT (BENEFIT-11) (2016) (0)
- MRI-BASED CLASSIFICATION ACCURACY OF DEMENTIA TYPE IS DETERMINED BY MRI MODALITY (2017) (0)
- Proposal for a morphologic classification of atypical idiopathic inflammatory demyelinating lesions of the brain based on conventional magnetic resonance imaging (2006) (0)
- 152 AttackMS natalizumab for the treatment of people with inflammatory demyeli- nation suggestive of multiple sclerosis (2022) (0)
- Similar Local Tolerability Profiles Following Double-Blind Treatment With Generic or Branded Glatiramer Acetate in Multiple Sclerosis (P3.256) (2015) (0)
- Comprar Neuroimaging in Dementia | Nick C Fox | 9783642008177 | Springer (2011) (0)
- GREY MATTER CONNECTIVITY IS RELATED TO COGNITIVE IMPAIRMENT IN EARLY AND LATE ONSET AD (2014) (0)
- [18F]AV1451 PET IN RELATION TO ATROPHY ACROSS THE ALZHEIMER’S DISEASE SPECTRUM (2018) (0)
- An Automated and High Precision Quantitative Analysis of the ACR Phantom (2021) (0)
- Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review (2018) (0)
- Transient gadolinium leakage in natalizumab-treated multiple sclerosis (2014) (0)
- Imaging blood-brain barrier dysfunction: A state-of-the-art review from a clinical perspective (2023) (0)
- 2915 Using the ADNI 1 data set to assess the back-toback reproducibility of brain volumetrics (2013) (0)
- CORTICAL T1-W/T2-W RATIO VALUES ARE HIGHER IN ALZHEIMER’S DISEASE COMPARED TO CONTROLS (2018) (0)
- AMYLOID-BETA ACCUMULATION AFFECTS IN VIVO STAGING OF TAU DEPOSITION IN COGNITIVELY IMPAIRED INDIVIDUALS (2019) (0)
- Medial temporal lobe atrophy and white matter changes are associated with mild cognitive deficits in non-disabled elderly (2005) (0)
- Machine learning to arterial spin labeling in Mild cognitive impairment and alzheimer Disease 1 (0)
- Response: Brain miliary enhancement (2020) (0)
- Genetically identical twin-pair difference models support the amyloid cascade hypothesis. (2023) (0)
- Comparison of the back-to-back reproducibility of the Siena/FSL whole brain atrophy measurement at 3T and 1.5T using the ADNI MPRAGE MRIs (2011) (0)
- Author response: Differences in topological progression profile among neurodegenerative diseases from imaging data (2019) (0)
- Postrelapse MS Treatment with Alemtuzumab Better than SC IFN- -1a (2014) (0)
- The effect of caffeine on cerebral blood flow in a test-retest study using pseudo-continuous ASL (2011) (0)
- IC-02-04: White matter hyperintensities in Alzheimer patients and non-demented elderly: Postmortem quantitative MRI and neuropathological characteristics (2008) (0)
- THINNER CORTICAL THICKNESS IN PATIENTS WITH SUBJECTIVE COGNITIVE DECLINE IS RELATED TO POOR MEMORY PERFORMANCE AND FASTER DECLINE OF EXECUTIVE FUNCTION (2016) (0)
- Optical coherence tomography and ophthalmological findings in patients with CIS treated with interferon beta-1b: 11-year follow-up in BENEFIT (BENEFIT 11) (2015) (0)
- COMPARING ATROPHY PATTERNS IN EARLY CLINICAL STAGES ACROSS DISTINCT PHENOTYPES OF ALZHEIMER'S DISEASE (2014) (0)
- Tournament (2015) (0)
- Data‐driven evidence for three distinct patterns of amyloid‐β accumulation (2021) (0)
- Magnetic Resonance Imaging Effects of Interferon Beta-1b in the BENEFIT Study (2015) (0)
- Alternatives for standard T 1-weighted images in brain atrophy measurements in Multiple Sclerosis using SIENA and SIENAX (2007) (0)
- [Cerebral magnetic resonance tomography in multiple sclerosis]. (1993) (0)
- Multi-parametric structural MRI in relation to cognitive dysfunction in long-standing multiple sclerosis (2016) (0)
- P1-413 CARLINA ACAULIS HAS ANTIOXIDANT EFFECTS AND AMELIORATES BETA-AMYLOID TOXICITY IN A C. ELEGANS MODEL (2014) (0)
- Corpus callosum atrophy in Alzheimer's disease and subcortical vascular dementia: The LADIS study (2010) (0)
- IDEAS becoming reality on the roadmap for biomarker validation in Alzheimer's disease (2019) (0)
- Neurodegenerative Diseases and Epilepsy (2015) (0)
- COST-EFFICIENT DIFFERENTIAL DIAGNOSTICS OF NEURODEGENERATIVE DISEASES USING A STRATIFIED APPROACH (2016) (0)
- Visual assessment in postmortem-proven dementias: Clinical expertise versus machine learning (2015) (0)
- Grey matter network measures are associated with cognitive decline in mild cognitive impairment (2018) (0)
- Validation of the EADC-ADNI Harmonized Protocol for Manual Hippocampal Segmentation: Preliminary Results (2013) (0)
- Thalamic tract integrity changes are associated with cognition and disinhibition in multiple sclerosis (2014) (0)
- Comparison of 3 D pseudo-CASL and H 2 15 O PET for quantification of cerebral blood flow (2012) (0)
- Functional eigenvector centrality dynamics are related to amyloid deposition in preclinical Alzheimer’s Disease (2022) (0)
- of Amyloid-Related Imaging Abnormalities in 2 Phase 3 Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer ’ s Disease Patients (2018) (0)
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease (2017) (0)
- Magnetic Resonance: Applications in Dementia (2002) (0)
- An efficient semi-supervised quality control system trained using physics-based MRI-artefact generators and adversarial training (2022) (0)
- Benefit 11: Long-term follow-up study of patients with clinically isolated syndrome treated with interferon beta-1b (2013) (0)
- Spatial mapping of brain lesions in clinically isolated syndrome with short-term conversion to multiple sclerosis (2012) (0)
- Imaging of gray matter lesions in MS (2010) (0)
- The power of magnetic resonance imaging IMRI) in monitoring active relapsing remitting multiple sclerosis (MS): implications for planning phase II treatment trials (1995) (0)
- COMPARING ATROPHY PATTERNS IN EARLY CLINICAL STAGES ACROSS DISTINCT PHENOTYPES OF ALZHEIMER'S DISEASE (2014) (0)
- GREY MATTER CONNECTIVITY IS ASSOCIATED WITH THE RATE OF COGNITIVE DECLINE IN MILD COGNITIVE IMPAIRMENT (2017) (0)
- PS1 - 6. Cerebral resting-state network changes in patients with type 1 diabetes with and without microangiopathy relate to cognitive functions (2011) (0)
- Effect of Two Dosing Frequencies of Subcutaneous Interferon (scIFN) β-1a on MRI Lesion and Brain Volume Changes in Patients with a First Clinical Demyelinating Event (FCDE): 5-year Results of Phase III REFLEX Study Extension (REFLEXION) (P7.250) (2015) (0)
- EARLY ALTERATIONS IN RESTING-STATE FUNCTIONAL CONNECTIVITY IS ASSOCIATED WITH AMYLOID PATHOLOGY IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWINS (2017) (0)
- Exploring the biomarker cascade model: Relating cortical volume loss to [11C]PiB, [18F]FDG and MMSE over time in Alzheimer's disease patients and normal controls (2012) (0)
- Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individuals (2021) (0)
- OCTiMS Study: A 3-Year Longitudinal Assessment of RNFL Thickness Measured by Optical Coherence Tomography in Patients with Relapsing–Remitting Multiple Sclerosis (S24.001) (2018) (0)
- IC-102-05 Differential effects of white matter lesions on medial temporal lobe atrophy in early versus late onset Alzheimer’s disease (2006) (0)
- METABOLIC BLOOD-BASED BIOMARKERS RELATE TO BRAIN ATROPHY AND WHITE MATTER HYPERINTENSITIES IN ALZHEIMER’S DISEASE (2018) (0)
- PREDICTING COGNITIVE DECLINE THROUGH STRUCTURAL MRI BIOMARKERS: RESULTS FROM THE EMIF-AD BIOMARKER DISCOVERY STUDY (2018) (0)
- P08.06.A Work resumption following lower-grade glioma surgery: a multicenter cohort study (2022) (0)
- More white matter hyperintensities and smaller brain volumes are related to lower cerebral blood flow measured with 3T arterial spin labeling magnetic resonance imaging (2013) (0)
- Mapping associations across multiple aspects of Alzheimer disease and the role of CSF biomarkers in individuals without dementia (2021) (0)
- P1-380 Homocysteine metabolism and brain changes in Alzheimer’s disease (2006) (0)
- Vitamin D as a Predictor of Functional Deficits in Multiple Sclerosis (P4.014) (2015) (0)
- Brain glucose metabolism in patients with mild to moderate Alzheimer's disease before and after six months treatment with intravenous immunoglobulin (octagam 10%): A phase II double blind, placebo-controlled multi-center study (2011) (0)
- Magnims: EC network for developing optimal MR techniques to monitor treatments for preventing disability in multiple sclerosis (1995) (0)
- MULTIMODAL BRAIN NETWORK ALTERATIONS IN ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT PATIENTS (2014) (0)
- Methylphenidate and galantamine in patients with vascular cognitive impairment–the proof-of-principle study STREAM-VCI (2020) (0)
- Long-term predictors of clinical outcomes in patients with multiple sclerosis randomized to fingolimod 0.5 mg in the phase 3 FREEDOMS, FREEDOMS II and TRANSFORMS studies (P4.384) (2018) (0)
- P2-378 Automatic segmentation of age-related white-matter changes in a multi-center study (2006) (0)
- OP-BRAI190145 1858..1875 (2019) (0)
- Validation of a continuous model of amyloid‐β CSF/PET discordance across cohorts and PET tracers (2022) (0)
- PATTERNS OF GLUCOSE HYPOMETABOLISM, SUBCORTICAL ATROPHY AND WHITE MATTER HYPERINTENSITIES IN THE BEHAVIORAL VARIANT OF ALZHEIMER’S DISEASE (2018) (0)
- MICROBLEEDS ARE ASSOCIATED WITH DEPRESSIVE SYMPTOMS IN ALZHEIMER’S DISEASE (2017) (0)
- Reproducibility of hippocampal atrophy rate at 1.5T and 3T for freesurfer and MAPS-HBSI using the ADNI1 data set (2015) (0)
- Automatic Segmentation of Age-related White-Matter Changes in a multi-centre study (2006) (0)
- Alzheimer's disease patients with microbleeds and additional white matter hyperintensities: Does it matter? (2012) (0)
- PS18 - 1. Exenatide blunts hyperactivation in CNS reward and satiety circuits elicited by viewing food cues in obese individuals (2013) (0)
- GENDER EFFECTS ON ATROPHY IN MS : COGNITIVE IMPLICATIONS (2009) (0)
- MRI in the assessment of putative treatments for multiple sclerosis (1996) (0)
- 4298 REGIONAL CHANGE IN DTI PARAMETERS DUE TO SCANNER UPGRADE : EFFECTS ON TBSS AND ROI ANALYSIS (2013) (0)
- Prediction of amyloid pathology in cognitively unimpaired individuals using structural MRI (2021) (0)
- Serum metabolic profile in early multiple sclerosis as predictor of long-term disease progression in BENEFIT (P5-3.013) (2023) (0)
- Efficient use of MRI for dose finding in multiple sclerosis (2013) (0)
- Alzheimer’s disease core biomarkers and prediction of dementia in MCI: The effect of age at onset (2015) (0)
- GREY MATTER CONNECTIVITY TRAJECTORIES ACROSS THE ALZHEIMER’S DISEASE CONTINUUM AND ASSOCIATIONS WITH COGNITIVE DECLINE (2019) (0)
- IDENTIFYING BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA AMONG PATIENTS WITH A LATE-ONSET FRONTAL LOBE SYNDROME: SUMMARY RESULTS OF THE LOF STUDY (2018) (0)
- Comparing quality of glioblastoma resections between care teams (2017) (0)
- A LONGITUDINAL STUDY OF THE EFFECTS OF EDUCATION AND INTRACRANIAL VOLUME ON COGNITIVE CHANGES AND MORTALITY RATES IN ALZHEIMER’S DISEASE (2019) (0)
- Clinicopathological correlations for black holes: an MRI marker for axonal loss? (2001) (0)
- Cognition and disinhibition in multiple sclerosis : impact of MRI changes within thalamic tracts Submitted (2016) (0)
- Grey matter graph properties are related to disease severity in Alzheimer's disease (2013) (0)
- AMYPAD-DPMS PRELIMINARY RESULTS: PARTICIPANTS’ BASELINE FEATURES (2019) (0)
- Residual approaches to capture resilience and resistance in aging and Alzheimer’s disease: A meta‐analysis (2021) (0)
- In vivo tau pathology is associated with synaptic loss and altered synaptic function (2021) (0)
- Early rate of ventricular enlargement predicts long-term clinical outcome in multiple sclerosis (2009) (0)
- Subject Index Vol. 20, 2005 (2005) (0)
- 4 . 2 MRI characteristics of clinical subtypes of mild cognitive impairment (2012) (0)
- The use of amyloid‐PET in memory clinic patients: AMYPAD Diagnostic and Patient Management Study (2022) (0)
- Impact of early treatment of MS with interferon beta-1b: cognitive outcomes at the 11-year follow-up of BENEFIT (BENEFIT 11) (2015) (0)
- Differential diagnosis of dementia combining web‐based cognitive testing and MRI (2020) (0)
- PROTOCOL HARMONISATION AND IN-VIVO COMPARISON OF ARTERIAL SPIN LABELLING PERFUSION MRI FOR MULTICENTER CLINICAL TRIALS (2018) (0)
- The optimal MRI technique for detecting cortical demyelination in multiple sclerosis: post-mortem validation of all so far suggested sequences (2019) (0)
- P2-200 Patterns of brain atrophy in early-onset versus late-onset Alzheimer's disease: relevance of posterior cingulate atrophy (2004) (0)
- Cerebral blood flow measured with arterial spin–labeled perfusion MRI at 3T and structural brain changes in Alzheimer's disease (2012) (0)
- DISCOVERY AND VALIDATION OF MULTIMODAL BIOMARKER SIGNATURES RELATING TO ALZHEIMER'S DISEASE PATHOLOGY AND PROGRESSION (2017) (0)
- Safety and Immunogenicity of Two Dosing Frequencies of Subcutaneous Interferon (scIFN) β-1a in Patients with a First Clinical Demyelinating Event (FCDE): 5-year Results of Phase III, Double-blind, Multicenter Trials (REFLEX/REFLEXION) (P7.211) (2015) (0)
- P11.37.B When to resect or biopsy for patients with supratentorial glioblastoma: a multivariable prediction model (2022) (0)
- Lesional Magnetization Transfer Ratio — a Feasible Outcome for Remyelinating Treatment Trials in MS (2010) (0)
- IS THE RELATION BETWEEN BLOOD PRESSURE AND COGNITION DEPENDENT ON AMYLOID PATHOLOGY OR PHYSICAL PERFORMANCE? RESULTS OF THE EMIF-AD 90+ STUDY (2018) (0)
- ATROPHY PATTERNS PREDICTING COGNITIVE DECLINE IN NON-DEMENTED SUBJECTS ARE INDEPENDENT OF AMYLOID PATHOLOGY (2016) (0)
- A COMBINED CLINICAL AND RADIOLOGICAL SURVIVAL PREDICTION TOOL FOR PONTINE GLIOMA (2012) (0)
- Cerebral blood flow and cognitive functioning in patients with disorders along the heart–brain axis Cerebral and the axis (2020) (0)
- Computer-aided diagnosis and prediction in brain disorders (2022) (0)
- White matter lesions on MRI in older individuals: Alzheimer's disease? (1991) (0)
- Cortical Cerebral Blood Flow in Aging: Effects of Haematocrit, Sex and Ethnicity (2018) (0)
- Quantitative regional validation of the rating scale for posterior cortical atrophy (2013) (0)
- THE NORMAL AGING BRAIN COLLECTION AMSTERDAM (NABCA): A COMPREHENSIVE COLLECTION OF POSTMORTEM IMAGING, NEUROPATHOLOGICAL AND MORPHOMETRIC DATASETS (2018) (0)
- Do microbleeds predict stroke in Alzheimer's disease (MISTRAL)? Study design and first results (2013) (0)
- The spatio-temporal relationship between concurrent lesion and brain atrophy changes in early multiple sclerosis: A post-hoc analysis of the REFLEXION study (2023) (0)
- Impact of the disclosure of amyloid‐PET results to patients with subjective cognitive decline: the AMYPAD Diagnostic and Patient Management Study (DPMS) (2020) (0)
- Biomarker Based and Individualized Prognosis for Patients with Mild Cognitive Impairment: Towards a Personalized Medicine Approach for AD (2019) (0)
- Spatial localisation of lesions predicts clinical deterioration in primary progressive multiple sclerosis: a 10-year multi-centre study (2009) (0)
- Portal Diagnosis and prognosis of Alzheimer s disease in subjects with mild cognitive impairment (2013) (0)
- Decreased cerebral blood flow in T 2 DM patients is not improved by treatment with liraglutide (2016) (0)
- COMORBID AMYLOID-β PATHOLOGY AFFECTS NEUROPSYCHIATRIC, NEUROPSYCHOLOGICAL, AND IMAGING FEATURES IN VASCULAR COGNITIVE DISORDERS (2019) (0)
- THE NORMAL AGING BRAIN COLLECTION AMSTERDAM (NABCA): A COMPREHENSIVE COLLECTION OF POSTMORTEM IMAGING, NEUROPATHOLOGICAL AND MORPHOMETRIC DATASETS (2018) (0)
- The Impact Of Reference Region Choice On The Apparent Ordering Of Amyloid Deposition (2019) (0)
- Efficacy and Safety of Temelimab, an Antibody Antagonist of the Human Endogenous Retrovirus Type-W env Protein, in Participants with Relapsing Remitting Multiple Sclerosis: A Double-Blind, Randomised, Placebo-Controlled Phase 2b Clinical Trial (2019) (0)
- THE HIPPOCAMPAL BOUNDARY SHIFT INTEGRAL IS 70% MORE REPRODUCIBLE THAN OTHER ATROPHY ALGORITHMS (2014) (0)
- Magnetic resonance imaging in the diagnosis of dementia in a unselected population of elderly individuals. Preliminary results from the AMSTEL project (1992) (0)
- Predictors of disease activity in patients with clinically isolated syndrome (CIS) treated with interferon beta 1b in the BENEFIT trial (2013) (0)
- MRI in MS - state of the art (2010) (0)
- The minimal common brain for the left and right hemisphere. (2013) (0)
- Periventricular gradients in NAWM abnormalities differ in MS, NMOSD and MOGAD (2023) (0)
- The value of arterial spin labelling perfusion MRI in brain age prediction (2023) (0)
- ' s response to reviews Prevalence of Abnormal Findings on Brain Magnetic Resonance ( MR ) Examinations Performed as a Title : Part of an Annual Medical Check-up : Results of Brain Docking (2005) (0)
- Test retest analysis of fMRI using visual stimulation: EPI compared to FLASH (1997) (0)
- CLASSIFICATION OF PATHOLOGY USING BRAIN SUBSTRUCTURE VOLUMES IN POST MORTEM CONFIRMED DEMENTIAS (2014) (0)
- Conference papers and abstracts (peer reviewed, 21 items) (2005) (0)
- IMPACT OF CO-MORBID AMYLOID PATHOLOGY ON CLINICAL PHENOTYPE OF PATIENTS WITH VASCULAR COGNITIVE DISORDERS (2016) (0)
- GREY MATTER CONNECTIVITY IS RELATED TO A STEEPER LOSS OF MEMORY AND LANGUAGE FUNCTIONING OVER TIME IN PATIENTS WITH SUBJECTIVE COGNITIVE DECLINE (2017) (0)
- Impact of interobserver variability in contouring of AVMs (2004) (0)
- Genetically identical twins are highly similar in levels and spatial distribution of tau pathology: A [18F]flortaucipir PET study (2021) (0)
- GREY MATTER CONNECTIVITY IS ASSOCIATED WITH CLINICAL PROGRESSION IN NON-DEMENTED, AMYLOID POSITIVE PATIENTS (2016) (0)
- Reduced hippocampal and thalamic activation patterns during memory encoding in MS (2009) (0)
- The EMIF-AD PreclinAD study: study design and baseline cohort overview (2018) (0)
- CORRELATION OF GREY MATTER NETWORK MEASURES IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS (2017) (0)
- ASSESSMENT OF EARLY AMYLOID PATHOLOGY USING [18F]FLUTEMETAMOL POSITRON EMISSION TOMOGRAPHY: COMPARING VISUAL READ, SEMI-QUANTITATIVE AND QUANTITATIVE METHODS (2018) (0)
- Featured Article Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's disease (2016) (0)
- Speci fi c Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged E ffi cacy of Cladribine Tablets A MAGNIFY-MS Substudy (0)
- Rationale and design of the “NEurodegeneration: Traumatic brain injury as Origin of the Neuropathology (NEwTON)” study: a prospective cohort study of individuals at risk for chronic traumatic encephalopathy (2022) (0)
- Title : Evaluation of prospective motion correction of high-resolution 3 D-T 2-FLAIR acquisitions in epilepsy patients (2018) (0)
- NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia (2005) (0)
- OP-BRCM210228 1..15 (2021) (0)
- Exploring the biomarker cascade model: Relating cortical volume loss to [11C]PIB, [18F]FDG and MMSE over time in Alzheimer's disease patients and normal controls (2012) (0)
- 113 Assessing predictors of NEDA in RRMS patients initiating dimethyl fumarate in a real-world setting (2022) (0)
- Brain Shrinkage in Anti-β-Amyloid Alzheimer Trials: Neurodegeneration or Pseudo-atrophy? (2023) (0)
- THE ADDED VALUE OF QUANTITATIVE AMYLOID PET IN DETERMINING ALZHEIMER’S DISEASE (AD) DEMENTIA RISK: THE AMYPAD PROGNOSTIC AND NATURAL HISTORY STUDY (2019) (0)
- Concerted alterations of functional connectivity and WM integrity in relationship to early amyloid deposition (2022) (0)
- WHITE MATTER HYPERINTENSITIES MEDIATE THE RELATIONSHIP BETWEEN GRAY MATTER VOLUME AND EXECUTIVE FUNCTION IN COGNITIVELY UNIMPAIRED MIDDLE-AGED INDIVIDUALS (2019) (0)
- Intracranial ganglioglioma: MR imaging. (1990) (0)
- NEUROIMAGING: BRAIN CONNECTIVITY O3-08-01 GREY MATTER CONNECTIVITY IS ASSOCIATED WITH TIME TO CLINICAL PROGRESSION IN MILD COGNITIVE IMPAIRMENT, INDEPENDENT OFAMYLOID STATUS (2019) (0)
- Peri-hippocampal developmental venous anomalies and memory loss: more than a normal variant? (2018) (0)
- PS11 - 50. Depressive symptoms exacerbate the negative effects of type 1 diabetes and microangiopathy on brain functioning (2012) (0)
- 2 . 3 Cumulative Enhancing Lesion Volume as Outcome Measure in MS Clinical Trials (2010) (0)
- natalizumab-associated progressive multifocal leukoencephalopathy The chameleon of neuroinflammation : magnetic resonance imaging characteristics of (2013) (0)
- Reply (1993) (0)
- MS-SMART study: systematic sampling bias concerns – Authors' reply (2020) (0)
- Cortical distribution of neurofilaments associates with pathological hallmarks and MRI measures of atrophy and diffusivity in Parkinson’s disease (2022) (0)
- Right temporal variant frontotemporal dementia is pathologically heterogeneous: a case-series and a systematic review (2021) (0)
- Cerebral microbleeds, cognitive functions and cerebral activity in type 1 diabetes patients with and without microvascular complications (2010) (0)
- Atrophy subtypes in Alzheimer ’ s disease are detectable in prodromal stage and associated with different cognitive trajectories (2019) (0)
- Longitudinal change in ATN biomarkers in cognitively normal individuals (2022) (0)
- Functional correlates of impaired working memory in multiple sclerosis patients: a multicentre study (2013) (0)
- More white matter hyperintensities and smaller brain volumes are related to lower cerebral blood flow as measured with 3T arterial spin labeling MRI (2013) (0)
- Genetic contribution to grey matter network disruptions and Alzheimer disease cerebrospinal fluid markers (2022) (0)
- Comparing ARIA‐E severity scales and effects of treatment management thresholds (2022) (0)
- Tau-related grey matter network breakdown across the Alzheimer’s disease continuum (2021) (0)
- Chapter 2 Amnestic mild cognitive impairment : Structural MRI findings predictive of conversion to Alzheimer ’ s disease (2011) (0)
- Sex differences inmemory clinic patients with possible vascular cognitive impairment (2020) (0)
- The progression of brain atrophy is similar in drug-free MS sub-types: A longitudinal study of a large patient population (2008) (0)
- The patients' experience of neuroimaging of primary brain tumors: a cross-sectional survey study. (2023) (0)
- P.327 Increased dynamic functional network reconfiguration in cognitively declining multiple sclerosis patients (2021) (0)
- THE USE OF RESIDUAL METHODS TO CAPTURE COGNITIVE RESERVE AND STUDY CLINICAL PROGRESSION IN ALZHEIMER’S DISEASE (2018) (0)
- Nutritional status and structural brain changes in Alzheimer’s disease: TheNUDADproject (2020) (0)
- Predicting conversion to secondary progressive MS: the role of MRI measures (2018) (0)
- A NOVEL NEUROIMAGING APPROACH TO CAPTURE COGNITIVE RESERVE (2016) (0)
- Impact of ApoE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults (2015) (0)
- IC-03-01: Imaging Alzheimer pathology in vivo: Quantitative comparison of [11C]PIB and [18F]FDDNP (2008) (0)
- Regional White Matter Abnormalities and Cognitive Impairment in MS: A Multicenter TBSS Study (P6.135) (2014) (0)
- Specific cerebellar atrophy patterns can distinguish physical disability and cognitive impairment in MS (2019) (0)
- Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning (2022) (0)
- Strategic white matter hyperintensity locations for cognitive impairment: A multicenter lesion-symptom mapping study in 3525 memory clinic patients. (2022) (0)
- Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis (2022) (0)
- REVEALS DISTINCT HYPOMETABOLIC TRAJECTORIES IN COGNITIVELY-DEFINED SUBGROUPS OF ALZHEIMER’S DISEASE (2019) (0)
- Evaluation of novel data‐driven metrics of amyloid β deposition for longitudinal PET studies (2022) (0)
- Functional eigenvector centrality dynamics are related to amyloid deposition in preclinical Alzheimer’s Disease (2022) (0)
- Predicting Response To Interferon beta-1b Therapy In Patients With Clinically Isolated Syndrome (P1.228) (2014) (0)
- P.048 International MAGNIMS-CMSC-NAIMS consensus recommendations on the use of standardized MRI in MS (2021) (0)
- PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases (2019) (0)
- A stepwise approach towards diagnostic workup in dementia using online cognitive tools (2021) (0)
- P1-307: Assessment of global cortical atrophy and medial temporal lobe atrophy in suspected and definite dementia: Comparison of magnetic resonance imaging and 64 multidetector row computed tomography (2008) (0)
- Diffusion weighted MRI of neonates with meningoencephalitis caused by Bacillus cereus (2003) (0)
- P1-300: Imaging Alzheimer pathology in vivo: Quantitative comparison of [11C]PIB and [18F]FDDNP (2008) (0)
- The association between blood MxA mRNA and long-term disease activity in early multiple sclerosis (2022) (0)
- Tau deposition is associated with grey matter network breakdown across different stages of the Alzheimer’s disease continuum (2021) (0)
- Specific patterns of thalamic functional connectivity changes related to disability and cognitive impairment in multiple sclerosis (2018) (0)
- WHEN MEASURING HIPPOCAMPAL ATROPHY, DO THE SEGMENTATION NOISE DISTRIBUTIONS OF METHODS, AS DETERMINED BY THE BACK TO BACK REPRODUCIBILITY, HAVE GAUSSIAN DISTRIBUTIONS? (2017) (0)
- PREDICTING PROGRESSION IN PRE-DEMENTIA STAGES OF ALZHEIMER’S DISEASE WITH A NEUROIMAGING MEASURE OF COGNITIVE RESERVE (2017) (0)
- Segmentation of glioblastomas in early post-operative multi-modal MRI with deep neural networks (2023) (0)
- 1 A multi-shell multi-tissue diffusion study of brain connectivity in early multiple sclerosis (2020) (0)
- Heterogeneity in Preclinical Alzheimer’s Disease Trial Cohort Identified by Image-based Data-Driven Disease Progression Modelling (2023) (0)
- ASSESSMENT OF EARLY AMYLOID PATHOLOGY USING [18F]FLUTEMETAMOL POSITRON EMISSION TOMOGRAPHY: COMPARING VISUAL READ, SEMI-QUANTITATIVE AND QUANTITATIVE METHODS (2018) (0)
- METHYLPHENIDATE IMPROVES EXECUTIVE FUNCTIONING IN PATIENTS WITH VASCULAR COGNITIVE IMPAIRMENT: FIRST RESULTS OF THE STREAM-VCI STUDY (2018) (0)
- COGNITIVE SUBTYPES IDENTIFIED USING NONNEGATIVE MATRIX FACTORISATION IN FOUR LARGE ALZHEIMER'S DISEASE DEMENTIA COHORTS (2016) (0)
- POSTERIOR ATROPHY SCALE: NORMATIVE VALUES FOR ITALIAN POPULATION (2018) (0)
- Grey and white matter atrophy in a large cohort of multiple sclerosis patients : Relation to MRI parameters and impact on clinical disability (2011) (0)
- Validation of the clinical classification scheme using MRI in the BENEFIT Study (2005) (0)
- P2-281 Fluid registration derived hippocampal atrophy rates: Reliability and comparison with manual measures, a methodological approach (2006) (0)
- Consistency of grey matter volume measurement in multiple sclerosis: comparison of FSL, FreeSurfer and SPM (2015) (0)
- 153 ChariotMS – cladribine to halt deterioration in people with advanced multiple sclerosis (pwAMS) (2022) (0)
- Head Motion Parameters in fMRI Differ Between Patients with Mild Cognitive Impairment and Alzheimer Disease Versus Elderly Control Subjects (2014) (0)
- Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment (2017) (0)
- Steps towards the implementation of amyloid‐PET in memory clinics: AMYPAD Diagnostic and Patient Management Study (2022) (0)
- Trial Enrichment using Siamese Neural Networks and PET imaging (2022) (0)
- MRI and CT in the diagnosis of vascular dementia. J Neurol Sci (2004) (0)
- DISCOVERY AND VALIDATION OF MULTIMODAL BIOMARKER SIGNATURES RELATING TO ALZHEIMER\textquotesingleS DISEASE PATHOLOGY AND PROGRESSION (2017) (0)
- PLASMA PRIMARY FATTY AMIDES ASSOCIATE TO CSF AMYLOID LEVELS AND ALZHEIMER’S DISEASE PROGRESSION IN THE EMIF-AD BIOMARKER DISCOVERY COHORT (2018) (0)
- Author response for "Cerebral effects of GLP ‐1 receptor blockade before and after Roux‐en‐Y Gastric Bypass in obese women: a proof‐of‐concept resting‐state fMRI study" (2020) (0)
- UvA-DARE (Digital Academic Repository) Cardiovascular and Interventional Radiological Society of Europe Commentary on the Treatment of Chronic Cerebrospinal Venous Insufficiency Reekers, (2011) (0)
- Baseline MRI and CSF measurements in cognitively normal individuals as prognostic markers of progression to mild cognitive impairment (2021) (0)
- The deep learning lesion segmentation method nicMSlesions only needs one manually delineated subject to outperform commonly used unsupervised methods (2018) (0)
- P1-248: Diagnostic utility of cross-sectional and longitudinal hippocampal volumetry in memory clinic patients (2008) (0)
- Amyloid‐dependent association of grey matter network disruptions with phospho‐tau in preclinical Alzheimer’s disease (2020) (0)
- Neurofilament light and cognitive performance: Associations with amyloid and vascular pathologies in individuals with mild cognitive impairment (2020) (0)
- Cerebral microbleeds : Imaging and Clinical Significance 1 (2018) (0)
- WHITE MATTER MICROSTRUCTURE AND AMYLOID AGGREGATION IN COGNITIVELY HEALTHY, ELDERLY IDENTICAL TWINS (2018) (0)
- Lesion-wise evaluation for effective performance monitoring of small object segmentation (2021) (0)
- Inflammation Magnetic Resonance Imaging (2012) (0)
- ChangesinMEG resting-state networksarerelatedtocognitive decline in type 1 diabetes mellitus patients (2014) (0)
- OP06.03: Fetal lung volume: three‐dimensional ultrasonography compared with magnetic resonance imaging (2006) (0)
- 2 . 2 T 2 w Subtraction MR Imaging in Phase II MS Trials : A Powerful New Outcome Measure (2010) (0)
- NI-31USING TUMOR LOCALIZATION MAPS TO IDENTIFY BRAIN LOCATIONS INVOLVED IN COGNITIVE FUNCTIONING IN GLIOMA PATIENTS BEFORE THERAPY (2014) (0)
- BRAIN VOLUME CHANGE AND DISABILITY IN FINGOLIMOD TRIALS (2014) (0)
- Mystery Case: Baló concentric sclerosis (2013) (0)
- Prediction of gadolinium enhancement status on MRI at baseline of multiple sclerosis trials (2004) (0)
- NORMAL-APPEARING TISSUE AT (ULTRA)HIGH FIELD (2015) (0)
- O1-02-06 Deactivation in healthy aging, mild cognitive impairment and Alzheimer's disease (2004) (0)
- ATN BIOMARKER MODEL AS A DETERMINANT OF COGNITIVE DECLINE AND INCIDENT CLINICAL PROGRESSION IN SUBJECTIVE COGNITIVE DECLINE: THE SCIENCE PROJECT (2019) (0)
- Impact of reduced injected dose on semi‐quantification of in vivo amyloid‐β pathology using [18F]flutemetamol (2022) (0)
- A standard benchmark for assessing the reproducibility of brain atrophy measures in Alzheimer's disease using the ADNI1 data set (2013) (0)
- Commercial volumetric MRI reporting tools in multiple sclerosis: a systematic review of the evidence (2022) (0)
- DeepBrainPrint: A Novel Contrastive Framework for Brain MRI Re-Identification (2023) (0)
- Multiomics machine learning identifies sleep and inflammation molecular pathways in prodromal Alzheimer's Disease (2023) (0)
- Amyloid‐β deposition in cognitively normal oldest‐old is associated with cortical thinning and faster memory decline (2020) (0)
- COGNITIVE FUNCTIONING IN PATIENTS WITH DISORDERS ALONG THE HEART-BRAIN AXIS: THE ROLE OF CEREBRAL BLOOD FLOW (2019) (0)
- Patterns of atrophy in Alzheimer's disease: Does cognition follow structure? (2012) (0)
- WHITE MATTER HYPERINTENSITIES AND VASCULAR RISK FACTORS IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS (2017) (0)
- Increased working memory performance in high-dissociative subjects (2003) (0)
- WHITE MATTER HYPERINTENSITIES PREDICT MILD COGNITIVE IMPAIRMENT AND DEMENTIA IN PATIENTS WITH SUBJECTIVE COGNITIVE COMPLAINTS (2014) (0)
- MRI study of morphologic features and CSF flow study to predict ventriculoperitoneal shunt responsiveness in patients with normal pressure hydrocephalus. (2008) (0)
- Distinct patterns of atrophy in postmortem confirmed dementias (2015) (0)
- Local increases in metabolite levels predict lesion formation and lesion severity in relapsing-remitting multiple sclerosis (2015) (0)
- EFFECT OF APOE-ε2 ON REGIONAL GRAY MATTER ATROPHY AND CLINICAL PHENOTYPE IN ALZHEIMER’S DISEASE (2017) (0)
- Biomarker testing in MCI patients—deciding who to test (2020) (0)
- Introduction to "Quantitative MRI of the Spinal Cord" (2014) (0)
- Differential gray matter connectivity correlates of CSF biomarkers: Results from the EPAD Cohort (2021) (0)
- Treatment with interferon reduces the appearance of lesions in clinically relevant white matter tracts in patients with clinically isolated syndrome (2016) (0)
- Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results (2018) (0)
- Title: Prediction of H3K27M-mutant brainstem glioma by amide proton transfer weighted imaging and its derived radiomics Running title: Brainstem glioma H3K27M-mutant prediction by APTw imaging (2021) (0)
- Longitudinal spinal cord atrophy in multiple sclerosis using the generalised boundary shift integral RUNNING HEAD: GBSI for spinal cord atrophy (2019) (0)
- ROBUST INDIVIDUALIZED PREDICTION MODELS WHICH ARE APPLICABLE ACROSS DIFFERENT COHORTS (2018) (0)
- P07.08 Higher functional hub load at diagnosis is associated with shorter survival in glioma patients (2016) (0)
- Functional connectivity changes of the motor network in patients with multiple sclerosis: a multicentre fMRI study (2009) (0)
- Segmentation of Age-Related White-Matter Changes in a large-scale, multi-centre study. (2006) (0)
- Volumetric Deep Grey Matter Differences in Pediatric Patients with Dyskinetic vs Spastic CP. (2013) (0)
- P1-235: An automated method for measuring longitudinal volume changes of the ventricular system (2008) (0)
- Vitamin D As Predictor Of Multiple Sclerosis Activity And Progression In Patients With CIS Treated Early With Interferon beta-1b (P5.016) (2014) (0)
- DETECTING ALZHEIMER’S DISEASE AT DIFFERENT LEVELS OF WHITE-MATTER HYPERINTENSITIES USING MRI (2019) (0)
- HIPPOCAMPAL INTRINSIC CONNECTIVITY SUPPORTS COGNITIVE RESERVE IN AMYLOID-POSITIVE COGNITIVELY NORMAL SUBJECTS AND ALZHEIMER’S DISEASE PATIENTS (2019) (0)
- 7T T2∗-WEIGHTED MRI REVEALS CORTICAL PHASE DIFFERENCES BETWEEN EARLY- AND LATE-ONSET AD (2014) (0)
- Cortical Involvement In Early And Late Stages Of Metachromatic Leukodystrophy (P7.342) (2014) (0)
- Tau and synaptic biomarkers but not amyloid‐β are associated with cerebral perfusion in the Alzheimer’s disease spectrum (2021) (0)
- COGNITIVE SUBTYPES IN DEMENTIA DUE TO ALZHEIMER'S DISEASE IDENTIFIED BY LATENT CLASS ANALYSIS (2014) (0)
- Strategies to reduce sample sizes in Alzheimer’s disease primary and secondary prevention trials using longitudinal amyloid PET imaging (2021) (0)
- ACROSS-SESSION REPRODUCIBILITY OF AUTOMATIC WHITE MATTER HYPERINTENSITIES SEGMENTATION: A EUROPEAN MULTI-SITE 3T STUDY (2017) (0)
- CROSS-SECTIONAL MODELING OF REGIONAL PERFUSION AND GRAY MATTER VOLUME IN ALZHEIMER'S DISEASE (2016) (0)
- Monozygotic twin similarities for AD biomarkers: the Twin60+study (2018) (0)
- Distinct patterns of atrophy in postmortem-confirmed dementias (2015) (0)
- Regional distribution of tau pathology in cognitively unimpaired, genetically identical twins (2020) (0)
- Predictors of freedom from detectable disease activity in patients with clinically isolated syndrome treated with interferon beta-1b in the BENEFIT trial (2014) (0)
- Amyloid‐β deposition in cognitively normal oldest‐old is associated with cortical thinning and faster memory decline (2020) (0)
- Ibudilast: a paradigm shift for progressive MS? (2020) (0)
- LATENT ATROPHY FACTORS IN POSTERIOR CORTICAL ATROPHY RELATE TO SPECIFIC COGNITIVE IMPAIRMENTS (2018) (0)
- Amyloid and Microbleeds in different dementias: retained or drained? (2011) (0)
- PROGNOSIS OF CLINICAL PROGRESSION IN SUBJECTIVE COGNITIVE DECLINE USING A CLINICAL DECISION SUPPORT SYSTEM (2017) (0)
- A voxelbased analysis of white matter hyperintensities in elderly subjects (2005) (0)
- Interpretable machine learning for dementia: A systematic review. (2023) (0)
- Abstracts from PACTRIMS (2013) (0)
- Quantitative amyloid‐PET measures in a memory clinic population (2022) (0)
- Thalamus atrophy progresses faster in subjects with early MS who have more damage in the connected white matter and who show increasing disability over time (2019) (0)
- Cerebrospinal fluid proteomic profiling of individuals with prodromal Alzheimer’s disease classified using two different neurodegenerative biomarkers (N) in A/T/N classification (2021) (0)
- Neuroimaging in Normal Brain Aging (2019) (0)
- Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study. (2023) (0)
- Advanced glioma and correlation with histological and molecular characteristics (2013) (0)
- The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics (2018) (0)
- Current status and quantitative results of the AMYPAD prognostic and natural history study (2021) (0)
- Vijverberg et al. 1 Grey matter network differences between behavioral variant Frontotemporal Dementia and Alzheimer’s disease (2017) (0)
- Application of Lesion Probability Maps to predict progression in primary-progressive multiple sclerosis: a 10-year multi- centre study (2009) (0)
- What does ( quantitative ) MRI of the MS cortical gray matter measure ? A post mortem imaging exploration . (2009) (0)
- CORTICAL T1-W/T2-W RATIO VALUES ARE HIGHER IN ALZHEIMER’S DISEASE COMPARED TO CONTROLS (2018) (0)
- EXTENSION AND VALIDATION OF AN AMYLOID STAGING MODEL: ASSOCIATIONS WITH CLINICAL MEASURES (2018) (0)
- IC-P-051 White matter hyperintensity load is a possible predictor of corpus callosum atrophy in the elderly: The LADIS study (2006) (0)
- P64: Disturbed directions in white matter hyperintensity based vascular dementia: an EEG connectivity study (2014) (0)
- EVENT-BASED MODELING OF THE TEMPORAL ORDERING OF REGIONAL b -AMYLOID DEPOSITION IN THE BRAIN PET IMAGING OF SYNAPTIC DENSITY (SYNAPTIC VESICLE GLYCOPROTEIN 2A, SV2A)INALZHEIMER’S DISEASE:INITIAL (2018) (0)
- A LONGITUDINAL STUDY OF THE EFFECTS OF EDUCATION AND INTRACRANIAL VOLUME ON COGNITIVE CHANGES AND MORTALITY RATES IN ALZHEIMER’S DISEASE (2019) (0)
- IC-P2-144: Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's disease (2008) (0)
- Sex differences in CSF biomarkers vary by Alzheimer ’ s disease stage and APOE ε 4 1 genotype 2 3 (2020) (0)
- Brain atrophy in MS: long-term prognostic value (2011) (0)
- BIOMARKER-BASED PERSONALIZED RISK ESTIMATES FOR PATIENTS WITH SUBJECTIVE COGNITIVE DECLINE (2017) (0)
- LOBAR MICROBLEEDS PREDICT STROKE IN PATIENTS WITH ALZHEIMER'S DISEASE: THE MISTRAL STUDY (2014) (0)
- LOSS OF GREY MATTER CONNECTIVITY IN THE PRECUNEUS IS ASSOCIATED WITH FASTER ATROPHY RATES IN PRECLINICAL ALZHEIMER’S DISEASE (2018) (0)
- NiftyPAD - Novel Python Package for Quantitative Analysis of Dynamic PET Data (2023) (0)
- REDUCED CALLOSAL WHITE MATTER INTEGRITY SURPASSES CEREBROSPINAL FLUID AND ATROPHY MARKERS AS PREDICTOR OF DECLINE IN SUBJECTS WITH MILD COGNITIVE IMPAIRMENT: A COMBINED VOLUMETRY AND DTI STUDY (2014) (0)
- Identification of plasma proteome signatures associated with ATN framework using SOMAscan (2020) (0)
- Reply from the authors [4] (2006) (0)
- Arterial Spin Labeling versus FDG-PET for Differential Diagnosis in Dementia – use of Z-maps for visual assessment (2016) (0)
- MRI results in patients with CIS treated with interferon beta-1b: 11-year follow up in BENEFIT (BENEFIT 11) (2015) (0)
- Chapter 5 LOWER CEREBRAL BLOOD FLOW IS ASSOCIATED WITH FASTER COGNITIVE DECLINE IN ALZHEIMER ’ S DISEASE (0)
- CEREBRAL BLOOD FLOW MEASURED WITH PHASE-CONTRAST MRI IN AD, MCI AND CONTROLS (2016) (0)
- Transferability of Alzheimer's disease progression subtypes to an independent population cohort (2023) (0)
- Cortical and subcortical gray matter structural alterations in normoglycemic obese and type 2 diabetes patients: relationship with adiposity, glucose, and insulin (2018) (0)
- Contents Vol. 20, 2005 (2005) (0)
- Apolipoprotein E epsilon 4 Affects Cognition, but Not Brain Structure and Functioning in Patients with Long-Standing Type 1 Diabetes (2017) (0)
- Personalized risk for clinical progression in cognitively normal subjects—the ABIDE project (2019) (0)
- Early detection of Alzheimer's disease subtypes in Amsterdam Dementia Cohort (2022) (0)
- WHITE MATTER HYPERINTENSITIES PREDICT MILD COGNITIVE IMPAIRMENT AND DEMENTIA IN PATIENTS WITH SUBJECTIVE COGNITIVE COMPLAINTS (2014) (0)
- DTI in Leukoencephalopathy with Brainstem and Spinal cord involvement and elevated Lactate ( LBSL ) : Local strongly increased (2009) (0)
- Application Of Quantitative Neuroimaging (Qni) Segmentations In Dementia (2018) (0)
- Diffuse Amyloid-β relates to lower structural degree and higher local efficiency in the posterior cingulate cortex: a post-mortem MRI and histology study. (2020) (0)
- Molecular dissection of the role of vitamin D in determining multiple sclerosis activity (2013) (0)
- RATIONALE AND DESIGN OF THE NL-ENIGMA STUDY, A DUTCH 24-WEEK RANDOMISED CONTROLLED STUDY TO EXPLORE THE EFFECT OF A NUTRITIONAL INTERVENTION ON BRAIN GLUCOSE METABOLISM IN EARLY ALZHEIMER'S DISEASE (2014) (0)
- IC-P3-177: An automated method for measuring longitudinal volume changes of the ventricular system (2008) (0)
- Chapter 3 DESIGN OF THE EXCERSION-VCI STUDY : THE EFFECT OF AEROBIC EXERCISE ON CEREBRAL PERFUSION IN PATIENTS WITH VASCULAR COGNITIVE IMPAIRMENT (0)
- IC-P-020 MRI biomarkers as predictors of mortality in dementia (2006) (0)
- Comparing ARIA‐E severity scales and effects of treatment management thresholds (2022) (0)
- SUSTAINED LOW RATE BRAIN VOLUME LOSS IN LONG TERM FINGOLIMOD TREATMENT (2015) (0)
- COGNITIVELY NORMAL APOE-ε2 HOMOZYGOTES DISPLAY GREATER HIPPOCAMPI: AN UNBIASED VOXEL-BASED ANALYSIS (2019) (0)
- Lower cerebral blood flow is related to more severe cognitive impairment in patients with dementia due to Alzheimer's disease (2015) (0)
- ExploreQC: A toolbox for MRI quality control in the EPAD multicentre study (2020) (0)
- CHAPTER 6 Quantification of cerebral blood flow in healthy subjects and type 1 diabetic patients : comparison of MRI arterial spin labeling and [ 15 O ] H 2 O PET Submitted (2013) (0)
- P2-308 Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression: The LADIS study (2006) (0)
- Computerized decision support to select memory clinic patients for amyloid PET: Which patient to test? (2020) (0)
- Impact of ApoE-Ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults (2015) (0)
- MILD COGNITIVE IMPAIRMENT WITH SUSPECTED NON AD PATHOLOGY (SNAP): PREDICTION OF PROGRESSION TO DEMENTIA (2014) (0)
- S13.1: Bayesian prediction of the number of lesions in multiple sclerosis trials (2004) (0)
- P3-063 Activation in the working memory network in healthy aging, mild cognitive impairment and Alzheimer's disease (2004) (0)
- Exploring the Relationship Between Serum GDF-15 and Disease Stability in Patients with a First Clinical Demyelinating Event Treated with Subcutaneous Interferon Β-1a Or Placebo in the REFLEX Study (2023) (0)
- Relevance of Brain Lesion Distribution and Frequency for Short-Term Conversion of Patients with Clinically Isolated Syndrome to Multiple Sclerosis (P03.033) (2012) (0)
- Comparison of static and dynamic analysis techniques for longitudinal analysis of amyloid PET (2020) (0)
- Predicting clinical progression in multiple sclerosis six and twelve years after onset (2017) (0)
- Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6 (2021) (0)
- Reply: (2012) (0)
- Impact of neurodegeneration and other pathology on clinical dysfunction in multiple sclerosis (2016) (0)
- Cognitive functioning and hippocampal connectivity in patients with longstanding type 1 (2021) (0)
- Decreased integrity of the monoaminergic tract is associated with a positive response to MPH in patients with vascular cognitive impairment - proof of principle study STREAM-VCI (2022) (0)
- PATTERNS OF GLUCOSE HYPOMETABOLISM, SUBCORTICAL ATROPHY AND WHITE MATTER HYPERINTENSITIES IN THE BEHAVIORAL VARIANT OF ALZHEIMER'S DISEASE (2018) (0)
- Investigating the clinico-anatomical dissociation in the behavioral variant of Alzheimer disease (2020) (0)
- Multimodal Spatio-Temporal Model of the Natural History of Alzheimer's Disease from Joint Serial Assessment of Amyloidosis, Tauopathy, Hypometabolism, and Atrophy (2019) (0)
- Less Cortical Folding in Adult Patients with Long-Standing Type 1 Diabetes Is Related to Cognition and Diabetes Duration (2017) (0)
- 14. Liraglutide Decreases Food Related CNS Activation after Short-Term, but Not after Longer-Term Treatment in Patients with Diabetes (159-OR) (2015) (0)
- Reply (2010) (0)
- Discrimination of Alzheimer's disease from cognitively healthy individuals: an arterial spin labeling MRI study (2010) (0)
- IC-P2-145: Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: A longitudinal study (2008) (0)
- What explains gray Matter atrophy in l ong-standing (2014) (0)
- Exome‐wide rare variant analysis of Alzheimer’s disease biomarkers: The EMIF‐AD multimodal biomarker discovery study (2021) (0)
- P1-302: Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's disease (2008) (0)
- CORRELATION OF CORTICAL THICKNESS IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS (2016) (0)
- Hippocampal functional connectivity and structural changes in Multiple Sclerosis (2009) (0)
- Optimal parametric imaging methods for dual‐time‐window [18F]flutemetamol and [18F]florbetaben PET studies (2021) (0)
- Heterogeneity of White Matter Hyperintensities in Alzheimer's Disease: Post-Mortem Quantitative MRI and Neuropathology (2009) (0)
- Widespread disruption of functional brain organization in early-onset Alzheimer's disease patients (2013) (0)
- REGIONAL DISTRIBUTION OF WHITE MATTER HYPERINTENSITIES RELATED TO ALZHEIMER'S DISEASE RISK FACTORS IN THE ALFA COHORT (2018) (0)
- Reproducing Fingerprints: A Step toward Clinical Adoption. (2019) (0)
- P3-061 Effects of galantamine on brain activation during episodic memory in Alzheimer's disease (2004) (0)
- Gray matter atrophy, but not vascular brain injury is related to cognitive impairment in patients with heart failure (2020) (0)
- Characterization of symptoms and determinants of disease burden in dementia with Lewy bodies: DEvELOP design and baseline results (2021) (0)
- Different patterns of cortical atrophy in early- and late-onset Alzheimer's disease (2012) (0)
- A 1-year serial clinical and MRI study of primary progressive multiple sclerosis (1970) (0)
- Dementias with Associated ‘Brain Swelling’ (2011) (0)
- Effect of Two Dosing Frequencies of Subcutaneous Interferon (scIFN) β-1a on Conversion to Multiple Sclerosis (MS) in Patients with a First Clinical Demyelinating Event (FCDE): 5-year Results of Phase III, Double-blind, Multicenter Trials (REFLEX/REFLEXION) (P7.206) (2015) (0)
- UvA-DARE ( Digital Academic Repository ) Immune functions in untreated and treated multiple sclerosis patients (2012) (0)
- Automatic brain extraction using deep learning (2021) (0)
- Abnormal connectivity inside the motor network in patients with multiple sclerosis: a multicentre fMRI study (2008) (0)
- Neuroimaging‐derived phenotypes in the European Prevention of Alzheimer Dementia (EPAD) Cohort Study (2021) (0)
- Magnetic resonance imaging of the brain in adults with severe falciparum malaria (2014) (0)
- Creating accurate reference segmentations of deep GM structures in MS patients by fast semi-automated outlining (2018) (0)
- Chapter 2 Quantification of MS pathology from MRI Quantification of pathology from magnetic resonance images in multiple sclerosis (2016) (0)
- Predicting Cognitive Decline in Older Adults Using Baseline Metrics of AD Pathologies, Cerebrovascular Disease, and Neurodegeneration (2022) (0)
- First results of the AMYPAD Prognostic and Natural History Study: amyloid‐PET Centiloid predicts cognitive functioning in a pre‐dementia population (2022) (0)
- Accelerating cortical atrophy as an explanation for cognitive decline in progressive MS (2018) (0)
- Slowing of cerebral atrophy after year 1 in a placebo-controlled trial of interferon beta 1b in secondary progressive multiple sclerosis (2007) (0)
- Parametric event-related fMRI of word encoding and retrieval (2001) (0)
- P2-070: Increased randomness of functional brain networks in Alzheimer's disease: ‘small-world' network analysis of non-linear functional connectivity (2008) (0)
- Opportunities for Molecular Imaging in Multiple Sclerosis Management: Linking Probe to Treatment. (2022) (0)
- GREY MATTER CONNECTIVITY TRAJECTORIES ACROSS THE ALZHEIMER’S DISEASE CONTINUUM AND ASSOCIATIONS WITH COGNITIVE DECLINE (2019) (0)
- WHITE MATTER HYPERINTENSITIES ARE ASSOCIATED WITH HIPPOCAMPAL ATROPHY RATES AFTER ADJUSTING FOR OTHER VASCULAR MARKERS IN PREDEMENTIA DISEASE STAGES (2017) (0)
- Reduced cortical thickness in patients with subjective cognitive decline is related to clinical progression (2015) (0)
- S2-02-01 MRI and CSF analysis probe different stages of AD and have complementary value (2007) (0)
- PS9 - 5. Proliferative retinopathy in type 1 diabetes is associated with cerebral microbleeds and decreased skin capillary density (2013) (0)
- P3714Cerebral blood flow and cognitive functioning in the heart-brain axis (2019) (0)
- Neurology in Practice and Practical (2006) (0)
- CORRELATION OF CORTICAL THICKNESS IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS (2016) (0)
- Author response: Clinical relevance of acute cerebral microinfarcts in vascular cognitive impairment (2020) (0)
- Associations between gut microbiota composition and AD biomarkers (2021) (0)
- Efficacy and toxicity of cerebral glioma treatment (2005) (0)
- Cognitive decline in possible vascular cognitive impairment (VCI): Does the form of vascular brain injury matter? (2021) (0)
- The boundary shift integral is much more reproducible than other hippocampal atrophy algorithms (2014) (0)
- Chapter 6. Use of Imaging in Multiple Sclerosis (2008) (0)
- Different patterns of cortical atrophy in early- and late-onset Alzheimer's disease (2012) (0)
- Betaferon(R) in newly emerging multiple sclerosis for initial treatment (BENEFIT): Subgroup analysis (2006) (0)
- Title: Altered eigenvector centrality is related to local resting-state network functional connectivity in patients with longstanding type 1 diabetes mellitus (2017) (0)
- IC-P-093 Fluid registration derived hippocampal atrophy rates: Reliability and comparison with manual measures, a methodological approach (2006) (0)
- Physical activity levels in cognitively normal and cognitively impaired oldest-old and the association with dementia risk factors: a pilot study (2023) (0)
- EFFECT OF APOE ε2 ON REGIONAL GRAY MATTER ATROPHY AND CLINICAL PHENOTYPE IN ALZHEIMER’S DISEASE (2017) (0)
- Overlap of Neuroanatomical Involvement in Frontotemporal Dementia and Primary Psychiatric Disorders: A Meta-analysis (2022) (0)
- DIFFERENT COMBINATIONS OF DIAGNOSTIC TESTS DISCRIMINATE SPECIFIC SUBTYPES OF DEMENTIA (2018) (0)
- The role of the parahippocampal cortex in spatial memory: an fMRI Study (2001) (0)
- Correction to: Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis—a systematic review (2021) (0)
- 12. A correlative triad of clinical, gadolinium-DTPA-enhanced MRI and CSF myelin basic protein in multiple sclerosis patients treated with high dose intravenous methylprednisolone (1992) (0)
- Imaging signature of multiple sclerosis phenotypes in grey matter. (2016) (0)
- PS12 - 6. Selective cognitive decline is related to focal brain volume loss in type 1 diabetes patients with microangiopathy: a 4 year follow-up (2013) (0)
- Title: Brain structural and functional alterations in MOG antibody disease Authors (2020) (0)
- Tau‐first subtype of Alzheimer’s disease progression consistently identified through PET and CSF (2020) (0)
- A special thanks to our reviewers for 2013. (2014) (0)
- Vascular and amyloid pathologies in memory clinic patients: Synergetic or independent? (2015) (0)
- Normalized brain volume and white matter hyperintensities as determinants of cerebral blood flow in Alzheimer ’ s disease (2014) (0)
- Regional functional connectivity changes in AD and MCI: dual regression applied to resting state fMRI (2011) (0)
- Assessing underlying Alzheimer's disease pathology in MCI patients from the amsterdam dementia cohort by use of the predictad software tool (2015) (0)
- BEST COMBINATORIAL LOW-COST MARKERS TO PREDICT MCI CONVERSION: AN EMIF-AD FEDERATION STUDY (2017) (0)
- Towards an improved classification of relapsing demyelinating syndromes of the central nervous system in children (2016) (0)
- Response to the ‘Letter to the editor’—10.1007/s00234-022–02906-z (2022) (0)
- THE HIPPOCAMPAL BOUNDARY SHIFT INTEGRAL IS 70% MORE REPRODUCIBLE THAN OTHER ATROPHY ALGORITHMS (2014) (0)
- GREY MATTER CONNECTIVITY IS ASSOCIATED WITH THE RATE OF COGNITIVE DECLINE IN MILD COGNITIVE IMPAIRMENT (2017) (0)
- Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis. (2023) (0)
- ASSOCIATIONS BETWEEN CEREBROSPINAL FLUID NEURODEGENERATIVE MARKERS, NEUROFILAMENT-LIGHT AND TOTAL TAU AND CEREBROVASCULAR IMAGING MARKERS (2019) (0)
- Book review (1996) (0)
- Onset of clinical andMRI e ffi cacy of ocrelizumab in relapsing multiple sclerosis (0)
- , MD arterial spin labeling May contribute to the Prediction of cognitive Deterioration in healthy elderly individuals 1 (2015) (0)
- LONGITUDINAL DECREASES IN FUNCTIONAL CONNECTIVITY AND COGNITIVE DECLINE IN PARKINSON’S DISEASE (2014) (0)
- Genetic contribution to grey matter network disruptions and Alzheimer disease cerebrospinal fluid markers (2022) (0)
- Basal forebrain and hippocampus as predictors of conversion to Alzheimer’s disease in patients with mild cognitive impairment: A multicenter DTI and volumetry study (2015) (0)
- VCI: What's in a name?— Prevalence of vascular abnormalities on MRI in a memory clinic population (2012) (0)
- Plasma biomarkers predict amyloid pathology in cognitively normal monozygotic twins after 10 years (2023) (0)
- "Lesion filling" with LEAP method increases sensitivity to grey matter atrophy in MS (2011) (0)
- Short and long-term predictors of relapses or disability worsening in patients with multiple sclerosis in the phase 3 FREEDOMS and FREEDOMS II studies (2017) (0)
- Infratentorial and spinal cord lesions, cumulative predictors of disability? (2018) (0)
- ALEMTUZUMAB PERSISTENTLY SLOWS BRAIN VOLUME LOSS IN RRMS (2016) (0)
- Effects of MR based attenuation correction on clinical interpretation and quantification of [18F]flutemetamol scans: A comparison between PET/CT and PET/MR (2015) (0)
- Cerebral atrophy in dementia with Lewy bodies studied using voxel-based morphometry (2002) (0)
- A NOVEL NEUROIMAGING APPROACH TO CAPTURE COGNITIVE RESERVE (2016) (0)
- FDG-PET REVEALS DISTINCT HYPOMETABOLIC TRAJECTORIES IN COGNITIVELY DEFINED SUBGROUPS OF ALZHEIMER’S DISEASE (2019) (0)
- IC-P2-100: Diagnostic utility of cross-sectional and longitudinal hippocampal volumetry in memory clinic patients (2008) (0)
- O1-03-04 Relevance of temporo-parietal atrophy in MCI conversion to Alzheimer’s disease: A voxel-based morphometry study (2006) (0)
- Quantification of [18 F]florbetaben amyloid-PET imaging in a mixed memory clinic population: The ABIDE project. (2022) (0)
- Concerted alterations of functional connectivity and WM integrity in relationship to early amyloid deposition (2022) (0)
- Regional gray matter volumes changes in relapsing-remitting and secondary progressive multiple sclerosis - a longitudinal comparative voxel-based morphometry study (2010) (0)
- Scientific Exhibition Audiovisual and Informatique (1993) (0)
- How to Use This Book (2011) (0)
- Patterns of grey matter atrophy in patients with MS: a multivariate analysis using source-based morphometry (2019) (0)
- POSTERIOR ATROPHY SCALE: NORMATIVE VALUES FOR ITALIAN POPULATION (2018) (0)
- CHAPTER 5 Amyloid-independent atrophy patterns predict time to progression to dementia in MCI (2017) (0)
- LOWER STRUCTURAL DEGREE AND HIGHER LOCAL EFFICIENCY RELATED TO DIFFUSE AMYLOID-BETA LOAD IN CORTEX OF NON-NEUROLOGICAL AGED DONORS (2018) (0)
- 456 Qualitative assessment of cerebral atrophy on MRI. Inter- and intro-observer reliability in dementia and normal aging (1996) (0)
- P18.02 Comparing quality of glioblastoma resections between care teams (2016) (0)
- [P1–291]: WITHDRAWN (2017) (0)
- Cognitive decline in multiple sclerosis is associated with structural network disruption - a single-subject network approach (2016) (0)
- Correction: Prognostic implications of a carefully performed neurological assessment in patients with a first event suggestive of multiple sclerosis (2011) (0)
- Impact of gradient number and voxel size on DTI tractography for resective brain surgery (2017) (0)
- Neuroimaging in Dementia: A Clinical Approach (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Frederik Barkhof?
Frederik Barkhof is affiliated with the following schools:
